Processing 00000000.tx.1: Desensitization of Mitochondrial Ca2+ and Insulin Secretion Responses in the Beta Cell* Pierre Maechler, Eleanor D. 

Phrase: "Desensitization of Mitochondrial Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0178702:Desensitization [Therapeutic or Preventive Procedure]
   770   C1709852:Desensitization [Molecular Function]

Phrase: "and"

Phrase: "Insulin Secretion Responses in the Beta Cell"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0871261:responses [Organism Attribute]
   714 E C1704632:Response [Finding]
   714 E C1706817:Response [Intellectual Product]
   714 E C2911692:Response [Mental Process]

Phrase: "* Pierre Maechler,"

Phrase: "Eleanor D."
Processing 00000000.tx.2: Kennedy, Haiyan Wang, and Claes B. 

Phrase: "Kennedy,"

Phrase: "Haiyan Wang,"

Phrase: "and"

Phrase: "Claes B."
Processing 00000000.tx.3: Wollheim From the Division of Clinical Biochemistry, Department of Internal Medicine, University Medical Center, CH-1211 Geneva 4,Switzerland  ABSTRACT Top Abstract Introduction Procedures Results Discussion References The role of mitochondria in the desensitization of insulin secretion was investigated. 

Phrase: "Wollheim From the Division of Clinical Biochemistry,"

Phrase: "Department of Internal Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "University Medical Center,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]
   901   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   901   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   827   C0041740:University [Manufactured Object,Organization]
   827   C0205099:Center [Spatial Concept]
   827   C0205476:Medical [Functional Concept]

Phrase: "CH-1211 Geneva 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0558269:Ch. [Professional or Occupational Group]
   812   C1552984:[Ch] [Quantitative Concept]

Phrase: "Switzerland  ABSTRACT Top Abstract Introduction Procedures Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The role of mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in the desensitization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0178702:Desensitization [Therapeutic or Preventive Procedure]
  1000   C1709852:Desensitization [Molecular Function]

Phrase: "of insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "investigated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]
Processing 00000000.tx.4: In rat pancreatic beta cells, both insulin secretion and mitochondrial [Ca2+] increases were desensitized following two challenges with the mitochondrial substrate methyl succinate. 

Phrase: "In rat pancreatic beta cells,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   923   C0030281:Pancreatic beta Cells [Cell]
           Beta cell
   812   C0007634:Cells [Cell]
   812   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   812   C0330390:Beta [Plant]
   812   C0439096:Beta [Intellectual Product]
   812   C2004068:Beta [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "both insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "mitochondrial"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026237:Mitochondrial [Cell Component]
  1000   C0521451:Mitochondrial [Functional Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "] increases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:increases [Functional Concept]

Phrase: "were"

Phrase: "desensitized"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "two challenges with the mitochondrial substrate methyl succinate."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   744   C0805586:challenges [Health Care Activity]
   711 E C0798503:Challenge [Clinical Attribute]
   711 E C3274764:Challenge [Conceptual Entity]
Processing 00000000.tx.5: In the beta cell line INS-1, similar results were observed when a 5-min interval separated two 5-min pulses. 

Phrase: "In the beta cell line"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0007600:Cell Line [Cell]
   827   C0205132:Line [Spatial Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]
   734   C0030281:Beta cell [Cell]

Phrase: "INS-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "when"

Phrase: "a 5-min interval"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]

Phrase: "separated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086972:Separated [Finding]
  1000   C0443299:separated [Spatial Concept]
  1000   C0687118:Separated [Functional Concept]

Phrase: "two 5-min pulses."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0034107:Pulses [Health Care Activity]
   812   C0391850:PULSES [Physiologic Function]
   779 E C0232117:PULSE [Clinical Attribute]
   779 E C1947910:Pulse [Phenomenon or Process]
Processing 00000000.tx.6: In contrast, ATP generation monitored in luciferase-expressing INS-1 cells was stimulated to the same extent during both exposures to methyl succinate. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "ATP generation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0079411:Generation [Temporal Concept]
   861   C3146294:Generation [Activity]
   768 E C1414672:Genesis [Gene or Genome]
   768 E C2984892:Genesis [Gene or Genome]

Phrase: "monitored in luciferase-expressing"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   737   C0030695:monitor [Health Care Activity]
   737   C0150369:monitor [Health Care Activity]
   737   C0181904:Monitor [Medical Device]
   737   C0596972:Monitor [Medical Device]
   737   C1521743:Monitor [Professional or Occupational Group]
   737   C1704646:Monitor [Manufactured Object]

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "stimulated to the same extent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439792:Extent [Spatial Concept]
   760   C0445247:Same [Qualitative Concept]
   760   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "during both exposures"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0274281:exposures [Injury or Poisoning]
  1000   C0728853:exposures [Phenomenon or Process]
   966 E C0332157:Exposure [Clinical Attribute]

Phrase: "to methyl succinate."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0066765:methyl succinate [Organic Chemical]
   861   C0038617:succinate [Organic Chemical]
   861   C0220918:succinate [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.7: Succinate, like -glycerophosphate, activates the electron transport chain at complex II. 

Phrase: "Succinate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038617:succinate [Organic Chemical]
  1000   C0220918:succinate [Organic Chemical,Pharmacologic Substance]

Phrase: "like -glycerophosphate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017881:glycerophosphate [Carbohydrate,Lipid]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the electron transport chain at complex II."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   814   C2244392:electron transport chain [Molecular Function]
   748   C0337112:Chain [Manufactured Object]
   748   C1524075:Chain [Idea or Concept]
Processing 00000000.tx.8: As a consequence, the mitochondrial membrane hyperpolarizes, promoting ATP synthesis and Ca2+ influx into the mitochondria through the uniporter. 

Phrase: "As a consequence,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0686907:Consequence [Functional Concept]

Phrase: "the mitochondrial membrane"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0596952:Mitochondrial membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "hyperpolarizes"

Phrase: ","

Phrase: "promoting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promoting [Activity]

Phrase: "ATP synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1157223:ATP synthesis [Molecular Function]
  1000   C1510700:ATP Synthesis [Functional Concept]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "and"

Phrase: "Ca2+ influx into the mitochondria"

Phrase: "through the uniporter."
Processing 00000000.tx.9: The mitochondrial desensitization was further studied in permeabilized INS-1 cells. 

Phrase: "The mitochondrial desensitization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0178702:Desensitization [Therapeutic or Preventive Procedure]
   861   C1709852:Desensitization [Molecular Function]

Phrase: "was"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "studied in permeabilized"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0557651:Study [Manufactured Object]
   756   C2603343:Study [Research Activity]

Phrase: "INS-1 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.10: Increasing extramitochondrial [Ca2+] from 100to 500nM enhanced succinate oxidation 4-fold. 

Phrase: "Increasing extramitochondrial"

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]"

Phrase: "from 100to 500nM"

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "succinate oxidation 4-fold."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332462:Fold [Spatial Concept]
   812   C1880834:FOLD [Phenomenon or Process]
Processing 00000000.tx.11: At 500 nM Ca2+, 1mM succinate caused a blunted mitochondrial [Ca2+] increase upon the second, compared with the first, stimulation. 

Phrase: "At 500 nM Ca2+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "1mM succinate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0038617:succinate [Organic Chemical]
   861   C0220918:succinate [Organic Chemical,Pharmacologic Substance]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a blunted mitochondrial"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026237:Mitochondrial [Cell Component]
   861   C0521451:Mitochondrial [Functional Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]"

Phrase: "increase upon the second,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0205436:Second [Quantitative Concept]
   770   C0442805:Increase [Functional Concept]
   770   C0457385:Second [Temporal Concept]
   770   C0565930:/second [Quantitative Concept]
   770   C1561503:second [Idea or Concept]
   770   C1705190:Second [Qualitative Concept]
   715 E C1517378:Gain [Quantitative Concept]

Phrase: "compared with the first,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205435:First [Quantitative Concept]
   770   C1279901:First [Qualitative Concept]
   770   C1707455:Compared [Activity]

Phrase: "stimulation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292856:Stimulation [Therapeutic or Preventive Procedure]
  1000   C1948023:Stimulation [Natural Phenomenon or Process]
Processing 00000000.tx.12: These effects were mimicked by -glycerophosphate, and there was cross-desensitization between the two compounds. 

Phrase: "These effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "were"

Phrase: "mimicked by -glycerophosphate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0017881:glycerophosphate [Carbohydrate,Lipid]

Phrase: "and"

Phrase: "there"

Phrase: "was"

Phrase: "cross-desensitization between the two compounds."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0178702:Desensitization [Therapeutic or Preventive Procedure]
   753   C1709852:Desensitization [Molecular Function]
   753   C2828360:Cross [Conceptual Entity]
Processing 00000000.tx.13: Succinate hyperpolarized the mitochondrial membrane during both the first and second applications. 

Phrase: "Succinate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038617:succinate [Organic Chemical]
  1000   C0220918:succinate [Organic Chemical,Pharmacologic Substance]

Phrase: "hyperpolarized"

Phrase: "the mitochondrial membrane during both"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0596952:Mitochondrial membrane [Cell Component]
   760   C0025255:Membrane [Tissue]
   760   C0596901:Membrane [Cell Component]
   760   C1706182:Membrane [Manufactured Object]

Phrase: "the first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "and"

Phrase: "second applications."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0185125:applications [Health Care Activity]
   827 E C1947919:Application [Intellectual Product]
   827 E C2347934:Application [Intellectual Product]
   827 E C3539080:APPLICATION [Quantitative Concept]
Processing 00000000.tx.14: This suggests that the uniporter itself, rather than the respiratory chain, is desensitized. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the uniporter"

Phrase: "itself,"

Phrase: "rather than"

Phrase: "the respiratory chain,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162362:Respiratory Chain [Molecular Function]
  1000   C1325653:respiratory chain [Cell Component]
   861   C0337112:Chain [Manufactured Object]
   861   C1524075:Chain [Idea or Concept]

Phrase: "is"

Phrase: "desensitized."
Processing 00000000.tx.15: These results emphasize the key role of the mitochondria not only in the stimulation of insulin secretion, but also in its desensitization.  

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "emphasize"

Phrase: "the key role of the mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "not only in the stimulation of insulin secretion,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   833   C2245393:stimulation of insulin secretion [Cell Function]
   793   C2259155:stimulation of secretion [Cell Function]
   770   C1256369:insulin secretion [Cell Function]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0036536:secretion [Biologic Function]
   744   C0036537:Secretion [Body Substance]
   744   C0205171:Only [Quantitative Concept]
   744   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   744   C1518422:Not [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1720467:Only [Intellectual Product]
   744   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "but"

Phrase: "also in its desensitization."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0178702:Desensitization [Therapeutic or Preventive Procedure]
   770   C1709852:Desensitization [Molecular Function]
Processing 00000000.tx.16: INTRODUCTION Top Abstract Introduction Procedures Results Discussion References Desensitization is a common feature of cell biology in general and of insulin secretion in particular. 

Phrase: "INTRODUCTION Top Abstract Introduction Procedures Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Desensitization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0178702:Desensitization [Therapeutic or Preventive Procedure]
  1000   C1709852:Desensitization [Molecular Function]

Phrase: "is"

Phrase: "a common feature of cell biology"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C1562749:Cell feature [Organism Attribute]
   753   C1521970:Feature [Qualitative Concept]
   753   C1706388:Feature [Conceptual Entity]
   753   C2346469:Feature [Qualitative Concept]
   753   C2348519:Feature [Qualitative Concept]

Phrase: "in general"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205246:General [Spatial Concept]
  1000   C1553889:General [Idea or Concept]

Phrase: "and of insulin secretion"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C1256369:insulin secretion [Cell Function]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]
   770   C1515981:And [Idea or Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in particular."
Processing 00000000.tx.17: However, the molecular mechanism of desensitization toward nutrient stimuli is poorly understood. 

Phrase: "However,"

Phrase: "the molecular mechanism of desensitization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "toward nutrient stimuli"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0234402:Stimuli [Phenomenon or Process]

Phrase: "is"

Phrase: "poorly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205169:Poorly [Qualitative Concept]

Phrase: "understood."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0162340:Understand [Mental Process]
Processing 00000000.tx.18: Nesher and Cerasi (1) first observed that successive short stimuli with glucose or arginine in the isolated perfused rat pancreas resulted in the inhibition of the insulin secretory response to the second stimulus. 

Phrase: "Nesher"

Phrase: "and"

Phrase: "Cerasi"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that successive short stimuli with glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0234402:Stimuli [Phenomenon or Process]

Phrase: "or"

Phrase: "arginine in the isolated perfused rat pancreas"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "resulted in the inhibition of the insulin secretory response"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   762   C1510574:Response Inhibition [Mental Process]
   762   C3463820:Response Inhibition [Activity]
           Inhibition
   742   C0021467:Inhibition [Mental Process]
   742   C0021469:Inhibition [Molecular Function]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0871261:Response [Organism Attribute]
   742   C1327616:Secretory [Cell Function]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C1704632:Response [Finding]
   742   C1706817:Response [Intellectual Product]
   742   C2911692:Response [Mental Process]
   708   C1274040:Result [Functional Concept]
   708   C1546471:Result [Idea or Concept]
   708   C2825142:Result [Finding]

Phrase: "to the second stimulus."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0234402:Stimulus [Phenomenon or Process]
Processing 00000000.tx.19: Insensitivity of the pancreatic beta cell to glucose was reported in pancreata taken from hyperglycemic rats (2) and is found in several diabetic animal models (3). 

Phrase: "Insensitivity of the pancreatic beta cell"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0237677:Insensitivity [Finding]

Phrase: "to glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "was"

Phrase: "reported in pancreata"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C3496591:Reported [Clinical Attribute]
   756   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   756   C1278931:Pancreas [Body Part, Organ, or Organ Component]
   756 E C3273238:Report [Intellectual Product]

Phrase: "taken from hyperglycemic rats"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0034693:rats [Mammal]
   770   C0034721:Rats [Mammal]
   770   C1883727:Taken [Conceptual Entity]
   737 E C1515187:Take [Health Care Activity]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "is"

Phrase: "found in several diabetic animal models"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0599779:Models, Animal [Animal]
   753   C0003062:Animal [Animal]
   753   C0150312:Found [Quantitative Concept]
   753   C0241863:DIABETIC [Finding]
   753   C3161035:Models [Intellectual Product]
   719 E C0243095:Find [Finding]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.20: A reduced responsiveness of the pancreatic beta cell to glucose has also been described after prolonged exposure of beta cells to hexose in vitro (4, 5) or in human subjects (6). 

Phrase: "A reduced responsiveness of the pancreatic beta cell"

Phrase: "to glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "described after prolonged exposure of beta cells to hexose"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   762   C0332157:Exposure to [Clinical Attribute]
           Exposure
   742   C0007634:Cells [Cell]
   742   C0019494:Hexose [Carbohydrate]
   742   C0274281:Exposure, NOS [Injury or Poisoning]
   742   C0330390:Beta [Plant]
   742   C0439096:Beta [Intellectual Product]
   742   C0439590:Prolonged [Temporal Concept]
   742   C1552738:described [Idea or Concept]
   742   C2004068:Beta [Qualitative Concept]
   742   C3282337:Cells [Cell]
   731   C0030281:Beta cell [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "or in human subjects"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0178693:human subjects [Research Activity]
   770   C0086418:Human [Human]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.21: This desensitization phenomenon is distinguished from glucose toxicity, the latter being irreversible, whereas the former implies a reversible state of cellular refractoriness due to repeated exposures to an agonist (7). 

Phrase: "This desensitization phenomenon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1882365:Phenomenon [Phenomenon or Process]

Phrase: "is"

Phrase: "distinguished from glucose toxicity,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C0040539:toxicity [Qualitative Concept]
   770   C0600688:Toxicity [Injury or Poisoning]

Phrase: "the latter"

Phrase: "being"

Phrase: "irreversible,"

Phrase: "whereas"

Phrase: "the former"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205156:Former [Temporal Concept]
  1000   C0750523:FORMER [Idea or Concept]

Phrase: "implies"

Phrase: "a reversible state of cellular refractoriness"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1301808:State [Geographic Area]
   753   C1442792:State [Functional Concept]
   753   C3148680:State [Geographic Area]

Phrase: "due to repeated exposures"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0274281:exposures [Injury or Poisoning]
   861   C0728853:exposures [Phenomenon or Process]
   827 E C0332157:Exposure [Clinical Attribute]

Phrase: "to an agonist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987634:Agonist [Pharmacologic Substance]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.22: Desensitization can occur at any of the multiple steps coupling glucose recognition to insulin secretion, including the exocytotic process itself, as shown in permeabilized cells exposed to repeated Ca2+ pulses (8). 

Phrase: "Desensitization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0178702:Desensitization [Therapeutic or Preventive Procedure]
  1000   C1709852:Desensitization [Molecular Function]

Phrase: "can"

Phrase: "occur at any of the multiple steps"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   748   C0439064:Multiple [Quantitative Concept]
   748   C1261552:steps [Conceptual Entity]
   748   C1709305:Occur [Activity]
   748   C2745955:OCCUR [Temporal Concept]
   714 E C1704379:Step [Functional Concept]
   714 E C1705117:Step [Quantitative Concept]
   714 E C2825408:Step [Manufactured Object]

Phrase: "coupling"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1948027:Coupling [Functional Concept]
   966 E C0010222:couple [Family Group]

Phrase: "glucose recognition to insulin secretion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0524637:Recognition [Mental Process]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the exocytotic process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]

Phrase: "itself,"

Phrase: "as"

Phrase: "shown in permeabilized cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737   C1547282:Show [Intellectual Product]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "exposed to repeated Ca2+ pulses"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0332157:Exposed to [Clinical Attribute]
           Exposed
   760   C0034107:Pulses [Health Care Activity]
   760   C0205341:Repeated [Functional Concept]
   760   C0391850:PULSES [Physiologic Function]
   760   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   726 E C0232117:PULSE [Clinical Attribute]
   726 E C1947910:Pulse [Phenomenon or Process]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.23: In the pancreatic beta cell, mitochondrial metabolism plays a pivotal role in the generation of signals coupling glucose recognition to insulin secretion (9-13). 

Phrase: "In the pancreatic beta cell,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0030281:Pancreatic beta cell [Cell]
           Beta cell
   827   C0007634:Cell [Cell]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   827   C2004068:Beta [Qualitative Concept]

Phrase: "mitochondrial metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a pivotal role in the generation of signals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "coupling"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1948027:Coupling [Functional Concept]
   966 E C0010222:couple [Family Group]

Phrase: "glucose recognition to insulin secretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0524637:Recognition [Mental Process]

Phrase: "(9-13"

Phrase: ")."
Processing 00000000.tx.24: The main trigger of exocytosis is an increase in cytosolic Ca2+ concentration (for a review, see Ref. 12). 

Phrase: "The main trigger of exocytosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0032930:Trigger [Clinical Attribute]
   760   C1444748:Trigger [Qualitative Concept]

Phrase: "is"

Phrase: "an increase in cytosolic Ca2+ concentration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "("

Phrase: "for a review,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Ref. 12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.25: In addition, Ca2+ controls several other cellular functions, among them mitochondrial metabolism (14-16). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "several"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439064:Several [Quantitative Concept]
  1000   C0443302:Several [Quantitative Concept]

Phrase: "other cellular functions,"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   983   C0007613:Cellular Function [Cell Function]
   861   C0542341:Functions [Functional Concept]
   827 E C0031843:function [Physiologic Function]
   827 E C0700205:FUNCTION [Classification]
   827 E C1705273:Function [Intellectual Product]
   777 E C0205245:Functional [Functional Concept]
   777 E C2700217:Functional [Conceptual Entity]

Phrase: "among them mitochondrial metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "(14-16"

Phrase: ")."
Processing 00000000.tx.26: An increase in mitochondrial Ca2+ concentration ([Ca2+]m),1 following an elevation in cytosolic Ca2+ concentration ([Ca2+]c), participates in the activation of the respiratory chain through stimulation of Ca2+-sensitive NADH-generating dehydrogenases (15-20). 

Phrase: "An increase in mitochondrial Ca2+ concentration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "("

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]"

Phrase: "m),"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "an elevation in cytosolic Ca2+ concentration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439775:Elevation [Therapeutic or Preventive Procedure]
   753   C0702240:Elevation [Spatial Concept]

Phrase: "("

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "participates in the activation of the respiratory chain"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0162362:Respiratory Chain [Molecular Function]
   770   C1325653:respiratory chain [Cell Component]
   744   C0337112:Chain [Manufactured Object]
   744   C0521346:respiratory [Functional Concept]
   744   C1524075:Chain [Idea or Concept]
   744   C1546767:Respiratory [Intellectual Product]
   744   C1879547:Activation [Activity]

Phrase: "through stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292856:Stimulation [Therapeutic or Preventive Procedure]
  1000   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "of Ca2+-sensitive NADH-generating dehydrogenases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   836   C0027293:NADH Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0030016:Dehydrogenases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(15-20"

Phrase: ")."
Processing 00000000.tx.27: NADH and FADH2 transfer reducing equivalents to the respiratory chain, thereby ensuring adequate ATP synthesis (15). 

Phrase: "NADH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027289:NADH [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "and"

Phrase: "FADH2 transfer reducing equivalents to the respiratory chain,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0439185:Equivalents [Quantitative Concept]
   711 E C0205163:Equivalent [Qualitative Concept]

Phrase: "thereby"

Phrase: "ensuring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0218063:Ensure [Food]

Phrase: "adequate ATP synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1157223:ATP synthesis [Molecular Function]
   901   C1510700:ATP Synthesis [Functional Concept]
   827   C0220781:synthesis [Biologic Function]
   827   C1883254:Synthesis [Activity]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.28: Transfer of reducing equivalents to the electron transport chain increases the mitochondrial membrane potential (m), which enhances the driving force for mitochondrial Ca2+ uptake mediated by a low affinity uniporter (21). 

Phrase: "Transfer of reducing equivalents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040671:Transfer [Mental Process]
   770   C1705822:Transfer [Activity]

Phrase: "to the electron transport chain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2244392:electron transport chain [Molecular Function]
   827   C0337112:Chain [Manufactured Object]
   827   C1524075:Chain [Idea or Concept]
   734   C0013846:Electron Transport [Molecular Function]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the mitochondrial membrane potential"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C1720920:Membrane Potential, Mitochondrial [Cell Function]
   901   C0025251:Membrane Potential [Cell Function]
   901   C0596952:Mitochondrial membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   827   C3245505:Potential [Qualitative Concept]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "("

Phrase: "m)"

Phrase: ","

Phrase: "which"

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the driving force for mitochondrial Ca2+ uptake"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0441722:Force [Phenomenon or Process]
   748   C0563538:Force [Phenomenon or Process]
   746   C3494415:Mitochondrial Dynamic [Cell Function]

Phrase: "mediated by a low affinity uniporter"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C0205251:low [Qualitative Concept]
   753   C1299352:Low [Qualitative Concept]
   753   C1510827:Affinity [Natural Phenomenon or Process]
   753   C1550472:low [Idea or Concept]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.29: This m-dependent Ca2+ entry permits an amplification of [Ca2+]m, relative to [Ca2+]c, further favoring the stimulation of the aforementioned dehydrogenases (22, 23). 

Phrase: "This"

Phrase: "m-"

Phrase: "dependent Ca2+ entry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1705654:Entry [Intellectual Product]

Phrase: "permits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0023636:Permit [Regulation or Law]
  1000   C0329040:Permit [Fish]

Phrase: "an amplification of [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "relative to [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "favoring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309049:favoring [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "the stimulation of the aforementioned dehydrogenases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   753   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "(22,"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.30: On the other hand, the hyperpolarization of the mitochondrial membrane exerts a negative feedback by lowering the oxygen consumption and the rate of H+ cycling (24, 25). 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "the hyperpolarization of the mitochondrial membrane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   783   C2262820:membrane hyperpolarization [Cell Function]

Phrase: "exerts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "a negative feedback by lowering"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0015744:Feedback [Phenomenon or Process]
   760   C0205160:Negative [Qualitative Concept]
   760   C1513916:Negative [Finding]
   760   C2825415:Negative [Conceptual Entity]
   760   C2825491:Negative [Qualitative Concept]
   760   C2911691:Feedback [Mental Process]

Phrase: "the oxygen consumption"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0030055:Oxygen Consumption [Clinical Attribute]
  1000   C1305742:oxygen consumption [Diagnostic Procedure]
   861   C0009830:Consumption [Activity]
   861   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1947907:Consumption [Physiologic Function]

Phrase: "and"

Phrase: "the rate of H+ cycling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "(24,"

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.31: In glucose-stimulated beta cells, insulin secretion is initiated by the activation of mitochondrial metabolism, leading to an increase in [Ca2+]c (10, 26, 27). 

Phrase: "In glucose-stimulated beta cells,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   827   C0030281:Beta cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0330390:Beta [Plant]
   812   C0439096:Beta [Intellectual Product]
   812   C2004068:Beta [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "initiated by the activation of mitochondrial metabolism,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0025519:Metabolism [Organism Function]
   748   C0025520:metabolism [Functional Concept]
   748   C0026237:Mitochondrial [Cell Component]
   748   C0521451:Mitochondrial [Functional Concept]
   748   C1879547:Activation [Activity]
   714   C1548602:Initiate [Idea or Concept]
   714   C1704686:Initiate [Functional Concept]

Phrase: "leading to an increase in [Ca2+"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   753   C0332152:Leading [Temporal Concept]
   753   C0442805:Increase [Functional Concept]
   753   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1522538:Leading [Functional Concept]
   719 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   719 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   719 E C2348269:Lead [Element, Ion, or Isotope]
   719 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "]c (10,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "26,"

Phrase: "27"

Phrase: ")."
Processing 00000000.tx.32: Subsequently, the rise in [Ca2+]m appears to be essential for the maintenance of metabolism-secretion coupling (12, 13). 

Phrase: "Subsequently,"

Phrase: "the rise in [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "essential for the maintenance of metabolism-secretion coupling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205224:Essential [Qualitative Concept]

Phrase: "(12,"

Phrase: "13"

Phrase: ")."
Processing 00000000.tx.33: The partial reduction of glucose oxidation by blockade of the [Ca2+]c increase (17, 28) may reflect a need for permissive [Ca2+]c levels in optimal glucose-stimulated insulin secretion (29). 

Phrase: "The partial reduction of glucose oxidation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0030012:Oxidation-Reduction [Molecular Function]
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "by blockade"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332206:Blockade [Functional Concept]
  1000   C3540676:Blockade [Pharmacologic Substance]

Phrase: "of the [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]

Phrase: "(17,"

Phrase: "28"

Phrase: ")"

Phrase: "may"

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "a need for permissive"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0027552:Need [Qualitative Concept]
   770   C0686904:need [Functional Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c levels in optimal glucose-stimulated insulin secretion"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   767   C0202098:insulin levels [Laboratory Procedure]
   767   C0428405:insulin levels [Laboratory or Test Result]
   767   C0428548:glucose levels [Laboratory or Test Result]
   750 E C0337438:glucose level [Laboratory Procedure]
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.34: Using cells stably expressing the calcium-sensitive photoprotein aequorin targeted to the mitochondria, we have previously shown that desensitization of insulin secretion is associated with a parallel loss of the [Ca2+]m response (23). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "cells stably"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "the calcium-sensitive photoprotein aequorin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0001694:Aequorin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "targeted to the mitochondria,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0026237:Mitochondria [Cell Component]
   770   C1521840:Targeted [Functional Concept]
   737 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "we"

Phrase: "have"

Phrase: "previously"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that desensitization of insulin secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0178702:Desensitization [Therapeutic or Preventive Procedure]
   760   C1709852:Desensitization [Molecular Function]

Phrase: "is"

Phrase: "associated with a parallel loss of the [Ca2+"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   744   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C1517945:Loss [Quantitative Concept]
   744   C2348042:Parallel [Qualitative Concept]
   744   C2826345:PARALLEL [Research Activity]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "]m response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.35: These findings and other recent studies point to a pivotal role for the mitochondria in metabolism-secretion coupling (11, 17, 20, 30-32), not only as a relay in the metabolic cascade, but also as a primary source of an as yet unidentified factor triggering insulin exocytosis (13). 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "and"

Phrase: "other recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "point to a pivotal role"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C2924612:Point A [Body Location or Region]
   760   C0035820:Role [Social Behavior]
   760   C1552961:Point [Quantitative Concept]
   760   C1705810:Role [Conceptual Entity]
   760   C2347617:point [Quantitative Concept]

Phrase: "for the mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "in metabolism-secretion coupling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1948027:Coupling [Functional Concept]

Phrase: "(11,"

Phrase: "17,"

Phrase: "20,"

Phrase: "30-32"

Phrase: ")"

Phrase: ","

Phrase: "not only as a relay"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205171:Only [Quantitative Concept]
   760   C1518422:Not [Functional Concept]
   760   C1709893:Relay [Medical Device]
   760   C1720467:Only [Intellectual Product]

Phrase: "in the metabolic cascade,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1707310:Cascade [Manufactured Object]

Phrase: "but"

Phrase: "also as a primary source of an as yet unidentified factor"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   754   C0960756:factor A [Organic Chemical]
   754   C1547939:Source, Unidentified [Intellectual Product]
   738   C0205225:Primary [Qualitative Concept]
   738   C0205427:Unidentified [Qualitative Concept]
   738   C0439631:Primary [Therapeutic or Preventive Procedure]
   738   C0449416:Source [Finding]
   738   C1521761:Factor [Functional Concept]
   738   C1705919:Source [Idea or Concept]
   738   C2827422:Factor [Conceptual Entity]

Phrase: "triggering"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0032930:Trigger [Clinical Attribute]
   966   C1444748:Trigger [Qualitative Concept]

Phrase: "insulin exocytosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015283:Exocytosis [Cell Function]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.36: The existence of this putative mitochondrial factor is further suggested by studies showing impaired glucose-stimulated insulin secretion in insulinoma cells depleted of the mitochondrial genome (33, 34). 

Phrase: "The existence of this putative mitochondrial factor"

Phrase: "is"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "suggested by studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0947630:studies [Laboratory Procedure]
   756 E C0557651:Study [Manufactured Object]
   756   C1705535:Suggest [Idea or Concept]
   756 E C2603343:Study [Research Activity]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "impaired glucose-stimulated insulin secretion in insulinoma cells"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C1256369:insulin secretion [Cell Function]
   767   C1719133:Glucose/Insulin [Quantitative Concept]
   750   C0030281:Insulin Cell [Cell]
   750   C1327616:Cell secretion [Cell Function]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0036536:secretion [Biologic Function]
   744   C0036537:Secretion [Body Substance]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]

Phrase: "depleted of the mitochondrial genome"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1819716:Genome, Mitochondrial [Gene or Genome]
   760   C0017428:Genome [Gene or Genome]
   760   C0026237:Mitochondrial [Cell Component]
   760   C0333668:Depleted [Functional Concept]
   760   C0521451:Mitochondrial [Functional Concept]
   760   C2338314:Genome [Conceptual Entity]

Phrase: "(33,"

Phrase: "34"

Phrase: ")."
Processing 00000000.tx.37: To study the involvement of the mitochondria in the desensitization process, we have monitored insulin secretion and three parameters that reflect mitochondrial activation: 1) m using the fluorescent probe rhodamine 123,2) [Ca2+]m employing a cell line stably expressing mitochondrial aequorin, and 3) generation of ATP using a cell line stably expressing cytosolic luciferase. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the involvement of the mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1314939:Involvement [Functional Concept]

Phrase: "in the desensitization process,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]

Phrase: "we"

Phrase: "have"

Phrase: "monitored insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C1256369:insulin secretion [Cell Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "three parameters"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0449381:Parameters [Finding]
   827 E C0549193:Parameter [Spatial Concept]
   827 E C1704769:Parameter [Conceptual Entity]
   827 E C2350001:Parameter [Quantitative Concept]

Phrase: "that"

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "mitochondrial activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the fluorescent probe rhodamine 123,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0073192:Rhodamine 123 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   812   C0600322:Rhodamine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "employing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:employing [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "a cell line stably"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007600:Cell Line [Cell]
   812   C0205132:Line [Spatial Concept]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]

Phrase: "expressing"

Phrase: "mitochondrial aequorin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001694:Aequorin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "generation of ATP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0079411:Generation [Temporal Concept]
   790   C3146294:Generation [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a cell line stably"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007600:Cell Line [Cell]
   812   C0205132:Line [Spatial Concept]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]

Phrase: "expressing"

Phrase: "cytosolic luciferase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.38: The tricarboxylic acid cycle intermediate succinate was used as a mitochondrial substrate. 

Phrase: "The tricarboxylic acid cycle intermediate succinate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0038617:succinate [Organic Chemical]
   804   C0220918:succinate [Organic Chemical,Pharmacologic Substance]
   717   C0008858:Tricarboxylic Acid Cycle [Molecular Function]

Phrase: "was"

Phrase: "used as a mitochondrial substrate."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0026237:Mitochondrial [Cell Component]
   760   C0521451:Mitochondrial [Functional Concept]
   760   C1273517:used [Finding]
   760   C1710236:Substrate [Manufactured Object]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.39: Some of these experiments were performed in cells isolated from rat islets, whereas the remainder were in cells derived from the rat insulinoma cell line INS-1 (35). 

Phrase: "Some of these experiments"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0205392:Some [Quantitative Concept]
   770   C0681814:Experiments [Research Activity]
   770   C3540770:Some [Intellectual Product]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "were"

Phrase: "performed in cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C0884358:Performed [Functional Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "isolated from rat islets,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0034693:Rat, NOS [Mammal]
   770   C0034721:Rat [Mammal]
   770   C0205409:Isolated [Functional Concept]
   770   C1548221:Isolated [Idea or Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "whereas"

Phrase: "the remainder"

Phrase: "were in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "derived from the rat insulinoma cell line"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   804   C1514733:Rat Cell Line [Cell]
   778   C0007600:Cell Line [Cell]
   748   C0007634:Cell [Cell]
   748   C0021670:insulinoma [Neoplastic Process]
   748   C0034693:Rat, NOS [Mammal]
   748   C0034721:Rat [Mammal]
   748   C0205132:Line [Spatial Concept]
   748   C1269647:Cell [Cell]
   748   C1441547:Derived [Qualitative Concept]
   748   C1550648:Line [Substance]
   748   C1552960:Line [Quantitative Concept]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C3245521:derived [Idea or Concept]

Phrase: "INS-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.40: To study the dissociation between the [Ca2+]m signal and ATP generation, experiments were performed in Staphylococcus -toxin-permeabilized INS-1 cells, which permits the control of the mitochondrial environment with respect to cytosolic [Ca2+] and [ATP] (13). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the dissociation between the [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0086168:Dissociation [Mental or Behavioral Dysfunction]

Phrase: "]m signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "and"

Phrase: "ATP generation,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0079411:Generation [Temporal Concept]
   861   C3146294:Generation [Activity]
   768 E C1414672:Genesis [Gene or Genome]
   768 E C2984892:Genesis [Gene or Genome]

Phrase: "experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed in Staphylococcus -toxin-permeabilized"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0040548:Staphylococcus toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   760   C0038170:Staphylococcus [Bacterium]
   760   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   760   C0884358:Performed [Functional Concept]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "INS-1 cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "which"

Phrase: "permits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0023636:Permit [Regulation or Law]
  1000   C0329040:Permit [Fish]

Phrase: "the control of the mitochondrial environment"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: "with respect to cytosolic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosolic [Cell Component]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]"

Phrase: "and ["

Phrase: "ATP"

Phrase: "]"

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.41: The results show that [Ca2+]m increases and insulin secretion are strongly desensitized by mitochondrial substrates, whereas generation of ATP and m activation are not. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m increases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:increases [Functional Concept]

Phrase: "and"

Phrase: "insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "are"

Phrase: "strongly"

Phrase: "desensitized by mitochondrial substrates,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0026237:Mitochondrial [Cell Component]
   770   C0521451:Mitochondrial [Functional Concept]
   737   C1710236:Substrate [Manufactured Object]

Phrase: "whereas"

Phrase: "generation of ATP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0079411:Generation [Temporal Concept]
   790   C3146294:Generation [Activity]

Phrase: "and"

Phrase: "m activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "are"

Phrase: "not."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]
Processing 00000000.tx.42: The study provides evidence that the mitochondrial Ca2+ uniporter is desensitized, rather than the activation of the electron transport chain.  

Phrase: "The study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "the mitochondrial Ca2+ uniporter"

Phrase: "is"

Phrase: "desensitized"

Phrase: ","

Phrase: "rather than"

Phrase: "the activation of the electron transport chain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C2259159:activation of transport [Cell Function]
   748   C1879547:Activation [Activity]
Processing 00000000.tx.43: EXPERIMENTAL PROCEDURES Top Abstract Introduction Procedures Results Discussion References Cell Culture-- INS-1 cells were cultured in RPMI 1640medium as described previously (23, 35, 36). 

Phrase: "EXPERIMENTAL PROCEDURES Top Abstract Introduction Procedures Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Cell Culture"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0007585:Cell Culture [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "-"

Phrase: "-"

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured in RPMI 1640medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "35,"

Phrase: "36"

Phrase: ")."
Processing 00000000.tx.44: Stable clones of INS-1 cells expressing mitochondrial aequorin (22) were established (INS-1/EK3) as detailed elsewhere (23) and cultured in the presence of 250 g/ml G418 (Promega, Madison, WI) for continuous selection of cells expressing the plasmid with the associated neomycin resistance. 

Phrase: "Stable clones of"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0009013:Clones [Cell]
   756 E C1522642:Clone [Tissue]
   706 E C1704387:Clonal [Qualitative Concept]

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "mitochondrial aequorin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001694:Aequorin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(22"

Phrase: ")"

Phrase: "were"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "("

Phrase: "INS-1/EK3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0915156:EK3 [Amino Acid, Peptide, or Protein,Enzyme,Receptor]

Phrase: ")"

Phrase: "as"

Phrase: "detailed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522508:Detailed [Qualitative Concept]
   966 E C1561567:detail [Functional Concept]

Phrase: "elsewhere"

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "cultured in the presence of 250 g/ml G418"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   764   C1300565:g/mL [Quantitative Concept]
   762 E C1637390:mL/g [Quantitative Concept]
   742   C0052009:G418 [Antibiotic,Organic Chemical]
   742   C0392148:Presence [Therapeutic or Preventive Procedure]
   742   C0439267:g% [Quantitative Concept]
   742   C0439526:/mL [Quantitative Concept]
   708   C0010453:Culture [Idea or Concept]
   708   C0220814:culture [Functional Concept]
   708   C0430400:Culture [Laboratory Procedure]
   708   C2242979:Culture [Laboratory Procedure]

Phrase: "(Promega,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: "Madison,"

Phrase: "WI) for continuous selection of cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0043193:WI [Geographic Area]

Phrase: "expressing"

Phrase: "the plasmid with the associated neomycin resistance."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.45: Clonal INS-1 lines expressing cytosolic luciferase under the control of doxycycline-dependent transcriptional transactivator were established (INS-r3-LUC7) (36). 

Phrase: "Clonal INS-1 lines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1522642:Clonal [Tissue]
   770   C1704387:Clonal [Qualitative Concept]

Phrase: "expressing"

Phrase: "cytosolic luciferase under the control of doxycycline-dependent transcriptional transactivator"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]

Phrase: "were"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "("

Phrase: "INS-r3-LUC7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1416935:Luc7 [Gene or Genome]

Phrase: ")"

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.46: Following two successive stable transfections, resistant clones were cultured with 250g/ml G418 and 100g/ml hygromycin B (Calbiochem). 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "two successive stable transfections,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0040669:Transfections [Genetic Function,Molecular Biology Research Technique]

Phrase: "resistant clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0009013:Clones [Cell]
   827 E C1522642:Clone [Tissue]
   777 E C1704387:Clonal [Qualitative Concept]
   755 E C0796368:clonality [Diagnostic Procedure]

Phrase: "were"

Phrase: "cultured with 250g/ml G418"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0052009:G418 [Antibiotic,Organic Chemical]
   760   C0439526:/mL [Quantitative Concept]
   726   C0010453:Culture [Idea or Concept]
   726   C0220814:culture [Functional Concept]
   726   C0430400:Culture [Laboratory Procedure]
   726   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "100g/ml hygromycin B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020406:Hygromycin B [Carbohydrate,Pharmacologic Substance]
   812   C0063201:hygromycin [Organic Chemical]

Phrase: "(Calbiochem"

Phrase: ")."
Processing 00000000.tx.47: Pancreatic islet cells were isolated by collagenase digestion from male Wistar rats weighing ~200 g (17) and cultured free floating in RPMI 1640medium for 2-4 days. 

Phrase: "Pancreatic islet cells"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   983   C0734999:Pancreatic islet cell [Cell]
   901   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
           Pancreatic islet
   867 E C1522529:Islet Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "isolated by collagenase digestion"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0012238:Digestion [Organism Function]
   770   C0162745:COLLAGENASE [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C0205409:Isolated [Functional Concept]
   770   C1548221:Isolated [Idea or Concept]
   770   C2349986:Digestion [Research Activity]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]
   715 E C0443277:Peptic [Functional Concept]

Phrase: "from male Wistar rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0034716:Rats, Wistar [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C2700262:Wistar [Mammal]

Phrase: "weighing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1305866:Weighing [Diagnostic Procedure]

Phrase: "~200 g (17"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0062549:G 17 [Amino Acid, Peptide, or Protein,Hormone]
   827   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "cultured free floating in RPMI 1640medium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0443223:Free-floating [Qualitative Concept]
   753   C0332296:free [Functional Concept]
   753   C1880497:Free [Qualitative Concept]
   753   C1996904:Free [Qualitative Concept]
   719   C1708071:Float [Qualitative Concept]

Phrase: "for 2-4 days."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1442455:2 Days [Temporal Concept]
   827   C0439228:days [Temporal Concept]
   793 E C0332173:/day [Temporal Concept]
   793 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.48: Transient Transfection of Primary Cells-- Rat pancreatic islet cells were isolated as described above, trypsinized, and seeded on 13-mm diameter extracellular matrix-coated coverslips (Eldan, Jerusalem, Israel) at 4105 cells/ml in RPMI 1640medium. 

Phrase: "Transient Transfection of Primary Cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "--"

Phrase: "Rat pancreatic islet cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   906   C0734999:Pancreatic islet cell [Cell]
   861   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   827 E C1522529:Islet Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "isolated as described above,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0205409:Isolated [Functional Concept]
   770   C1548221:Isolated [Idea or Concept]
   770   C1552738:described [Idea or Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "trypsinized"

Phrase: ","

Phrase: "and"

Phrase: "seeded on 13-mm diameter extracellular matrix-coated coverslips"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   764   C0015350:Extracellular Matrix [Tissue]
   742   C0521119:Extracellular [Cell Component]
   742   C1301886:Diameter [Quantitative Concept]
   742   C1522408:Coated [Qualitative Concept]
   742   C1704640:Matrix [Spatial Concept]
   742   C1706515:Matrix [Body Substance]
   708   C0036563:Seed [Plant]
   708 E C0453946:Coat [Manufactured Object]
   708   C1705192:Seed [Laboratory Procedure]
   708   C1882540:{Seed} [Quantitative Concept]
   708   C2346495:Seed [Conceptual Entity]
   708 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "(Eldan,"

Phrase: "Jerusalem,"

Phrase: "Israel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022271:Israel [Geographic Area]

Phrase: ")"

Phrase: "at 4105 cells/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2699156:Cells/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "in RPMI 1640medium."
Processing 00000000.tx.49: Two days later, the cells were transfected with 10l of LipofectAMINE (Gibco BRL, Basel, Switzerland) and 1g of vector encoding mitochondrially targeted aequorin as described previously (17). 

Phrase: "Two days later,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0439228:days [Temporal Concept]
   793 E C0332173:/day [Temporal Concept]
   793 E C0439505:/day [Temporal Concept]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with 10l of LipofectAMINE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0253711:Lipofectamine [Indicator, Reagent, or Diagnostic Aid,Lipid]

Phrase: "(Gibco BRL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412820:BRL [Gene or Genome]

Phrase: "Basel,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331779:Basel [Health Care Related Organization]

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "1g of vector"

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "mitochondrially targeted aequorin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0001694:Aequorin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.50: Three days later, the cells were used for the experiments. 

Phrase: "Three days later,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0439228:days [Temporal Concept]
   793 E C0332173:/day [Temporal Concept]
   793 E C0439505:/day [Temporal Concept]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "used for the experiments."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   770   C0681814:Experiments [Research Activity]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1706386:Experiment [Conceptual Entity]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.51: This transfection procedure resulted in 10-15% of cells being transfected as judged by immunofluorescence of the hemagglutinin tag incorporated at the N terminus of aequorin (22, 23). 

Phrase: "This transfection procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C1948041:Procedure [Therapeutic or Preventive Procedure]
   861   C2700391:Procedure [Activity]
   861   C3274430:PROCEDURE [Health Care Activity]
   861   C3538935:Procedure [Idea or Concept]
   861   C3539779:Procedure [Intellectual Product]

Phrase: "resulted in 10-15% of cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
   719   C2825142:Result [Finding]

Phrase: "being"

Phrase: "transfected"

Phrase: "as"

Phrase: "judged by immunofluorescence of the hemagglutinin tag"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0016318:Immunofluorescence [Laboratory Procedure]
   748   C0018909:Haemagglutinin, NOS [Immunologic Factor]
   748   C0037293:Tag [Neoplastic Process]
   748   C0079603:Immunofluorescence [Laboratory Procedure]
   748   C0181496:Tag [Manufactured Object]
   748   C1710492:TAG [Gene or Genome]
   714   C0221191:Judge [Professional or Occupational Group]

Phrase: "incorporated at the N terminus of aequorin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0001694:Aequorin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(22,"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.52: Permeabilization of Cells-- Attached INS-1 cells were grown on coverslips coated with an extracellular matrix generated by confluent A431 cells, which were detached with 1% Triton X-100 (37). 

Phrase: "Permeabilization of Cells"

Phrase: "--"

Phrase: "Attached INS-1 cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0231441:Attached [Finding]

Phrase: "were"

Phrase: "grown on coverslips"

Phrase: "coated with an extracellular matrix"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0015350:Extracellular Matrix [Tissue]
   760   C0521119:Extracellular [Cell Component]
   760   C1522408:Coated [Qualitative Concept]
   760   C1704640:Matrix [Spatial Concept]
   760   C1706515:Matrix [Body Substance]
   726 E C0453946:Coat [Manufactured Object]
   726 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "generated by confluent A431 cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0007634:Cells [Cell]
   760   C0205200:Confluent [Qualitative Concept]
   760   C3146294:Generated [Activity]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "which"

Phrase: "were"

Phrase: "detached with 1% Triton X-100"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   790   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   753   C0242759:Triton [Geographic Area]
   753   C0687118:Detached [Functional Concept]
   753   C1561504:detached [Idea or Concept]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.53: INS-1 cells were permeabilized after a 2-5-day culture period. 

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "permeabilized after a 2-5-day culture period."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0010453:Culture [Idea or Concept]
   744   C0220814:culture [Functional Concept]
   744   C0332173:/day [Temporal Concept]
   744   C0430400:Culture [Laboratory Procedure]
   744   C0439228:day [Temporal Concept]
   744   C0439505:/day [Temporal Concept]
   744   C0439531:/period [Temporal Concept]
   744   C1948053:Period [Temporal Concept]
   744   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.54: Cells were first washed with a Ca2+-free HEPES-balanced Krebs-Ringer bicarbonate buffer (as described below except for the omission of CaCl2 and the addition of 0.4 mM EGTA). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "with a Ca2+-free HEPES-balanced Krebs-Ringer bicarbonate buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0005367:Bicarbonate [Inorganic Chemical,Pharmacologic Substance]
   793   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   793   C0973231:Bicarbonate [Inorganic Chemical]
   793   C1875730:RINGER'S [Organic Chemical,Pharmacologic Substance]
   793   C2722820:BICARBONATE [Organic Chemical,Pharmacologic Substance]

Phrase: "("

Phrase: "as"

Phrase: "described below"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1552738:described [Idea or Concept]

Phrase: "except for the omission"

Phrase: "of CaCl2"

Phrase: "and"

Phrase: "the addition of 0.4 mM EGTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1883712:Addition [Functional Concept]

Phrase: ")."
Processing 00000000.tx.55: They were then permeabilized with Staphylococcus aureus -toxin (1g/coverslip, i.e. per 4-5105 cells) (8, 38) at 37C for 8min in 100l of an intracellular type buffer adjusted to ~100 nM free Ca2+ (140mM KCl, 5mM NaCl, 7mM MgSO4, 20mM HEPES, pH 7.0,1mM ATP, 10.2mM EGTA, and 1.65mM CaCl2). 

Phrase: "They"

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "permeabilized with Staphylococcus aureus -toxin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0038172:Staphylococcus aureus [Bacterium]
   806   C1318973:Staphylococcus aureus NOS [Disease or Syndrome]
   797   C0040548:Staphylococcus toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   760   C0038170:Staphylococcus [Bacterium]
   760   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]

Phrase: "(1g/coverslip,"

Phrase: "i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "per 4-5105 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "(8,"

Phrase: "38"

Phrase: ")"

Phrase: "at 37C"

Phrase: "for 8min"

Phrase: "in 100l"

Phrase: "of an intracellular type buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "adjusted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456081:Adjusted [Functional Concept]

Phrase: "to ~100 nM free Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "(140mM KCl,"

Phrase: "5mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "7mM MgSO4,"

Phrase: "20mM HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "pH 7.0,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "1mM ATP,"

Phrase: "10.2mM EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "1.65mM CaCl2"

Phrase: ")."
Processing 00000000.tx.56: For [Ca2+]m measurements, perifusion was started with the same low Ca2+ intracellular buffer for 2-5 min, which was then switched to the stimulatory intracellular buffer with a free Ca2+ concentration of ~500 nM (140mM KCl, 5mM NaCl, 7mM MgSO4, 20mM HEPES, pH 7.0,10mM ATP, 10.2mM EGTA, and 6.67mM CaCl2). 

Phrase: "For"

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m measurements,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242485:measurements [Functional Concept]

Phrase: "perifusion"

Phrase: "was"

Phrase: "started with the same low Ca2+ intracellular buffer"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   744   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0175996:intracellular [Cell Component]
   744   C0178719:Intracellular [Spatial Concept]
   744   C0205251:low [Qualitative Concept]
   744   C0445247:Same [Qualitative Concept]
   744   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C1272689:Started [Qualitative Concept]
   744   C1299352:Low [Qualitative Concept]
   744   C1550472:low [Idea or Concept]
   711 E C0439659:Start [Temporal Concept]

Phrase: "for 2-5 min,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0702093:/min [Temporal Concept]
   734   C0450346:2 5 [Quantitative Concept]

Phrase: "which"

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "switched to the stimulatory intracellular buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0175996:intracellular [Cell Component]
   753   C0178719:Intracellular [Spatial Concept]
   719   C1707719:Switch [Manufactured Object]

Phrase: "with a free Ca2+ concentration of ~500 nM (140mM KCl,"

Phrase: "5mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "7mM MgSO4,"

Phrase: "20mM HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "pH 7.0,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "10mM ATP,"

Phrase: "10.2mM EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "6.67mM CaCl2"

Phrase: ")."
Processing 00000000.tx.57: Measurements of Luminescence and Insulin Secretion-- Luciferase- or aequorin-expressing cells were seeded on 13-mm diameter coverslips 3-5 days prior to analysis and maintained in the same medium as described above except for the addition of G418 and hygromycin. 

Phrase: "Measurements of Luminescence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C1450269:Luminescence Measurements [Laboratory Procedure]
   790   C0242485:measurements [Functional Concept]

Phrase: "and"

Phrase: "Insulin Secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "--"

Phrase: "Luciferase-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]

Phrase: "or"

Phrase: "aequorin-expressing cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "seeded on 13-mm diameter coverslips 3-5 days"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   742   C0439228:days [Temporal Concept]
   742   C1301886:Diameter [Quantitative Concept]
   708   C0036563:Seed [Plant]
   708 E C0332173:/day [Temporal Concept]
   708 E C0439505:/day [Temporal Concept]
   708   C1705192:Seed [Laboratory Procedure]
   708   C1882540:{Seed} [Quantitative Concept]
   708   C2346495:Seed [Conceptual Entity]

Phrase: "prior to analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "maintained in the same medium"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0009458:Medium [Intellectual Product]
   760   C0439536:Medium [Quantitative Concept]
   760   C0445247:Same [Qualitative Concept]
   760   C1314677:Maintained [Functional Concept]
   760   C1705217:Medium [Substance]
   760   C3244283:medium [Intellectual Product]
   726 E C0024501:Maintain [Activity]

Phrase: "as described above"

Phrase: "except for the addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of G418"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052009:G418 [Antibiotic,Organic Chemical]

Phrase: "and"

Phrase: "hygromycin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0063201:hygromycin [Organic Chemical]
Processing 00000000.tx.58: For intact cell experiments, cells were seeded on plastic polyornithine-treated coverslips at a density of 4105 cells/ml. 

Phrase: "For intact cell experiments,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C0682538:intact cell [Cell]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "seeded on plastic polyornithine-treated coverslips"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   753   C0032167:Plastic [Substance]
   753   C0071632:polyornithine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0332293:treated [Therapeutic or Preventive Procedure]
   753   C1522326:Treated [Functional Concept]
   719   C0036563:Seed [Plant]
   719 E C1292734:TREAT [Functional Concept]
   719   C1705192:Seed [Laboratory Procedure]
   719   C1882540:{Seed} [Quantitative Concept]
   719   C2346495:Seed [Conceptual Entity]

Phrase: "at a density"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0178587:density [Quantitative Concept]
   928 E C0439794:Dense [Qualitative Concept]

Phrase: "of 4105 cells/ml."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2699156:Cells/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.59: For permeabilized cell experiments, cells were seeded at 2105 cells/ml on A431 extracellular matrix-coated coverslips as described above. 

Phrase: "For permeabilized cell experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "seeded at 2105 cells/ml"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   806   C2699156:Cells/mL [Quantitative Concept]
   760   C0007634:Cells [Cell]
   760   C0439526:/mL [Quantitative Concept]
   760   C3282337:Cells [Cell]
   726   C0036563:Seed [Plant]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726   C1705192:Seed [Laboratory Procedure]
   726   C1882540:{Seed} [Quantitative Concept]
   726 E C1948049:Cell [Spatial Concept]
   726   C2346495:Seed [Conceptual Entity]

Phrase: "on A431 extracellular matrix-coated coverslips"

Phrase: "as described above."
Processing 00000000.tx.60: Prior to luminescence measurements, cells were maintained in glucose- and glutamine-free RPMI 1640medium plus 10mM HEPES for 2-5 h at 37C. 

Phrase: "Prior to luminescence measurements,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1450269:Luminescence Measurements [Laboratory Procedure]
   861   C0242485:measurements [Functional Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "maintained in glucose-"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   790   C1314677:Maintained [Functional Concept]
   756 E C0024501:Maintain [Activity]

Phrase: "and"

Phrase: "glutamine-free RPMI 1640medium plus 10mM HEPES for 2-5 h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "at 37C."
Processing 00000000.tx.61: This period also served to load aequorin-expressing cells with 2.5M coelenterazine (Molecular Probes, Inc., Eugene, OR), the prosthetic group of aequorin (23). 

Phrase: "This period also"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0439531:/period [Temporal Concept]
   861   C1948053:Period [Temporal Concept]
   789 E C0332182:Periodic [Temporal Concept]
   789 E C1706381:PERIODIC [Intellectual Product]
   761 E C0031084:Periodicities [Temporal Concept]

Phrase: "served"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "load"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1550025:Load [Idea or Concept]
  1000   C1704782:Load [Manufactured Object]
  1000   C1708715:Load [Activity]

Phrase: "aequorin-expressing cells with 2.5M coelenterazine"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   748   C0007634:Cells [Cell]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "(Molecular Probes,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: "Inc.,"

Phrase: "Eugene,"

Phrase: "OR"

Phrase: ")"

Phrase: ","

Phrase: "the prosthetic group of aequorin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.62: Luminescence was measured by placing the coverslip in a 0.5-ml thermostatted chamber at 37C ~5 mm from the photon detector. 

Phrase: "Luminescence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1450275:luminescence [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "measured by placing"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   790   C0442504:placing [Spatial Concept]
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]
   756 E C1704765:Place [Functional Concept]
   756 E C1882509:Place [Activity]
   756 E C3496241:place [Disease or Syndrome]

Phrase: "the coverslip in a 0.5-ml"

Phrase: "thermostatted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710386:Thermostat [Manufactured Object]

Phrase: "chamber at 37C ~5 mm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "from the photon detector."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0180392:Detector [Medical Device]
   861   C1705235:Detector [Manufactured Object]
Processing 00000000.tx.63: We used a photomultiplier apparatus (EMI 9789,Thorn-EMI, Middlesex, United Kingdom), and data were collected every second on a computer photon-counting board (EMI C660) prior to calibration as described previously for [Ca2+]m (23). 

Phrase: "We"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a photomultiplier apparatus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243111:apparatus [Manufactured Object]
   861   C1947951:Apparatus [Anatomical Structure]

Phrase: "(EMI 9789,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1880489:EMI [Phenomenon or Process]

Phrase: "Thorn-EMI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1880489:EMI [Phenomenon or Process]

Phrase: "Middlesex,"

Phrase: "United Kingdom"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041700:United Kingdom [Geographic Area]
   861   C1708611:Kingdom [Classification]
   827   C0166872:unite [Biomedical or Dental Material]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "every second on a computer photon-counting board"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0585312:Every second [Temporal Concept]
   744   C0205436:Second [Quantitative Concept]
   744   C0457385:Second [Temporal Concept]
   744   C0565930:/second [Quantitative Concept]
   744   C1561503:second [Idea or Concept]
   744   C1705190:Second [Qualitative Concept]

Phrase: "(EMI C660"

Phrase: ")"

Phrase: "prior to calibration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006751:Calibration [Quantitative Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously for"

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]"

Phrase: "m ("

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.64: The cells were perifused constantly at a rate of 1ml/min, and where indicated, 1-min fractions of the effluent were collected for insulin measurements. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "perifused"

Phrase: "constantly at a rate of 1ml/min,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0702093:/min [Temporal Concept]
   748   C0871208:Rate [Activity]
   748   C1521828:Rate [Quantitative Concept]

Phrase: "and"

Phrase: "where"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ","

Phrase: "1-min fractions of the effluent"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   809   C3642197:Fraction of 1 [Quantitative Concept]
   773   C1264633:Fraction of [Quantitative Concept]
           Fractions
   719 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "collected for insulin measurements."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   816   C0202098:Insulin measurement [Laboratory Procedure]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0242485:measurements [Functional Concept]
   770   C1516695:Collected [Idea or Concept]
   770   C1516698:Collected [Functional Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.65: Suspensions of islet cells were perifused with the same buffers as INS-1 cells using a perifusion apparatus (23). 

Phrase: "Suspensions of islet cells"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0038960:Suspensions [Biomedical or Dental Material]
   737 E C1382107:Suspension [Substance]
   737 E C1705537:Suspension [Functional Concept]

Phrase: "were"

Phrase: "perifused with the same buffers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0006353:Buffers [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0445247:Same [Qualitative Concept]

Phrase: "as"

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a perifusion apparatus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243111:apparatus [Manufactured Object]
   861   C1947951:Apparatus [Anatomical Structure]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.66: Intact cells were perifused with HEPES-balanced Krebs-Ringer bicarbonate buffer (135mM NaCl, 3.6 mM KCl, 10mM HEPES, pH 7.4,2mM NaHCO3, 0.5mM NaH2PO4, 0.5 mM MgCl2, 1.5mM CaCl2, and 2.8mM glucose) plus 10M beetle luciferin (Promega) for luciferase-expressing cells. 

Phrase: "Intact cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0682538:intact cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "perifused with HEPES-balanced Krebs-Ringer bicarbonate buffer"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0005367:Bicarbonate [Inorganic Chemical,Pharmacologic Substance]
   744   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   744   C0205415:Balanced [Functional Concept]
   744   C0973231:Bicarbonate [Inorganic Chemical]
   744   C1875730:RINGER'S [Organic Chemical,Pharmacologic Substance]
   744   C2722820:BICARBONATE [Organic Chemical,Pharmacologic Substance]

Phrase: "(135mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "3.6 mM KCl,"

Phrase: "10mM HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "2mM NaHCO3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0074722:NaHCO3 [Organic Chemical,Pharmacologic Substance]

Phrase: "0.5mM NaH2PO4,"

Phrase: "0.5 mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "1.5mM CaCl2,"

Phrase: "and"

Phrase: "2.8mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ")"

Phrase: "plus 10M beetle luciferin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0024076:luciferin [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: ")"

Phrase: "for luciferase-expressing cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.67: Luciferase luminescence was used for the monitoring of [ATP] in living cells as described previously (36). 

Phrase: "Luciferase luminescence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1450275:luminescence [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "used for the monitoring of [ATP"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   767   C1524063:Use of [Functional Concept]
   753   C0150369:Monitoring [Health Care Activity]
   753   C1273517:used [Finding]
   753   C1516647:monitoring [Research Activity]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: "]"

Phrase: "in living cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.68: Permeabilized cells were perifused with the intracellular buffer described above. 

Phrase: "Permeabilized cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "perifused with the intracellular buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0175996:intracellular [Cell Component]
   760   C0178719:Intracellular [Spatial Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "above."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]
Processing 00000000.tx.69: For insulin secretion experiments, 0.1% bovine serum albumin (Sigma) was added to buffers as carrier, and insulin was measured by radioimmunoassay using rat insulin as a standard (35). 

Phrase: "For insulin secretion experiments,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C1256369:insulin secretion [Cell Function]

Phrase: "0.1% bovine serum albumin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   840   C0728877:serum albumin [Laboratory or Test Result]
   804   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0007452:Bovine [Mammal]
   804   C0229671:Serum [Body Substance]
   804   C1140701:bovine [Mammal]
   804   C1546774:Serum [Intellectual Product]
   804   C1550100:Serum [Body Substance]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "was"

Phrase: "added to buffers"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0006353:Buffers [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   790   C1524062:Added [Functional Concept]
   756 E C1883712:Add [Functional Concept]

Phrase: "as carrier,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007294:Carrier [Finding]
  1000   C0560175:Carrier [Finding]
  1000   C1706209:Carrier [Medical Device]
  1000   C3273162:Carrier [Intellectual Product]

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "measured by radioimmunoassay"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0034580:Radioimmunoassay [Laboratory Procedure]
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "rat insulin as a standard"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.70: Mitochondrial Membrane Potential-- m was measured as described (13, 39). 

Phrase: "Mitochondrial Membrane Potential"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C1720920:Membrane Potential, Mitochondrial [Cell Function]
   901   C0025251:Membrane Potential [Cell Function]
   901   C0596952:Mitochondrial membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   827   C3245505:Potential [Qualitative Concept]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "--"

Phrase: "m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "was"

Phrase: "measured as described"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0444706:Measured [Qualitative Concept]
   790   C1552738:described [Idea or Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "(13,"

Phrase: "39"

Phrase: ")."
Processing 00000000.tx.71: Briefly, after a culture period in glucose-free RPMI 1640medium, cells were loaded with 10g/ml rhodamine 123for 10min at 37C. 

Phrase: "Briefly,"

Phrase: "after"

Phrase: "a culture period in glucose-free RPMI 1640medium,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0439531:/period [Temporal Concept]
   744   C1948053:Period [Temporal Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "loaded with 10g/ml rhodamine 123for 10min"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   748   C0439526:/mL [Quantitative Concept]
   748   C0600322:Rhodamine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C1708715:Loaded [Activity]
   714 E C1550025:Load [Idea or Concept]
   714 E C1704782:Load [Manufactured Object]

Phrase: "at 37C."
Processing 00000000.tx.72: For cell suspension measurements, after centrifugation, the cells were permeabilized as described above and transferred to a fluorometer cuvette, and the fluorescence excited at 490nm was measured at 530nm at 37C with gentle stirring in an LS-50B fluorometer (Perkin-Elmer, Buckinghamshire, United Kingdom). 

Phrase: "For cell suspension measurements,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0242485:measurements [Functional Concept]

Phrase: "after"

Phrase: "centrifugation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "permeabilized as described above"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "transferred to a fluorometer cuvette,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0180266:cuvette [Medical Device]
   760   C0180919:FLUOROMETER [Medical Device]
   760   C0348011:transferred [Functional Concept]
   726 E C0040671:Transfer [Mental Process]
   726 E C1705822:Transfer [Activity]

Phrase: "and"

Phrase: "the fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016315:Fluorescence [Natural Phenomenon or Process]
   928 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "excited at 490nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0549255:Excited [Activity]

Phrase: "was"

Phrase: "measured at 530nm"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "at 37C"

Phrase: "with gentle stirring"

Phrase: "in an LS-50B fluorometer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0180919:FLUOROMETER [Medical Device]

Phrase: "(Perkin-Elmer,"

Phrase: "Buckinghamshire,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454842:Buckinghamshire [Geographic Area]

Phrase: "United Kingdom"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041700:United Kingdom [Geographic Area]
   861   C1708611:Kingdom [Classification]
   827   C0166872:unite [Biomedical or Dental Material]

Phrase: ")."
Processing 00000000.tx.73: For measurements on attached cells, the cells grown on A431-coated glass coverslips were loaded with rhodamine 123prior to permeabilization (see above). 

Phrase: "For measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242485:measurements [Functional Concept]

Phrase: "on attached cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "grown on A431-coated glass coverslips"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   753   C0017596:Glass [Manufactured Object]
   753   C1522408:Coated [Qualitative Concept]
   753   C1947936:Glass [Medical Device]
   719 E C0453946:Coat [Manufactured Object]
   719 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "loaded with rhodamine 123prior"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0600322:Rhodamine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C1708715:Loaded [Activity]
   737 E C1550025:Load [Idea or Concept]
   737 E C1704782:Load [Manufactured Object]

Phrase: "to permeabilization"

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.74: Cells were then placed in a thermostatted microincubator (Medical Systems Corp., Greenvale, NY) on an inverted microscope (Nikon Diaphot) with a 40 oil immersion objective. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "placed in a thermostatted microincubator"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   726   C0442504:Place [Spatial Concept]
   726   C1704765:Place [Functional Concept]
   726   C1710386:Thermostat [Manufactured Object]
   726   C1882509:Place [Activity]
   726   C3496241:place [Disease or Syndrome]

Phrase: "(Medical Systems Corp.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0683758:Corp. [Organization]

Phrase: "Greenvale,"

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")"

Phrase: "on an inverted microscope"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0181839:Microscope [Medical Device]
   861   C1706379:Microscope [Medical Device]

Phrase: "(Nikon Diaphot"

Phrase: ")"

Phrase: "with a 40 oil immersion objective."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0018017:Objective [Intellectual Product]
   812   C1571702:Objective [Qualitative Concept]
Processing 00000000.tx.75: Fluorescence excitation was filtered at 485nm, and emission was split at 505 nm and further filtered at 530nm (Omega Optical Inc., Brattleboro, VT). 

Phrase: "Fluorescence excitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0549255:Excitation [Activity]

Phrase: "was"

Phrase: "filtered at 485nm,"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   756   C0180860:Filter [Manufactured Object]
   756   C0581406:Filter [Medical Device]
   756   C1522664:Filter [Intellectual Product]
   756   C1704449:Filter [Conceptual Entity]
   756   C1704684:Filter [Medical Device]
   756   C1875155:FILTER [Medical Device]
   718 E C0080194:Strain [Injury or Poisoning]
   718 E C0442694:Straining [Physiologic Function]
   718 E C0456178:strain [Intellectual Product]
   718 E C1518614:Strain [Organism]
   718 E C2987481:Strain [Mental Process]

Phrase: "and"

Phrase: "emission"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0233929:Emission [Body Substance]
  1000   C2349995:Emission [Substance]

Phrase: "was"

Phrase: "split at 505 nm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1534709:Split [Functional Concept]
   770   C1881714:SPLIT [Phenomenon or Process]

Phrase: "and"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "filtered at 530nm"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   756   C0180860:Filter [Manufactured Object]
   756   C0581406:Filter [Medical Device]
   756   C1522664:Filter [Intellectual Product]
   756   C1704449:Filter [Conceptual Entity]
   756   C1704684:Filter [Medical Device]
   756   C1875155:FILTER [Medical Device]
   718 E C0080194:Strain [Injury or Poisoning]
   718 E C0442694:Straining [Physiologic Function]
   718 E C0456178:strain [Intellectual Product]
   718 E C1518614:Strain [Organism]
   718 E C2987481:Strain [Mental Process]

Phrase: "(Omega Optical Inc.,"

Phrase: "Brattleboro,"

Phrase: "VT"

Phrase: ")."
Processing 00000000.tx.76: The signal was recorded at 100Hz with a photomultiplier (Nikon P100S) and a computerized acquisition system (40). 

Phrase: "The signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "recorded at 100Hz"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0034869:Record [Intellectual Product]

Phrase: "with a photomultiplier"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597229:Photomultiplier [Medical Device]

Phrase: "(Nikon P100S"

Phrase: ")"

Phrase: "and"

Phrase: "a computerized acquisition system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.77: The cell layer was perifused at 1ml/min with the 500nM free Ca2+ intracellular buffer (see above) supplemented with 0.1g/ml rhodamine 123. 

Phrase: "The cell layer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0934502:Layer [Body Part, Organ, or Organ Component]
   861   C1522408:Layer [Qualitative Concept]
   861   C1561599:Layer [Intellectual Product]

Phrase: "was"

Phrase: "perifused at 1ml/min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0702093:/min [Temporal Concept]

Phrase: "with the 500nM free Ca2+ intracellular buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: ")"

Phrase: "supplemented with 0.1g/ml rhodamine 123."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0073192:Rhodamine 123 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0439526:/mL [Quantitative Concept]
   748   C0600322:Rhodamine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   714   C0242295:Supplement [Food]
   714   C1947943:Supplement [Intellectual Product]
   714   C2348609:Supplement [Functional Concept]
Processing 00000000.tx.78: Succinate Oxidation to CO2 in Permeabilized INS-1 Cells-- INS-1 cells were seeded at 4105 cells/2 ml on 35-mm diameter dishes coated with A431 extracellular matrix as described above. 

Phrase: "Succinate Oxidation to CO2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030011:Oxidation [Molecular Function]

Phrase: "in Permeabilized"

Phrase: "INS-1 Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "-"

Phrase: "-"

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "seeded at 4105 cells/2 ml"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   783   C2699156:Cells/mL [Quantitative Concept]
   753   C0007634:Cells [Cell]
   753   C0439526:/mL [Quantitative Concept]
   753   C3282337:Cells [Cell]
   719   C0036563:Seed [Plant]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719   C1705192:Seed [Laboratory Procedure]
   719   C1882540:{Seed} [Quantitative Concept]
   719 E C1948049:Cell [Spatial Concept]
   719   C2346495:Seed [Conceptual Entity]

Phrase: "on 35-mm diameter dishes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0020498:DISH [Disease or Syndrome]

Phrase: "coated with A431 extracellular matrix"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0015350:Extracellular Matrix [Tissue]
   760   C0521119:Extracellular [Cell Component]
   760   C1522408:Coated [Qualitative Concept]
   760   C1704640:Matrix [Spatial Concept]
   760   C1706515:Matrix [Body Substance]
   726 E C0453946:Coat [Manufactured Object]
   726 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "as described above."
Processing 00000000.tx.79: Cells were maintained 3-4 days prior to the experiment in the standard RPMI 1640medium to subconfluency. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "maintained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1314677:Maintained [Functional Concept]
   966 E C0024501:Maintain [Activity]

Phrase: "3-4 days prior to the experiment"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   774   C1442459:3 Days [Temporal Concept]
   748   C0439228:days [Temporal Concept]
   714 E C0332173:/day [Temporal Concept]
   714 E C0439505:/day [Temporal Concept]

Phrase: "in the standard RPMI 1640medium"

Phrase: "to subconfluency."
Processing 00000000.tx.80: Attached cells were then incubated in glucose- and glutamine-free RPMI 1640medium plus 10mM HEPES for 2h at 37C, transferred to a thermostatted glass chamber, and permeabilized according to the procedure described above. 

Phrase: "Attached cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated in glucose-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "and"

Phrase: "glutamine-free RPMI 1640medium plus 10mM HEPES for 2h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "at 37C,"

Phrase: "transferred to a thermostatted glass chamber,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0017596:Glass [Manufactured Object]
   753   C0348011:transferred [Functional Concept]
   753   C0935616:Chamber [Body Part, Organ, or Organ Component]
   753   C1947936:Glass [Medical Device]
   719 E C0040671:Transfer [Mental Process]
   719 E C1705822:Transfer [Activity]
   719   C1710386:Thermostat [Manufactured Object]

Phrase: "and"

Phrase: "permeabilized according to the procedure"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   760   C0680240:according [Social Behavior]
   760   C1948041:Procedure [Therapeutic or Preventive Procedure]
   760   C2700391:Procedure [Activity]
   760   C3274430:PROCEDURE [Health Care Activity]
   760   C3538935:Procedure [Idea or Concept]
   760   C3539779:Procedure [Intellectual Product]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "above."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]
Processing 00000000.tx.81: Cells were then washed with the corresponding intracellular buffer adjusted to either 100or 500nM free Ca2+ and preincubated for 10min in that buffer. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "washed with the corresponding intracellular buffer"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0175996:intracellular [Cell Component]
   753   C0178719:Intracellular [Spatial Concept]
   753   C1548982:Washed [Idea or Concept]
   719 E C0441648:Wash [Activity]

Phrase: "adjusted to either 100or 500nM free Ca2+"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0332296:free [Functional Concept]
   748   C0456081:Adjusted [Functional Concept]
   748   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C1880497:Free [Qualitative Concept]
   748   C1996904:Free [Qualitative Concept]

Phrase: "and"

Phrase: "preincubated for 10min"

Phrase: "in"

Phrase: "that buffer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.82: Succinate oxidation was initiated by replacing the buffer with 1ml of the respective fresh ones containing 1mM [2,3-14C]succinate (NEN Life Science Products; 0.1Ci/chamber). 

Phrase: "Succinate oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "was"

Phrase: "initiated by replacing"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1299987:replacing [Functional Concept]
   756   C1548602:Initiate [Idea or Concept]
   756 E C1554078:Replace [Idea or Concept]
   756   C1704686:Initiate [Functional Concept]

Phrase: "the buffer with 1ml of the respective fresh ones"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1mM"

Phrase: "[2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3-14C"

Phrase: "]succinate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038617:succinate [Organic Chemical]
  1000   C0220918:succinate [Organic Chemical,Pharmacologic Substance]

Phrase: "(NEN Life Science Products"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   923   C0332070:Life Science Products [Health Care Related Organization]
   812   C1514468:Products [Entity]
   779 E C1704444:Product [Quantitative Concept]

Phrase: "; 0.1Ci/chamber"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: ")."
Processing 00000000.tx.83: After a 1-h incubation at 37C in sealed chambers, 0.5ml of 0.1M HCl was added onto the cell layers to stop the reaction, and 1 ml of benzethonium hydroxide (Sigma) was injected into the bottom of the chamber to bind the CO2 liberated by the cells (41). 

Phrase: "After a 1-h incubation"

Phrase: "at 37C"

Phrase: "in sealed chambers,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0179874:chambers [Medical Device]
   827 E C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "0.5ml of 0.1M HCl"

Phrase: "was"

Phrase: "added onto the cell layers to"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   753   C0007634:Cell [Cell]
   753   C0934502:layers [Body Part, Organ, or Organ Component]
   753   C1269647:Cell [Cell]
   753   C1524062:Added [Functional Concept]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   719 E C1522408:Layer [Qualitative Concept]
   719 E C1561599:Layer [Intellectual Product]
   719 E C1883712:Add [Functional Concept]

Phrase: "stop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1947925:Stop [Activity]
  1000   C2746065:Stop [Temporal Concept]

Phrase: "the reaction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "and"

Phrase: "1 ml of benzethonium hydroxide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439526:/mL [Quantitative Concept]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "was"

Phrase: "injected into the bottom of the chamber to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0935616:Chamber [Body Part, Organ, or Organ Component]
   744   C1511276:Bottom [Spatial Concept]
   744   C1552825:bottom [Idea or Concept]
   711   C1720154:Inject [Functional Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "the CO2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347816:Co2+ [Element, Ion, or Isotope]

Phrase: "liberated by the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(41"

Phrase: ")."
Processing 00000000.tx.84: Following an overnight incubation at room temperature, 14CO2 production was measured in benzethonium extracted with 5ml of EtOH and counted in an LS6500 liquid scintillation counter (Beckman Instruments). 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "an overnight incubation at room temperature, 14CO2 production"

Phrase: "was"

Phrase: "measured in benzethonium"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0005041:Benzethonium [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]
   734 E C0086799:Phemerol [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "extracted with 5ml of EtOH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0001962:ETOH [Organic Chemical]
   760   C0185115:Extracted [Therapeutic or Preventive Procedure]
   760   C3541890:EXTRACTED [Finding]
   726 E C2828366:Extract [Substance]

Phrase: "and"

Phrase: "counted in an LS6500 liquid scintillation counter"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C0036405:Scintillation Counter [Medical Device]
   778   C1710025:Scintillation Counter [Manufactured Object]
   748   C0302908:Liquid [Substance]
   748   C0677601:Counter [Manufactured Object]
   748   C0678573:scintillation [Natural Phenomenon or Process]
   748   C1304698:Liquid [Finding]
   748   C1546699:Liquid NOS [Intellectual Product]
   748   C1561501:Liquid NOS [Substance]
   748   C1705206:Counter [Medical Device]
   714   C0750480:Count [Activity]
   714   C1705566:Count [Quantitative Concept]

Phrase: "(Beckman Instruments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0348000:instruments [Medical Device]

Phrase: ")."
Processing 00000000.tx.85: Statistical Analysis-- Where applicable, values are expressed as the meanS.E., and significance of difference was calculated by Student's t-test for unpaired data. 

Phrase: "Statistical Analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "--"

Phrase: "Where applicable, values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "expressed as the meanS.E.,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C1704970:Means [Conceptual Entity]
   726 E C0444504:Mean [Quantitative Concept]
   726 E C2347634:Mean [Quantitative Concept]
   726 E C2348143:Mean [Quantitative Concept]

Phrase: "and"

Phrase: "significance of difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0237881:Significance [Quantitative Concept]
   790   C0750502:Significance [Idea or Concept]
   718 E C1546944:Significant [Qualitative Concept]

Phrase: "was"

Phrase: "calculated by Student's t-test"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0022885:Test [Laboratory Procedure]
   760   C0038492:student [Professional or Occupational Group]
   760   C0039593:Test [Functional Concept]
   760   C0392366:test [Intellectual Product]
   760   C0444686:Calculated [Functional Concept]
   760   C1441506:Calculated [Activity]
   760   C1443182:Calculated [Laboratory Procedure]
   760   C1551041:student [Idea or Concept]
   760   C1552573:student [Intellectual Product]

Phrase: "for unpaired data."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2825413:Unpaired Data [Idea or Concept]
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]
Processing 00000000.tx.86: Traces without S.E. values are representative of at least three independent experiments.  

Phrase: "Traces without"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0442822:Trace [Quantitative Concept]
   799   C1524031:Trace [Qualitative Concept]
   799   C1883002:Trace [Functional Concept]

Phrase: "S."

Phrase: "E. values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "representative of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1882932:Representative [Activity]

Phrase: "at least three independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.87: RESULTS Top Abstract Introduction Procedures Results Discussion References Insulin Secretion in Islets-- Rat pancreatic islets were maintained in culture for 2-4 days prior to the experiments. 

Phrase: "RESULTS Top Abstract Introduction Procedures Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Insulin Secretion in Islets"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C1256369:insulin secretion [Cell Function]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "--"

Phrase: "Rat pancreatic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "maintained in culture"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0010453:Culture [Idea or Concept]
   790   C0220814:culture [Functional Concept]
   790   C0430400:Culture [Laboratory Procedure]
   790   C1314677:Maintained [Functional Concept]
   790   C2242979:Culture [Laboratory Procedure]
   756 E C0024501:Maintain [Activity]

Phrase: "for 2-4 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1442455:2 Days [Temporal Concept]
   827   C0439228:days [Temporal Concept]
   793 E C0332173:/day [Temporal Concept]
   793 E C0439505:/day [Temporal Concept]

Phrase: "prior to the experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.88: Stimulation of insulin secretion with 16.7mM glucose for 10min was repeated after a 10-min interval of perifusion at 2.8mM glucose. 

Phrase: "Stimulation of insulin secretion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2245393:stimulation of insulin secretion [Cell Function]
   881   C2259155:stimulation of secretion [Cell Function]
   770   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   770   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "with 16.7mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "for 10min"

Phrase: "was"

Phrase: "repeated after a 10-min interval"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C0456692:/10 min [Temporal Concept]
   767   C1547391:Repeat interval [Idea or Concept]
   753   C0205341:Repeated [Functional Concept]
   753   C0702093:/min [Temporal Concept]
   753   C1272706:Interval [Temporal Concept]
   753   C1552654:Interval [Idea or Concept]
   753   C1552713:Interval [Intellectual Product]
   719 E C1547730:Repeat [Temporal Concept]
   719 E C1705914:Repeat [Conceptual Entity]

Phrase: "of perifusion at 2.8mM glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.89: This revealed that the secretory response was desensitized during the second stimulation, displaying ~50% reduction (Fig. 1A). 

Phrase: "This"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "the secretory response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "was"

Phrase: "desensitized during the second stimulation,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0205436:Second [Quantitative Concept]
   760   C0457385:Second [Temporal Concept]
   760   C0565930:/second [Quantitative Concept]
   760   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   760   C1561503:second [Idea or Concept]
   760   C1705190:Second [Qualitative Concept]
   760   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "displaying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displaying [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "~50% reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0301630:Reduction [Natural Phenomenon or Process]
   861   C0392756:Reduction [Qualitative Concept]
   861   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.90: The tricarboxylic acid cycle intermediate succinate, rendered cell-permeant by the ester binding of a methyl group (42), also produced a desensitization of the insulin exocytotic response with a pattern similar to that produced by glucose (Fig. 1B). 

Phrase: "The tricarboxylic acid cycle intermediate succinate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0038617:succinate [Organic Chemical]
   804   C0220918:succinate [Organic Chemical,Pharmacologic Substance]
   717   C0008858:Tricarboxylic Acid Cycle [Molecular Function]

Phrase: "rendered cell-permeant by the ester binding of a methyl group"

Phrase: "(42"

Phrase: ")"

Phrase: ","

Phrase: "also"

Phrase: "produced"

Phrase: "a desensitization of the insulin exocytotic response"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0178702:Desensitization [Therapeutic or Preventive Procedure]
   748   C1709852:Desensitization [Molecular Function]

Phrase: "with a pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449774:Pattern [Spatial Concept]

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "produced by glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.91: Finally, KCl was used to raise [Ca2+]c by membrane depolarization (29, 17). 

Phrase: "Finally,"

Phrase: "KCl"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "raise"

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c by membrane depolarization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1553033:[c] [Quantitative Concept]

Phrase: "(29,"

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.92: Again, the second of two exposures to 20mM KCl revealed a blunted insulin secretory response (Fig. 1C). 

Phrase: "Again,"

Phrase: "the second of two exposures"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205436:Second [Quantitative Concept]
   760   C0457385:Second [Temporal Concept]
   760   C0565930:/second [Quantitative Concept]
   760   C1561503:second [Idea or Concept]
   760   C1705190:Second [Qualitative Concept]

Phrase: "to 20mM KCl"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "a blunted insulin secretory response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0871261:Response [Organism Attribute]
   812   C1704632:Response [Finding]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]

Phrase: "(Fig. 1C"

Phrase: ")."
Processing 00000000.tx.93: View larger version (24K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(24K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.94: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.95: Desensitization of insulin secretion in rat islets following repeated stimulation. 

Phrase: "Desensitization of insulin secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0178702:Desensitization [Therapeutic or Preventive Procedure]
   770   C1709852:Desensitization [Molecular Function]

Phrase: "in rat islets"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "repeated stimulation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]
Processing 00000000.tx.96: Rat pancreatic islets were isolated and kept in culture for 2-4 days before insulin secretion experiments in a perifusion system. 

Phrase: "Rat pancreatic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "kept in culture"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0010453:Culture [Idea or Concept]
   790   C0220814:culture [Functional Concept]
   790   C0430400:Culture [Laboratory Procedure]
   790   C2242979:Culture [Laboratory Procedure]
   756   C0333118:Keep [Functional Concept]

Phrase: "for 2-4 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1442455:2 Days [Temporal Concept]
   827   C0439228:days [Temporal Concept]
   793 E C0332173:/day [Temporal Concept]
   793 E C0439505:/day [Temporal Concept]

Phrase: "before insulin secretion experiments"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C1256369:insulin secretion [Cell Function]

Phrase: "in a perifusion system."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.97: Stimulation with 16.7mM Glc for 10min was repeated after a 10-min interval (A). 

Phrase: "Stimulation with 16.7mM Glc"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   760   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "for 10min"

Phrase: "was"

Phrase: "repeated after a 10-min interval"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C0456692:/10 min [Temporal Concept]
   767   C1547391:Repeat interval [Idea or Concept]
   753   C0205341:Repeated [Functional Concept]
   753   C0702093:/min [Temporal Concept]
   753   C1272706:Interval [Temporal Concept]
   753   C1552654:Interval [Idea or Concept]
   753   C1552713:Interval [Intellectual Product]
   719 E C1547730:Repeat [Temporal Concept]
   719 E C1705914:Repeat [Conceptual Entity]

Phrase: "(A"

Phrase: ")."
Processing 00000000.tx.98: Using the same protocol, the effect of a 5mM concentration of the mitochondrial substrate methyl succinate (met-Suc) is shown in B. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the same protocol,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]

Phrase: "the effect of a 5mM concentration of the mitochondrial substrate methyl succinate (met-Suc)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C1280500:Effect [Qualitative Concept]
   736   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "shown in B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.99: Insulin exocytosis was also stimulated by depolarizing the cells with 20mM KCl (C). 

Phrase: "Insulin exocytosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015283:Exocytosis [Cell Function]

Phrase: "was"

Phrase: "also"

Phrase: "stimulated by depolarizing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "the cells with 20mM KCl"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:THE CELL [Cell]
           Cells
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.100: Values are the meanS.E. 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "the meanS.E."
Processing 00000000.tx.101: (n=4). 

Phrase: "(n=4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.102: [Ca2+]m in Primary Pancreatic Cells-- Primary rat pancreatic cells were transiently transfected with the cDNA encoding mitochondrially targeted aequorin. 

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m in Primary Pancreatic Cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0599757:cells m [Cell]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]

Phrase: "--"

Phrase: "Primary rat pancreatic cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected with the cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "mitochondrially targeted aequorin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0001694:Aequorin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.103: Monitoring of [Ca2+]m in these cells showed that 5mM methyl succinate increased [Ca2+]m during the first stimulation, but not during a second one repeated 5min later (Fig. 2A). 

Phrase: "Monitoring of [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m in these cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0599757:cells m [Cell]
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that 5mM methyl succinate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0066765:methyl succinate [Organic Chemical]
   827   C0038617:succinate [Organic Chemical]
   827   C0220918:succinate [Organic Chemical,Pharmacologic Substance]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m during the first stimulation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]

Phrase: "but"

Phrase: "not during a second one"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0205436:Second [Quantitative Concept]
   760   C0205447:One [Quantitative Concept]
   760   C0457385:Second [Temporal Concept]
   760   C0565930:/second [Quantitative Concept]
   760   C1518422:Not [Functional Concept]
   760   C1561503:second [Idea or Concept]
   760   C1705190:Second [Qualitative Concept]

Phrase: "repeated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205341:Repeated [Functional Concept]
   966 E C1547730:Repeat [Temporal Concept]
   966 E C1705914:Repeat [Conceptual Entity]

Phrase: "5min"

Phrase: "later"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0205087:Late [Temporal Concept]

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.104: This desensitization was also observed by raising [Ca2+]c through depolarization of the plasma membrane induced by 20mM KCl (Fig. 2B). 

Phrase: "This desensitization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0178702:Desensitization [Therapeutic or Preventive Procedure]
  1000   C1709852:Desensitization [Molecular Function]

Phrase: "was"

Phrase: "also"

Phrase: "observed by raising"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c through depolarization of the plasma membrane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1553033:[c] [Quantitative Concept]

Phrase: "induced by 20mM KCl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205263:Induced [Functional Concept]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.105: Contrary to clones stably expressing aequorin, the low expression levels after transient transfection (13) do not permit a reliable calibration since the total photon emission was 10-20-fold less in the later case. 

Phrase: "Contrary to clones stably"

Phrase: "expressing"

Phrase: "aequorin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001694:Aequorin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the low expression levels after transient transfection"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0441889:Levels [Qualitative Concept]
   745   C3244092:expression level [Idea or Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "(13"

Phrase: ")"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "permit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0023636:Permit [Regulation or Law]
  1000   C0329040:Permit [Fish]

Phrase: "a reliable calibration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006751:Calibration [Quantitative Concept]

Phrase: "since"

Phrase: "the total photon emission"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0233929:Emission [Body Substance]
   827   C2349995:Emission [Substance]

Phrase: "was"

Phrase: "10-20-fold less in the later case."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   767   C1630409:20/10 [Finding]
   744   C0332462:Fold [Spatial Concept]
   744   C0868928:Case [Functional Concept]
   744   C1706255:CASE [Medical Device]
   744   C1706256:Case [Conceptual Entity]
   744   C1880834:FOLD [Phenomenon or Process]
   711   C0205087:Late [Temporal Concept]
Processing 00000000.tx.106: Therefore, [Ca2+]m is expressed as photons emitted per second. 

Phrase: "Therefore,"

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "is"

Phrase: "expressed as photons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0086805:Photons [Substance]

Phrase: "emitted per second."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C0205436:Second [Quantitative Concept]
   790   C0457385:Second [Temporal Concept]
   790   C0565930:/second [Quantitative Concept]
   790   C1561503:second [Idea or Concept]
   790   C1705190:Second [Qualitative Concept]
   756   C0162676:EMIT [Laboratory Procedure]
   756   C1623049:EMIT [Laboratory Procedure]
   718 E C0027627:secondary [Neoplastic Process]
   718 E C0175668:Secondary [Temporal Concept]
Processing 00000000.tx.107: View larger version (20K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(20K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.108: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.109: Desensitization of [Ca2+]m increases in rat islet cells. 

Phrase: "Desensitization of [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "increases in rat islet cells."
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   806   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   773 E C1522529:Islet Cell [Cell]
   760   C0007634:Cells [Cell]
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   760   C0442805:Increase [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
   704 E C1517378:Gain [Quantitative Concept]
Processing 00000000.tx.110: Rat islet cells were transiently transfected with the cDNA encoding mitochondrially targeted aequorin and used 3days later. 

Phrase: "Rat islet cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   901   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   867 E C1522529:Islet Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected with the cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "mitochondrially targeted aequorin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0001694:Aequorin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "used 3days later."
Processing 00000000.tx.111: Cells were perifused at 37C with HEPES-balanced Krebs-Ringer bicarbonate buffer and exposed for 5min to 5mM methyl succinate (met-Suc) (A) or 20mM KCl (B). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "perifused at 37C"

Phrase: "with HEPES-balanced Krebs-Ringer bicarbonate buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0005367:Bicarbonate [Inorganic Chemical,Pharmacologic Substance]
   799   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   799   C0973231:Bicarbonate [Inorganic Chemical]
   799   C1875730:RINGER'S [Organic Chemical,Pharmacologic Substance]
   799   C2722820:BICARBONATE [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "exposed for 5min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332157:Exposed [Clinical Attribute]

Phrase: "to 5mM methyl succinate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0066765:methyl succinate [Organic Chemical]
   827   C0038617:succinate [Organic Chemical]
   827   C0220918:succinate [Organic Chemical,Pharmacologic Substance]

Phrase: "(met-Suc"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0038617:succinate [Organic Chemical]
   861   C0220918:succinate [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "(A)"

Phrase: "or"

Phrase: "20mM KCl"

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.112: Stimulation was repeated after a 5-min interval. 

Phrase: "Stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292856:Stimulation [Therapeutic or Preventive Procedure]
  1000   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "repeated after a 5-min interval."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   767   C1547391:Repeat interval [Idea or Concept]
   753   C0205341:Repeated [Functional Concept]
   753   C0702093:/min [Temporal Concept]
   753   C1272706:Interval [Temporal Concept]
   753   C1552654:Interval [Idea or Concept]
   753   C1552713:Interval [Intellectual Product]
   719 E C1547730:Repeat [Temporal Concept]
   719 E C1705914:Repeat [Conceptual Entity]
Processing 00000000.tx.113: The traces are representative of at least three independent experiments. 

Phrase: "The traces"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0442822:Trace [Quantitative Concept]
   966   C1524031:Trace [Qualitative Concept]
   966   C1883002:Trace [Functional Concept]

Phrase: "are"

Phrase: "representative of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1882932:Representative [Activity]

Phrase: "at least three independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.114: ATP Generation, [Ca2+]m, and Insulin Secretion in INS-1 Cells-- The insulin-secreting cell line INS-1 was stably transfected with mitochondrially targeted aequorin (INS-1/EK3) or with luciferase (INS-r3-LUC7), allowing the continuous measurement of [Ca2+]m or [ATP], respectively, in living perifused cells. 

Phrase: "ATP Generation,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0079411:Generation [Temporal Concept]
   861   C3146294:Generation [Activity]
   768 E C1414672:Genesis [Gene or Genome]
   768 E C2984892:Genesis [Gene or Genome]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Insulin Secretion in"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   882   C1256369:insulin secretion [Cell Function]
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C0036536:secretion [Biologic Function]
   790   C0036537:Secretion [Body Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "INS-1 Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "-"

Phrase: "-"

Phrase: "The insulin-secreting cell line INS-1"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   814   C0030281:Insulin-secreting cell [Cell]
           Insulin Cell
   778   C0007600:Cell Line [Cell]
   774   C0007634:THE CELL [Cell]
           Cell
   748   C0205132:Line [Spatial Concept]
   748   C1269647:Cell [Cell]
   748   C1550648:Line [Substance]
   748   C1552960:Line [Quantitative Concept]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "stably"

Phrase: "transfected with mitochondrially targeted aequorin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0001694:Aequorin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1521840:Targeted [Functional Concept]
   726 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "("

Phrase: "INS-1/EK3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0915156:EK3 [Amino Acid, Peptide, or Protein,Enzyme,Receptor]

Phrase: ")"

Phrase: "or with luciferase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]

Phrase: "("

Phrase: "INS-r3-LUC7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1416935:Luc7 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "allowing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowing [Social Behavior]

Phrase: "the continuous measurement of [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m or [ATP"

Phrase: "],"

Phrase: "respectively,"

Phrase: "in living perifused cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.115: The simultaneous monitoring of [Ca2+]m and insulin secretion demonstrated that both parameters exhibited an attenuated response when 5mM methyl succinate was added to the perifusion 5min after the first stimulation (Fig. 3, B and C, respectively). 

Phrase: "The simultaneous monitoring of [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "demonstrated"

Phrase: "that"

Phrase: "both parameters"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0449381:Parameters [Finding]
   966 E C0549193:Parameter [Spatial Concept]
   966 E C1704769:Parameter [Conceptual Entity]
   966 E C2350001:Parameter [Quantitative Concept]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "an attenuated response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "when"

Phrase: "5mM methyl succinate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0066765:methyl succinate [Organic Chemical]
   827   C0038617:succinate [Organic Chemical]
   827   C0220918:succinate [Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "added to the perifusion 5min"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1524062:Added [Functional Concept]
   726 E C1883712:Add [Functional Concept]

Phrase: "after the first stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C,"

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.116: The [Ca2+]m desensitization was not due to aequorin consumption or deleterious effects on the cells, as the [Ca2+]m response to methyl succinate was completely restored after an interval of 30min between the two pulses (Fig. 3D). 

Phrase: "The [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m desensitization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0178702:Desensitization [Therapeutic or Preventive Procedure]
   861   C1709852:Desensitization [Molecular Function]

Phrase: "was"

Phrase: "not due to aequorin consumption"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0001694:Aequorin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0009830:Consumption [Activity]
   760   C1518422:Not [Functional Concept]
   760   C1947907:Consumption [Physiologic Function]
   760   C3146286:Due [Idea or Concept]

Phrase: "or"

Phrase: "deleterious effects on the cells,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "as"

Phrase: "the [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m response to methyl succinate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0871261:Response [Organism Attribute]
   760   C1704632:Response [Finding]
   760   C1706817:Response [Intellectual Product]
   760   C2911692:Response [Mental Process]

Phrase: "was"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "restored after an interval of 30min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1272706:Interval [Temporal Concept]
   753   C1552654:Interval [Idea or Concept]
   753   C1552713:Interval [Intellectual Product]

Phrase: "between the two pulses"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0034107:Pulses [Health Care Activity]
   861   C0391850:PULSES [Physiologic Function]
   827 E C0232117:PULSE [Clinical Attribute]
   827 E C1947910:Pulse [Phenomenon or Process]

Phrase: "(Fig. 3D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450363:3D [Spatial Concept]
   861   C2986797:3D [Functional Concept]

Phrase: ")."
Processing 00000000.tx.117: The addition of 5mM methyl succinate to INS-1 cells produced an increase in cytosolic ATP, and the same rise could be elicited 5min later to the same extent during a second exposure to methyl succinate without any significant desensitization (Fig. 3A). 

Phrase: "The addition of 5mM methyl succinate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1883712:Addition [Functional Concept]

Phrase: "to"

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "produced"

Phrase: "an increase in cytosolic ATP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "and"

Phrase: "the same rise"

Phrase: "could"

Phrase: "be"

Phrase: "elicited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicited [Qualitative Concept]

Phrase: "5min"

Phrase: "later to the same extent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0205087:Late [Temporal Concept]

Phrase: "during a second exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0274281:Exposure, NOS [Injury or Poisoning]
   861   C0332157:Exposure [Clinical Attribute]

Phrase: "to methyl succinate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0066765:methyl succinate [Organic Chemical]
   861   C0038617:succinate [Organic Chemical]
   861   C0220918:succinate [Organic Chemical,Pharmacologic Substance]

Phrase: "without any significant desensitization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0178702:Desensitization [Therapeutic or Preventive Procedure]
   861   C1709852:Desensitization [Molecular Function]

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.118: Additional time points for the [Ca2+]m increases and recovery of the secretory responses have already been documented using glucose as a stimulus (23). 

Phrase: "Additional time points for the [Ca2+"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C2348792:Time Point [Temporal Concept]
   753   C0040223:Time [Temporal Concept]
   753   C3541383:Time [Temporal Concept]
   719   C1552961:Point [Quantitative Concept]
   719   C2347617:point [Quantitative Concept]

Phrase: "]m increases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:increases [Functional Concept]

Phrase: "and"

Phrase: "recovery of the secretory responses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0237820:Recovery [Activity]
   760   C1555688:recovery [Idea or Concept]
   760   C2004454:Recovery [Organism Function]

Phrase: "have"

Phrase: "already"

Phrase: "been"

Phrase: "documented"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1301725:Documented [Health Care Activity]
  1000   C1609436:documented [Idea or Concept]
   966 E C1301746:document [Intellectual Product]
   966 E C1547673:Document [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "glucose as a stimulus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.119: Moreover, glucose, which also increases cytosolic ATP levels (36), did not exhibit any desensitization using the protocol of Fig. 

Phrase: "Moreover,"

Phrase: "glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "which also"

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "cytosolic ATP levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "(36"

Phrase: ")"

Phrase: ","

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "any desensitization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0178702:Desensitization [Therapeutic or Preventive Procedure]
  1000   C1709852:Desensitization [Molecular Function]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the protocol of Fig."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0442711:Protocol [Intellectual Product]
   770   C1507394:Protocol [Intellectual Product]
   770   C1522729:Protocol [Intellectual Product]
   770   C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.120: 2A. 

Phrase: "2A."
Processing 00000000.tx.121: The ATP response to 12.8mM glucose was +23.32.0and +24.3 2.2% during the first and second applications, respectively (not significant, n=4). 

Phrase: "The ATP response to 12.8mM glucose"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C2246604:response to ATP [Cell Function]
   748   C0871261:Response [Organism Attribute]
   748   C1704632:Response [Finding]
   748   C1706817:Response [Intellectual Product]
   748   C2911692:Response [Mental Process]

Phrase: "was +"

Phrase: "23.32.0and +24.3 2.2%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0450348:23 [Quantitative Concept]

Phrase: "during the first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "and"

Phrase: "second applications,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0185125:applications [Health Care Activity]
   827 E C1947919:Application [Intellectual Product]
   827 E C2347934:Application [Intellectual Product]
   827 E C3539080:APPLICATION [Quantitative Concept]

Phrase: "respectively"

Phrase: "("

Phrase: "not significant, n=4"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1273937:Not significant [Finding]
   812   C0237881:significant [Quantitative Concept]
   812   C0750502:Significant [Idea or Concept]
   812   C1518422:Not [Functional Concept]
   812   C1546944:Significant [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.122: View larger version (23K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(23K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.123: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.124: Desensitization of the [Ca2+]m increase and insulin secretion, but not of ATP generation, in INS-1 cells. 

Phrase: "Desensitization of the [Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0178702:Desensitization [Therapeutic or Preventive Procedure]
   770   C1709852:Desensitization [Molecular Function]

Phrase: "]m increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]

Phrase: "and"

Phrase: "insulin secretion,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "but"

Phrase: "not of ATP generation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0079411:Generation [Temporal Concept]
   770   C1518422:Not [Functional Concept]
   770   C3146294:Generation [Activity]

Phrase: "in"

Phrase: "INS-1 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.125: ATP levels and [Ca2+]m were monitored in INS-1 cells stably expressing cytosolic luciferase and mitochondrial aequorin, respectively. 

Phrase: "ATP levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "and ["

Phrase: "Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "were"

Phrase: "monitored in"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   799   C0030695:monitor [Health Care Activity]
   799   C0150369:monitor [Health Care Activity]
   799   C0181904:Monitor [Medical Device]
   799   C0596972:Monitor [Medical Device]
   799   C1521743:Monitor [Professional or Occupational Group]
   799   C1704646:Monitor [Manufactured Object]

Phrase: "INS-1 cells stably"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "cytosolic luciferase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "mitochondrial aequorin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001694:Aequorin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "respectively."
Processing 00000000.tx.126: The cells were perifused in a thermostatted photon detection chamber, and the effluent was collected from cells expressing aequorin. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "perifused in a thermostatted photon detection chamber,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0086805:Photon [Substance]
   748   C0935616:Chamber [Body Part, Organ, or Organ Component]
   748   C1511790:Detection [Therapeutic or Preventive Procedure]
   714   C1710386:Thermostat [Manufactured Object]

Phrase: "and"

Phrase: "the effluent"

Phrase: "was"

Phrase: "collected from cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0007634:Cells [Cell]
   790   C1516695:Collected [Idea or Concept]
   790   C1516698:Collected [Functional Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "aequorin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001694:Aequorin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.127: Cells were stimulated with methyl succinate (met-Suc) and monitored for ATP levels (A), [Ca2+]m (B), and insulin secretion (C). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stimulated with methyl succinate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0066765:methyl succinate [Organic Chemical]
   770   C0038617:succinate [Organic Chemical]
   770   C0220918:succinate [Organic Chemical,Pharmacologic Substance]
   770   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "(met-Suc"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0038617:succinate [Organic Chemical]
   861   C0220918:succinate [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "monitored for ATP levels"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   770   C0441889:Levels [Qualitative Concept]
   737   C0030695:monitor [Health Care Activity]
   737   C0150369:monitor [Health Care Activity]
   737   C0181904:Monitor [Medical Device]
   737 E C0456079:Level [Classification]
   737   C0596972:Monitor [Medical Device]
   737   C1521743:Monitor [Professional or Occupational Group]
   737 E C1547707:Level [Geographic Area]
   737   C1704646:Monitor [Manufactured Object]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m (B),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.128: The two latter measurements were performed on the same cells. 

Phrase: "The two latter measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0242485:measurements [Functional Concept]

Phrase: "were"

Phrase: "performed on the same cells."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   760   C0007634:Cells [Cell]
   760   C0445247:Same [Qualitative Concept]
   760   C0884358:Performed [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
   726 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.129: The stimulus was given for 5min with a 5-min interval. 

Phrase: "The stimulus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234402:Stimulus [Phenomenon or Process]

Phrase: "was"

Phrase: "given for 5min"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1442162:GIVEN [Conceptual Entity]
   790   C1550718:given [Idea or Concept]
   790   C3244317:given [Intellectual Product]
   756 E C1947971:Give [Functional Concept]

Phrase: "with a 5-min interval."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
Processing 00000000.tx.130: D shows the resensitization of the mitochondria after 30min as evident from the methyl succinate-induced increase in [Ca2+]m. 

Phrase: "D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the resensitization of the mitochondria"

Phrase: "after 30min"

Phrase: "as evident"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0332120:Evidence [Functional Concept]

Phrase: "from the methyl succinate-induced increase in [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.131: The traces are representative of at least three independent experiments. 

Phrase: "The traces"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0442822:Trace [Quantitative Concept]
   966   C1524031:Trace [Qualitative Concept]
   966   C1883002:Trace [Functional Concept]

Phrase: "are"

Phrase: "representative of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1882932:Representative [Activity]

Phrase: "at least three independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.132: [Ca2+]m in Permeabilized INS-1 Cells-- The aequorin-expressing cells were then permeabilized with Staphylococcus -toxin, which forms very small holes (2-3-nm diameter) in the plasma membrane (38, 8). 

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m in Permeabilized"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0441923:M+ [Intellectual Product]

Phrase: "INS-1 Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "-"

Phrase: "-"

Phrase: "The aequorin-expressing cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "permeabilized with Staphylococcus -toxin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0040548:Staphylococcus toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   770   C0038170:Staphylococcus [Bacterium]
   770   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]

Phrase: "which"

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "very small holes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0544726:Holes [Finding]
   793 E C1823381:hole [Gene or Genome]
   793 E C1881060:HOLE [Event]

Phrase: "(2-3-nm diameter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1301886:Diameter [Quantitative Concept]

Phrase: ")"

Phrase: "in the plasma membrane"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "(38,"

Phrase: "8"

Phrase: ")."
Processing 00000000.tx.133: In this preparation, the cytosolic composition and hence the mitochondrial environment can be controlled. 

Phrase: "In this preparation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0455052:Preparation [Health Care Activity]
  1000   C1521827:Preparation [Functional Concept]

Phrase: "the cytosolic composition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0486616:Composition [Clinical Attribute]
   861   C1555710:composition [Idea or Concept]

Phrase: "and"

Phrase: "hence"

Phrase: "the mitochondrial environment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014406:Environment [Spatial Concept]

Phrase: "can"

Phrase: "be"

Phrase: "controlled."
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C2587213:Controlled [Functional Concept]
   966 E C0243148:control [Qualitative Concept]
   966 E C1550141:Control [Substance]
   966 E C1882979:Control [Conceptual Entity]
   966 E C3274648:Control [Qualitative Concept]
Processing 00000000.tx.134: The permeabilized cells were perifused with an intracellular type buffer containing a permissive free Ca2+ concentration of 500nM and 10mM ATP. 

Phrase: "The permeabilized cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "perifused with an intracellular type buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0175996:intracellular [Cell Component]
   753   C0178719:Intracellular [Spatial Concept]
   753   C0332307:Type [Qualitative Concept]
   753   C1547052:*Type [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "a permissive free Ca2+ concentration of 500nM"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0086045:Concentration [Mental Process]
   748   C0332296:free [Functional Concept]
   748   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C1446561:Concentration [Quantitative Concept]
   748   C1880497:Free [Qualitative Concept]
   748   C1996904:Free [Qualitative Concept]

Phrase: "and"

Phrase: "10mM ATP."
Processing 00000000.tx.135: The first addition of 1mM succinate induced a large transient peak in [Ca2+]m, but the second pulse 5min later was ineffective (Fig. 4A). 

Phrase: "The first addition of 1mM succinate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1883712:Addition [Functional Concept]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "a large transient peak in [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "but"

Phrase: "the second pulse 5min"

Phrase: "later"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0205087:Late [Temporal Concept]

Phrase: "was"

Phrase: "ineffective"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3242229:ineffective [Idea or Concept]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.136: The desensitization phenomenon was also observed with -glycerophosphate, which transfers reducing equivalents from the cytosol to the same site (complex II) in the electron transport chain as succinate (Fig. 4B). 

Phrase: "The desensitization phenomenon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1882365:Phenomenon [Phenomenon or Process]

Phrase: "was"

Phrase: "also"

Phrase: "observed with -glycerophosphate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0017881:glycerophosphate [Carbohydrate,Lipid]
   790   C1441672:Observed [Functional Concept]

Phrase: "which"

Phrase: "transfers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040671:Transfer [Mental Process]
  1000   C0728827:Transfers [Finding]
  1000   C1705822:Transfer [Activity]

Phrase: "reducing equivalents from the cytosol"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0439185:Equivalents [Quantitative Concept]
   726 E C0205163:Equivalent [Qualitative Concept]

Phrase: "to the same site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "(complex II"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2263441:complex II [Molecular Function]

Phrase: ")"

Phrase: "in the electron transport chain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2244392:electron transport chain [Molecular Function]
   827   C0337112:Chain [Manufactured Object]
   827   C1524075:Chain [Idea or Concept]
   734   C0013846:Electron Transport [Molecular Function]

Phrase: "as succinate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038617:succinate [Organic Chemical]
  1000   C0220918:succinate [Organic Chemical,Pharmacologic Substance]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.137: Glycerophosphate has been shown to produce ATP in isolated islet mitochondria (43). 

Phrase: "Glycerophosphate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017881:glycerophosphate [Carbohydrate,Lipid]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "produce"

Phrase: "ATP in isolated islet mitochondria"

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.138: More important, using 5-min intervals, succinate desensitized the effect of -glycerophosphate on [Ca2+]m and vice versa (Fig. 4, C and D). 

Phrase: "More important,"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "5-min intervals,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1272706:intervals [Temporal Concept]
   793 E C1552654:Interval [Idea or Concept]
   793 E C1552713:Interval [Intellectual Product]

Phrase: "succinate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038617:succinate [Organic Chemical]
  1000   C0220918:succinate [Organic Chemical,Pharmacologic Substance]

Phrase: "desensitized"

Phrase: "the effect of -glycerophosphate on [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "vice versa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0814670:vice [Idea or Concept]

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "C"

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.139: This latter effect shows that the desensitization mechanism appears to be located downstream of the oxidation of FADH2. 

Phrase: "This latter effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the desensitization mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "located downstream of the oxidation of FADH2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0030011:Oxidation [Molecular Function]
   748   C0044036:FADH2 [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0522506:Downstream [Spatial Concept]
Processing 00000000.tx.140: It should be noted that when Ca2+ was substituted with the Ca2+ surrogate Sr2+ in the intracellular type buffer, a very similar desensitization of the mitochondrial [Sr2+] increase was observed upon repeated succinate stimulation.2 As for intact cells, the desensitization was not an irreversible process due to a toxic effect or to the loss of functional aequorin since resensitization was observed after 30min using either succinate or -glycerophosphate (Fig. 5, A and B, respectively). 

Phrase: "It"

Phrase: "should"

Phrase: "be"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "when"

Phrase: "Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "was"

Phrase: "substituted with the Ca2+ surrogate Sr2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "in the intracellular type buffer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "a very similar desensitization of the mitochondrial"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0178702:Desensitization [Therapeutic or Preventive Procedure]
   748   C1709852:Desensitization [Molecular Function]

Phrase: "[Sr2+"

Phrase: "] increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "observed upon repeated succinate stimulation.2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0038617:succinate [Organic Chemical]
   753   C0205341:Repeated [Functional Concept]
   753   C0220918:succinate [Organic Chemical,Pharmacologic Substance]
   753   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   753   C1441672:Observed [Functional Concept]
   753   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "As for intact cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0682538:intact cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "the desensitization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0178702:Desensitization [Therapeutic or Preventive Procedure]
  1000   C1709852:Desensitization [Molecular Function]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "an irreversible process due to a toxic effect"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0013277:Due Process [Regulation or Law]
   744   C1184743:Process [Body Part, Organ, or Organ Component]
   744   C1522240:Process [Phenomenon or Process]

Phrase: "or to the loss of functional aequorin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0001694:Aequorin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205245:Functional [Functional Concept]
   748   C0542341:Functional [Functional Concept]
   748   C1517945:Loss [Quantitative Concept]
   748   C2700217:Functional [Conceptual Entity]

Phrase: "since"

Phrase: "resensitization"

Phrase: "was"

Phrase: "observed after 30min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "either succinate or -glycerophosphate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017881:glycerophosphate [Carbohydrate,Lipid]

Phrase: "(Fig. 5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.141: View larger version (19K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(19K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.142: 4.  

Phrase: "4."
Processing 00000000.tx.143: Desensitization of [Ca2+]m increases by succinate and -glycerophosphate in permeabilized INS-1 cells. 

Phrase: "Desensitization of [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "increases by succinate"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   790   C0038617:succinate [Organic Chemical]
   790   C0220918:succinate [Organic Chemical,Pharmacologic Substance]
   790   C0442805:Increase [Functional Concept]
   734 E C1517378:Gain [Quantitative Concept]
   706 E C0205217:Increased [Quantitative Concept]
   706 E C0439661:Acquired [Temporal Concept]
   706 E C0442808:Increasing [Functional Concept]
   706 E C1301820:Obtain [Functional Concept]
   706 E C1706701:Acquire [Activity]
   706 E C3245488:acquired [Intellectual Product]

Phrase: "and -"

Phrase: "glycerophosphate in permeabilized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0017881:glycerophosphate [Carbohydrate,Lipid]

Phrase: "INS-1 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.144: INS-1 cells expressing mitochondrial aequorin were permeabilized with -toxin and perifused with an intracellular type buffer containing 500nM free Ca2+ and 10mM ATP. 

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "mitochondrial aequorin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001694:Aequorin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "permeabilized with -toxin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]

Phrase: "and"

Phrase: "perifused with an intracellular type buffer containing 500nM free Ca2+"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   739   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   739   C0175996:intracellular [Cell Component]
   739   C0178719:Intracellular [Spatial Concept]
   739   C0332256:Containing [Functional Concept]
   739   C0332296:free [Functional Concept]
   739   C0332307:Type [Qualitative Concept]
   739   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   739   C1547052:*Type [Quantitative Concept]
   739   C1880497:Free [Qualitative Concept]
   739   C1996904:Free [Qualitative Concept]
   739   C2700400:Containing [Activity]

Phrase: "and"

Phrase: "10mM ATP."
Processing 00000000.tx.145: The effects of repeated exposures to a 1mM concentration of the tricarboxylic acid cycle intermediate succinate (Suc) (A) and to a 2mM concentration of the cytosolic glycerophosphate shuttle intermediate DL--glycerophosphate (Glycerol-P) (B) on [Ca2+]m were recorded. 

Phrase: "The effects of repeated exposures"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "to a 1mM concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of the tricarboxylic acid cycle intermediate succinate (Suc)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0038617:succinate [Organic Chemical]
   804   C0220918:succinate [Organic Chemical,Pharmacologic Substance]
   717   C0008858:Tricarboxylic Acid Cycle [Molecular Function]

Phrase: "(A)"

Phrase: "and to a 2mM concentration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]
   760   C1515981:And [Idea or Concept]

Phrase: "of the cytosolic glycerophosphate shuttle intermediate DL--glycerophosphate"

Phrase: "(Glycerol-P) (B) on [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "were"

Phrase: "recorded."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0034869:Record [Intellectual Product]
Processing 00000000.tx.146: The stimulus was given for 5min with a 5-min interval. 

Phrase: "The stimulus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234402:Stimulus [Phenomenon or Process]

Phrase: "was"

Phrase: "given for 5min"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1442162:GIVEN [Conceptual Entity]
   790   C1550718:given [Idea or Concept]
   790   C3244317:given [Intellectual Product]
   756 E C1947971:Give [Functional Concept]

Phrase: "with a 5-min interval."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
Processing 00000000.tx.147: C shows that the succinate-induced increase in [Ca2+]m desensitized the mitochondria for a following exposure to DL--glycerophosphate, and the converse effect can be seen in D.

Phrase: "C"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the succinate-induced increase in [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "desensitized"

Phrase: "the mitochondria for a following exposure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0026237:Mitochondria [Cell Component]

Phrase: "to DL--glycerophosphate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017881:glycerophosphate [Carbohydrate,Lipid]

Phrase: "and"

Phrase: "the converse effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "seen in D."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0205397:Seen [Qualitative Concept]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]
Processing 00000000.tx.148: The traces are representative of at least three independent experiments. 

Phrase: "The traces"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0442822:Trace [Quantitative Concept]
   966   C1524031:Trace [Qualitative Concept]
   966   C1883002:Trace [Functional Concept]

Phrase: "are"

Phrase: "representative of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1882932:Representative [Activity]

Phrase: "at least three independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.149: View larger version (24K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(24K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.150: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.151: Resensitization of [Ca2+]m in permeabilized INS-1 cells. 

Phrase: "Resensitization of [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m in permeabilized"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0441923:M+ [Intellectual Product]

Phrase: "INS-1 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.152: INS-1 cells expressing mitochondrial aequorin were permeabilized with -toxin and perifused with an intracellular type buffer containing 500nM free Ca2+ and 10mM ATP. 

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "mitochondrial aequorin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001694:Aequorin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "permeabilized with -toxin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]

Phrase: "and"

Phrase: "perifused with an intracellular type buffer containing 500nM free Ca2+"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   739   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   739   C0175996:intracellular [Cell Component]
   739   C0178719:Intracellular [Spatial Concept]
   739   C0332256:Containing [Functional Concept]
   739   C0332296:free [Functional Concept]
   739   C0332307:Type [Qualitative Concept]
   739   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   739   C1547052:*Type [Quantitative Concept]
   739   C1880497:Free [Qualitative Concept]
   739   C1996904:Free [Qualitative Concept]
   739   C2700400:Containing [Activity]

Phrase: "and"

Phrase: "10mM ATP."
Processing 00000000.tx.153: The cells were stimulated twice for 5min with 1mM succinate (Suc) with a 30-min interval (A). 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "twice for 5min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1720725:Twice [Intellectual Product]
   790   C1948050:Twice [Quantitative Concept]

Phrase: "with 1mM succinate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0038617:succinate [Organic Chemical]
   861   C0220918:succinate [Organic Chemical,Pharmacologic Substance]

Phrase: "(Suc"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038617:succinate [Organic Chemical]
  1000   C0220918:succinate [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "with a 30-min interval"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   734   C0456693:/30 min [Temporal Concept]
   734   C1442458:30 min [Temporal Concept]

Phrase: "(A"

Phrase: ")."
Processing 00000000.tx.154: A similar resensitization was observed when -glycerophosphate (Glycerol-P) was used as a mitochondrial electron donor (B). 

Phrase: "A similar resensitization"

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "when -"

Phrase: "glycerophosphate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017881:glycerophosphate [Carbohydrate,Lipid]

Phrase: "(Glycerol-P)"

Phrase: "was"

Phrase: "used as a mitochondrial electron donor"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   790   C0599915:electron donor [Chemical Viewed Functionally]
   753   C0013018:Donor [Population Group]
   753   C0013852:Electron [Quantitative Concept]
   753   C0026237:Mitochondrial [Cell Component]
   753   C0040288:Donor [Population Group]
   753   C0521451:Mitochondrial [Functional Concept]
   753   C1273517:used [Finding]
   753   C1527169:Donor NOS [Finding]
   753   C3463986:Electron [Bird]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.155: The traces are representative of at least three independent experiments. 

Phrase: "The traces"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0442822:Trace [Quantitative Concept]
   966   C1524031:Trace [Qualitative Concept]
   966   C1883002:Trace [Functional Concept]

Phrase: "are"

Phrase: "representative of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1882932:Representative [Activity]

Phrase: "at least three independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.156: To examine whether a [Ca2+]m increase per se causes desensitization to subsequent challenges, the free Ca2+ concentration of the buffer was varied. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "whether"

Phrase: "a [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "per se"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "desensitization to subsequent challenges,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0178702:Desensitization [Therapeutic or Preventive Procedure]
   770   C1709852:Desensitization [Molecular Function]

Phrase: "the free Ca2+ concentration of the buffer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0086045:Concentration [Mental Process]
   748   C0332296:free [Functional Concept]
   748   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C1446561:Concentration [Quantitative Concept]
   748   C1880497:Free [Qualitative Concept]
   748   C1996904:Free [Qualitative Concept]

Phrase: "was"

Phrase: "varied."
Processing 00000000.tx.157: To this end, the extramitochondrial [Ca2+] in permeabilized cells was kept at permissive 500nM levels or raised to 1.3M. 

Phrase: "To this end,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "the extramitochondrial"

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]"

Phrase: "in permeabilized cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "kept at permissive 500nM levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0441889:Levels [Qualitative Concept]
   726   C0333118:Keep [Functional Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "or"

Phrase: "raised to 1.3M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332060:3M [Health Care Related Organization]
   770   C0442818:Raised [Quantitative Concept]
Processing 00000000.tx.158: The stimulation for 5min with 1.3M Ca2+ induced a first transient peak in [Ca2+]m up to 1.7M, followed by a second phase that tended to stabilize to the level of extramitochondrial Ca2+. 

Phrase: "The stimulation for 5min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   770   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "with 1.3M Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "a first transient peak in [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m up to 1.7M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]

Phrase: "followed by a second phase"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0205390:Phase [Temporal Concept]
   760   C0205436:Second [Quantitative Concept]
   760   C0457385:Second [Temporal Concept]
   760   C0565930:/second [Quantitative Concept]
   760   C1561503:second [Idea or Concept]
   760   C1705190:Second [Qualitative Concept]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "that"

Phrase: "tended"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "stabilize to the level of extramitochondrial Ca2+."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0184512:stabilize [Qualitative Concept]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.159: The second exposure to 1.3M Ca2+ showed a complete desensitization of the first transient increase in [Ca2+]m above the equilibration value between the two compartments (Fig. 6). 

Phrase: "The second exposure to 1.3M Ca2+"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0332157:Exposure to [Clinical Attribute]
           Exposure
   748   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a complete desensitization of the first transient increase in [Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0178702:Desensitization [Therapeutic or Preventive Procedure]
   739   C1709852:Desensitization [Molecular Function]

Phrase: "]m above the equilibration value"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]

Phrase: "between the two compartments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1185625:Compartments [Body Space or Junction]
   861   C1382196:Compartments [Natural Phenomenon or Process]
   827 E C2986730:Compartment [Spatial Concept]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.160: Imposing the same experimental protocol except for a shortening of the exposures to 1.3M Ca2+ to 30s instead of 5min did not result in any desensitization of the [Ca2+]m increase.2 The latter observation is in agreement with results reported for permeabilized HeLa cells expressing mitochondrial aequorin (44). 

Phrase: "Imposing"

Phrase: "the same experimental protocol except for a shortening of the exposures"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   738   C0442711:Protocol [Intellectual Product]
   738   C1507394:Protocol [Intellectual Product]
   738   C1522729:Protocol [Intellectual Product]
   738   C2348563:Protocol [Intellectual Product]

Phrase: "to 1.3M Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "to 30s"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0227073:30S [Body Part, Organ, or Organ Component]

Phrase: "instead of 5min"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "result in any desensitization of the [Ca2+"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0178702:Desensitization [Therapeutic or Preventive Procedure]
   748   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C1709852:Desensitization [Molecular Function]
   748   C2825142:Result [Finding]

Phrase: "]m increase.2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
   827   C0442805:Increase [Functional Concept]

Phrase: "The latter observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302523:Observation [Research Activity]
   861   C0700325:observation [Health Care Activity]
   861   C1964257:Observation [Diagnostic Procedure]
   789 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "is in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0680240:Agreement [Social Behavior]

Phrase: "with results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "reported for permeabilized HeLa cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   806   C0018873:HeLa Cells [Cell]
           HeLa
   760   C0007634:Cells [Cell]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C3282337:Cells [Cell]
   760   C3496591:Reported [Clinical Attribute]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
   726 E C3273238:Report [Intellectual Product]

Phrase: "expressing"

Phrase: "mitochondrial aequorin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001694:Aequorin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.161: View larger version (13K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(13K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.162: 6.  

Phrase: "6."
Processing 00000000.tx.163: Desensitization of [Ca2+]m increases by extramitochondrial Ca2+ in permeabilized INS-1 cells. 

Phrase: "Desensitization of [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "increases by extramitochondrial Ca2+"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0442805:Increase [Functional Concept]
   770   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   715 E C1517378:Gain [Quantitative Concept]

Phrase: "in permeabilized"

Phrase: "INS-1 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.164: INS-1 cells expressing mitochondrial aequorin were permeabilized with -toxin and perifused with a buffer containing 500nM free Ca2+ and 10mM ATP. 

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "mitochondrial aequorin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001694:Aequorin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "permeabilized with -toxin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]

Phrase: "and"

Phrase: "perifused with a buffer containing 500nM free Ca2+"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0332256:Containing [Functional Concept]
   744   C0332296:free [Functional Concept]
   744   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C1880497:Free [Qualitative Concept]
   744   C1996904:Free [Qualitative Concept]
   744   C2700400:Containing [Activity]

Phrase: "and"

Phrase: "10mM ATP."
Processing 00000000.tx.165: The effects of repeated 5-min exposures to 1.3M free Ca2+ (final concentration) in the buffer on [Ca2+]m were tested with a 5-min interval. 

Phrase: "The effects of repeated 5-min exposures"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "to 1.3M free Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "(final concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: ")"

Phrase: "in the buffer on [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "were"

Phrase: "tested with a 5-min interval."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0392366:tested [Intellectual Product]
   753   C0702093:/min [Temporal Concept]
   753   C1272706:Interval [Temporal Concept]
   753   C1552654:Interval [Idea or Concept]
   753   C1552713:Interval [Intellectual Product]
   719 E C0022885:Test [Laboratory Procedure]
   719 E C0039593:Test [Functional Concept]
Processing 00000000.tx.166: The trace is representative of four independent experiments. 

Phrase: "The trace"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0442822:Trace [Quantitative Concept]
  1000   C1524031:Trace [Qualitative Concept]
  1000   C1883002:Trace [Functional Concept]

Phrase: "is"

Phrase: "representative of four independent experiments."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]
Processing 00000000.tx.167: Effect of Inhibitors of the Electron Transport Chain on [Ca2+]m in Permeabilized INS-1 Cells-- Succinate dehydrogenase generates FADH2, with the subsequent transfer of electrons to complex II of the electron transport chain (45). 

Phrase: "Effect of Inhibitors of the Electron Transport Chain on [Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1280500:Effect [Qualitative Concept]
   739   C2348382:Effect [Qualitative Concept]

Phrase: "]m in Permeabilized"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0441923:M+ [Intellectual Product]

Phrase: "INS-1 Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "--"

Phrase: "Succinate dehydrogenase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0038615:Succinate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0038617:succinate [Organic Chemical]
   861   C0220918:succinate [Organic Chemical,Pharmacologic Substance]

Phrase: "generates"

Phrase: "FADH2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0044036:FADH2 [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "with the subsequent transfer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040671:Transfer [Mental Process]
   861   C1705822:Transfer [Activity]

Phrase: "of electrons"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0013852:Electrons [Quantitative Concept]
   966 E C3463986:Electron [Bird]
   916 E C0013850:Electronic [Manufactured Object]
   916 E C1547561:Electronic [Idea or Concept]

Phrase: "to complex II"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2263441:complex II [Molecular Function]

Phrase: "of the electron transport chain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2244392:electron transport chain [Molecular Function]
   827   C0337112:Chain [Manufactured Object]
   827   C1524075:Chain [Idea or Concept]
   734   C0013846:Electron Transport [Molecular Function]

Phrase: "(45"

Phrase: ")."
Processing 00000000.tx.168: In permeabilized cells, the effect of succinate on the increase in [Ca2+]m was not affected by the presence of 100M rotenone, which blocks complex I of the respiratory chain (Fig. 7A). 

Phrase: "In permeabilized cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "the effect of succinate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on the increase in [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected by the presence of 100M rotenone,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0035871:Rotenone [Hazardous or Poisonous Substance,Organic Chemical]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C0392760:Affected [Functional Concept]
   748   C1314939:Affected [Functional Concept]
   714 E C0001721:Affect [Mental Process]

Phrase: "which"

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "complex I of the respiratory chain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   858   C1167290:respiratory chain complex I [Cell Component]
   820   C2363240:Respiratory Complex I [Amino Acid, Peptide, or Protein,Enzyme]
   790   C2245017:Complex I [Cell Component]
   753   C0021966:I- [Inorganic Chemical]
   753   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(Fig. 7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.169: On the other hand, the succinate-induced [Ca2+]m increase was completely abolished by 10M antimycin A, an inhibitor of complex III (Fig. 7B). 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "the succinate-induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205263:Induced [Functional Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "abolished by 10M antimycin A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0003387:Antimycin A [Antibiotic,Organic Chemical]
   760   C0052078:antimycin [Antibiotic,Organic Chemical]
   760   C1442446:10M [Temporal Concept]

Phrase: "an inhibitor of complex III"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(Fig. 7B"

Phrase: ")."
Processing 00000000.tx.170: This suggests that the desensitization occurs between complex II and the uniporter, the latter mediating Ca2+ uptake in the mitochondria. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the desensitization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0178702:Desensitization [Therapeutic or Preventive Procedure]
  1000   C1709852:Desensitization [Molecular Function]

Phrase: "occurs between complex II"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C2263441:complex II [Molecular Function]
   770   C0439855:Complex [Qualitative Concept]
   770   C1704241:Complex [Chemical Viewed Structurally]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]

Phrase: "and"

Phrase: "the uniporter,"

Phrase: "the latter"

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "Ca2+ uptake in the mitochondria."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243144:Uptake [Physiologic Function]
   760   C0347980:% uptake [Quantitative Concept]
   760   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.171: View larger version (19K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(19K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.172: 7.  

Phrase: "7."
Processing 00000000.tx.173: Effect of selective electron transport chain blockers on succinate-induced increases in [Ca2+]m in permeabilized INS-1 cells. 

Phrase: "Effect of selective electron transport chain blockers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "on succinate-induced increases in [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m in permeabilized"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0441923:M+ [Intellectual Product]

Phrase: "INS-1 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.174: Rotenone (100M), which inhibits complex I of the respiratory chain, did not alter the rise in [Ca2+]m during exposure to 1mM succinate (Suc) (A). 

Phrase: "Rotenone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035871:Rotenone [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "(100M"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "complex I of the respiratory chain,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   858   C1167290:respiratory chain complex I [Cell Component]
   820   C2363240:Respiratory Complex I [Amino Acid, Peptide, or Protein,Enzyme]
   790   C2245017:Complex I [Cell Component]
   753   C0021966:I- [Inorganic Chemical]
   753   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the rise in [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m during exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0441923:M+ [Intellectual Product]

Phrase: "to 1mM succinate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0038617:succinate [Organic Chemical]
   861   C0220918:succinate [Organic Chemical,Pharmacologic Substance]

Phrase: "(Suc"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038617:succinate [Organic Chemical]
  1000   C0220918:succinate [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "(A"

Phrase: ")."
Processing 00000000.tx.175: Antimycin A (10M), which inhibits complex III of the chain, blocked the succinate-induced rise in [Ca2+]m (B). 

Phrase: "Antimycin A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003387:Antimycin A [Antibiotic,Organic Chemical]
   861   C0052078:antimycin [Antibiotic,Organic Chemical]

Phrase: "(10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "complex III of the chain,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1167295:complex III [Cell Component]
   806   C1176474:Complex III [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0439070:III [Intellectual Product]
   760   C1705160:III [Qualitative Concept]

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "the succinate-induced rise in [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m (B)."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.176: The traces are representative of at least three independent experiments. 

Phrase: "The traces"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0442822:Trace [Quantitative Concept]
   966   C1524031:Trace [Qualitative Concept]
   966   C1883002:Trace [Functional Concept]

Phrase: "are"

Phrase: "representative of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1882932:Representative [Activity]

Phrase: "at least three independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.177: Effect of Free Ca2+ Concentration on m and [Ca2+]m in Permeabilized INS-1 Cells-- Ca2+ influx into the mitochondria through the uniporter is driven by the hyperpolarization of the mitochondrial membrane under conditions of permissive [Ca2+]c. 

Phrase: "Effect of Free Ca2+ Concentration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and ["

Phrase: "Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m in Permeabilized"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0441923:M+ [Intellectual Product]

Phrase: "INS-1 Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "--"

Phrase: "Ca2+ influx into the mitochondria"

Phrase: "through the uniporter"

Phrase: "is"

Phrase: "driven by the hyperpolarization of the mitochondrial membrane"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0596952:Mitochondrial membrane [Cell Component]
   767   C2262820:membrane hyperpolarization [Cell Function]
   744   C0025255:Membrane [Tissue]
   744   C0026237:Mitochondrial [Cell Component]
   744   C0521451:Mitochondrial [Functional Concept]
   744   C0596901:Membrane [Cell Component]
   744   C1706182:Membrane [Manufactured Object]
   711   C0013126:Drive [Mental Process]

Phrase: "under conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "of permissive"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   928   C0031166:Permissivenesses [Individual Behavior]
   928   C1521846:Permissiveness [Pathologic Function]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.178: The hyperpolarization occurs by the transfer of reducing equivalents to the electron transport chain and the resulting extrusion of protons. 

Phrase: "The hyperpolarization"

Phrase: "occurs by the transfer of reducing equivalents"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0040671:Transfer [Mental Process]
   748   C0392756:Reducing [Qualitative Concept]
   748   C0439185:Equivalents [Quantitative Concept]
   748   C1705822:Transfer [Activity]
   748   C1709305:Occur [Activity]
   748   C2745955:OCCUR [Temporal Concept]
   714 E C0205163:Equivalent [Qualitative Concept]

Phrase: "to the electron transport chain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2244392:electron transport chain [Molecular Function]
   827   C0337112:Chain [Manufactured Object]
   827   C1524075:Chain [Idea or Concept]
   734   C0013846:Electron Transport [Molecular Function]

Phrase: "and"

Phrase: "the resulting extrusion of protons."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0443213:Extrusion [Finding]
Processing 00000000.tx.179: We next tried to discriminate between the respiratory chain and the uniporter as the site of desensitization. 

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "tried"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "discriminate between the respiratory chain"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0162362:Respiratory Chain [Molecular Function]
   806   C1325653:respiratory chain [Cell Component]
   760   C0205235:Discriminate [Qualitative Concept]
   760   C0337112:Chain [Manufactured Object]
   760   C0521346:respiratory [Functional Concept]
   760   C1524075:Chain [Idea or Concept]
   760   C1546767:Respiratory [Intellectual Product]

Phrase: "and"

Phrase: "the uniporter as the site of desensitization."
Processing 00000000.tx.180: For this purpose, we studied the effect of succinate on [Ca2+]m in permeabilized cells perifused with nonpermissive (resting) or permissive free [Ca2+] (100and 500nM, respectively). 

Phrase: "For this purpose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1285529:Purpose [Functional Concept]

Phrase: "we"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the effect of succinate on [Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "]m in permeabilized cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0599757:cells m [Cell]
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]

Phrase: "perifused with nonpermissive"

Phrase: "("

Phrase: "resting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0035253:Resting [Daily or Recreational Activity]
  1000   C1512899:resting [Cell]
   966 E C1622890:ResT [Molecular Function]

Phrase: ")"

Phrase: "or"

Phrase: "permissive free"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332296:free [Functional Concept]
   861   C1880497:Free [Qualitative Concept]
   861   C1996904:Free [Qualitative Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]"

Phrase: "(100and 500nM,"

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.181: Under both conditions, succinate was efficient in hyperpolarizing the mitochondrial membrane (Fig. 8, A and B). 

Phrase: "Under both conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "succinate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038617:succinate [Organic Chemical]
  1000   C0220918:succinate [Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "efficient in hyperpolarizing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0442799:Efficient [Qualitative Concept]
   718 E C0013682:Efficiency [Quantitative Concept]

Phrase: "the mitochondrial membrane"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0596952:Mitochondrial membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "(Fig. 8,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.182: The dissipation of the proton gradient by carbonyl cyanide p-trifluoromethoxyphenylhydrazone (1M) completely depolarized m, indicating the polarized state of the mitochondrial membrane. 

Phrase: "The dissipation of the proton gradient"

Phrase: "by carbonyl cyanide p-trifluoromethoxyphenylhydrazone"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007044:Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone [Organic Chemical,Pharmacologic Substance]
  1000   C0667454:carbonylcyanide p-trifluoromethoxyphenylhydrazone [Organic Chemical]

Phrase: "(1M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470296:1M [Quantitative Concept]

Phrase: ")"

Phrase: "completely depolarized m,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "indicating"

Phrase: "the polarized state of the mitochondrial membrane."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1301808:State [Geographic Area]
   748   C1442792:State [Functional Concept]
   748   C3148680:State [Geographic Area]
Processing 00000000.tx.183: We then monitored [Ca2+]m using these two conditions sequentially. 

Phrase: "We then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "monitored"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "these two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "conditions"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
  1000   C0012634:condition [Disease or Syndrome]
  1000   C0348080:Condition [Qualitative Concept]
  1000   C1705253:Condition [Conceptual Entity]
   944 E C0040607:Training [Educational Activity]
   944 E C0220931:Training [Educational Activity]
   944 E C0336809:Train [Manufactured Object]
   944 E C1552514:Train [Manufactured Object]
   944 E C2673163:training [Qualitative Concept]
   916 E C0009647:Conditioned [Mental Process]

Phrase: "sequentially."
Processing 00000000.tx.184: As expected, the first addition of 1mM succinate did not increase [Ca2+]m when the permeabilized cells were perifused with 100 nM Ca2+. 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "the first addition of 1mM succinate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1883712:Addition [Functional Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "when"

Phrase: "the permeabilized cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "perifused with 100 nM Ca2+."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0312860:NM [Cell Function]
   760   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.185: One min later, the [Ca2+] of the buffer was clamped at 500nM, which raised the [Ca2+]m base line to ~300 nM. 

Phrase: "One min later,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0702093:/min [Temporal Concept]

Phrase: "the [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]"

Phrase: "of the buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "was"

Phrase: "clamped at 500nM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0175721:Clamp [Medical Device]
   756   C1705942:Clamp [Manufactured Object]
   756   C1883710:Clamp [Functional Concept]

Phrase: "which"

Phrase: "raised"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442818:Raised [Quantitative Concept]

Phrase: "the [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m base line to ~300 nM."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0312860:NM [Cell Function]
Processing 00000000.tx.186: Four min later, thus 5min after the first stimulation, the addition of succinate induced a large increase in [Ca2+]m (Fig. 8C). 

Phrase: "Four min later,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0702093:/min [Temporal Concept]

Phrase: "thus 5min after the first stimulation,"

Phrase: "the addition of succinate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1883712:Addition [Functional Concept]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "a large increase in [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]"

Phrase: "m ("

Phrase: "Fig. 8C"

Phrase: ")."
Processing 00000000.tx.187: This strongly suggests that the uniporter itself is undergoing desensitization since during both succinate exposures the mitochondrial membrane was hyperpolarized due to the activation of the electron transport chain. 

Phrase: "This strongly"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the uniporter"

Phrase: "itself"

Phrase: "is"

Phrase: "undergoing"

Phrase: "desensitization since during both succinate exposures"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0178702:Desensitization [Therapeutic or Preventive Procedure]
   753   C1709852:Desensitization [Molecular Function]

Phrase: "the mitochondrial membrane"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0596952:Mitochondrial membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "was"

Phrase: "hyperpolarized due to the activation of the electron transport chain."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   782   C2244392:electron transport chain [Molecular Function]
   777   C2259159:activation of transport [Cell Function]
   760   C0013846:Electron Transport [Molecular Function]
   760   C0678226:Due to [Functional Concept]
           due
   757   C1550030:Transport To [Idea or Concept]
   739   C0005528:Transport, NOS [Cell Function]
   739   C0013852:Electron [Quantitative Concept]
   739   C0337112:Chain [Manufactured Object]
   739   C1317949:Transport [Manufactured Object]
   739   C1524075:Chain [Idea or Concept]
   739   C1879547:Activation [Activity]
   739   C3146286:Due [Idea or Concept]
   739   C3463986:Electron [Bird]
   739   C3495449:transport [Medical Device]
Processing 00000000.tx.188: To support this contention further, m was recorded on an attached permeabilized cell preparation under similar conditions as those used for [Ca2+]m in Fig. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "this contention further,"

Phrase: "m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "was"

Phrase: "recorded on an attached permeabilized cell preparation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0920433:cell preparation [Laboratory Procedure]
   748   C0007634:Cell [Cell]
   748   C0231441:Attached [Finding]
   748   C0455052:Preparation [Health Care Activity]
   748   C1269647:Cell [Cell]
   748   C1521827:Preparation [Functional Concept]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   714   C0034869:Record [Intellectual Product]

Phrase: "under similar conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "as those"

Phrase: "used for"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   833   C1273517:used [Finding]
   799 E C0042153:use [Functional Concept]
   799 E C0457083:Use [Functional Concept]
   799 E C1947944:Use [Intellectual Product]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.189: 4. 

Phrase: "4."
Processing 00000000.tx.190: Two successive 5-min exposures to 1mM succinate were separated by a washing period of 5min (Fig. 8D). 

Phrase: "Two successive 5-min exposures to 1mM succinate"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   754   C0332157:Exposure to [Clinical Attribute]
       E   Exposure
   744   C0274281:exposures [Injury or Poisoning]
   744   C0728853:exposures [Phenomenon or Process]

Phrase: "were"

Phrase: "separated by a washing period of 5min"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0086972:Separated [Finding]
   748   C0439531:/period [Temporal Concept]
   748   C0441648:Washing [Activity]
   748   C0443299:separated [Spatial Concept]
   748   C0687118:Separated [Functional Concept]
   748   C1948053:Period [Temporal Concept]

Phrase: "(Fig. 8D"

Phrase: ")."
Processing 00000000.tx.191: Both exposures to succinate induced a hyperpolarization of m of similar magnitude, taking into account the slight drift of the base line. 

Phrase: "Both exposures to succinate"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   816   C0332157:Exposure to [Clinical Attribute]
       E   Exposure
   770   C0274281:exposures [Injury or Poisoning]
   770   C0728853:exposures [Phenomenon or Process]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "a hyperpolarization of m of similar magnitude,"

Phrase: "taking into"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1515187:Take [Health Care Activity]

Phrase: "account"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1551359:account [Idea or Concept]
  1000   C2741673:Account # [Clinical Attribute]
  1000   C2981730:Account [Classification]

Phrase: "the slight drift of the base line."
Processing 00000000.tx.192: View larger version (24K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(24K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.193: 8.  

Phrase: "8."
Processing 00000000.tx.194: Effect of free Ca2+ concentration on m and [Ca2+]m in permeabilized INS-1 cells. 

Phrase: "Effect of free Ca2+ concentration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and ["

Phrase: "Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m in permeabilized"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0441923:M+ [Intellectual Product]

Phrase: "INS-1 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.195: Rhodamine 123(Rh-123) was used to monitor m, and 1mM succinate (Suc) caused a hyperpolarization using buffers adjusted to either 100nM Ca2+ (A) or 500nM Ca2+ (B). 

Phrase: "Rhodamine 123"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0073192:Rhodamine 123 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0600322:Rhodamine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(Rh-123"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035493:Rh [Element, Ion, or Isotope]
   861   C2699077:Rh- [Classification]
   861   C2699078:Rh+ [Classification]

Phrase: ")"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "monitor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030695:monitor [Health Care Activity]
  1000   C0150369:monitor [Health Care Activity]
  1000   C0181904:Monitor [Medical Device]
  1000   C0596972:Monitor [Medical Device]
  1000   C1521743:Monitor [Professional or Occupational Group]
  1000   C1704646:Monitor [Manufactured Object]

Phrase: "m,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "1mM succinate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0038617:succinate [Organic Chemical]
   861   C0220918:succinate [Organic Chemical,Pharmacologic Substance]

Phrase: "(Suc"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038617:succinate [Organic Chemical]
  1000   C0220918:succinate [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a hyperpolarization"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "buffers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006353:Buffers [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "adjusted to either 100nM Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0456081:Adjusted [Functional Concept]
   760   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "(A)"

Phrase: "or"

Phrase: "500nM Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.196: In C, [Ca2+]m was monitored, and repeated exposures to 1mM succinate were applied first under the basal non-responding condition of 100nM Ca2+ and 5min later under the permissive condition of 500nM Ca2+. 

Phrase: "In C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "was"

Phrase: "monitored"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]

Phrase: ","

Phrase: "and"

Phrase: "repeated exposures to 1mM succinate"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0332157:Exposure to [Clinical Attribute]
       E   Exposure
   760   C0274281:exposures [Injury or Poisoning]
   760   C0728853:exposures [Phenomenon or Process]

Phrase: "were"

Phrase: "applied"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0185125:Applied [Health Care Activity]
   966 E C1632850:Apply [Functional Concept]
   966 E C1879355:Apply [Functional Concept]

Phrase: "first under the basal non-responding condition of 100nM Ca2+"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   739   C0012634:condition [Disease or Syndrome]
   739   C0205112:Basal [Spatial Concept]
   739   C0205435:First [Quantitative Concept]
   739   C0348080:Condition [Qualitative Concept]
   739   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   739   C1279901:First [Qualitative Concept]
   739   C1518422:Non [Functional Concept]
   739   C1705253:Condition [Conceptual Entity]

Phrase: "and"

Phrase: "5min"

Phrase: "later under the permissive condition of 500nM Ca2+."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C0205087:Late [Temporal Concept]
Processing 00000000.tx.197: It can be seen that even after the hyperpolarization of m by succinate at 100nM Ca2+, a normal rise in [Ca2+]m can be induced at permissive [Ca2+] 5min later with the same substance without any desensitization (C). 

Phrase: "It"

Phrase: "can"

Phrase: "be"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "that even after the hyperpolarization of m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441923:M+ [Intellectual Product]

Phrase: "by succinate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038617:succinate [Organic Chemical]
  1000   C0220918:succinate [Organic Chemical,Pharmacologic Substance]

Phrase: "at 100nM Ca2+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "a normal rise in [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "can"

Phrase: "be"

Phrase: "induced at permissive"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205263:Induced [Functional Concept]
   718   C0031166:Permissivenesses [Individual Behavior]
   718   C1521846:Permissiveness [Pathologic Function]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "] 5min"

Phrase: "later with the same substance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0205087:Late [Temporal Concept]

Phrase: "without any desensitization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0178702:Desensitization [Therapeutic or Preventive Procedure]
  1000   C1709852:Desensitization [Molecular Function]

Phrase: "(C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.198: In D, m was hyperpolarized during both exposures to 1mM succinate in attached permeabilized INS-1 cells perifused with the 500nM free Ca2+ intracellular buffer. 

Phrase: "In D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "was"

Phrase: "hyperpolarized during both exposures"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0274281:exposures [Injury or Poisoning]
   770   C0728853:exposures [Phenomenon or Process]
   737 E C0332157:Exposure [Clinical Attribute]

Phrase: "to 1mM succinate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0038617:succinate [Organic Chemical]
   861   C0220918:succinate [Organic Chemical,Pharmacologic Substance]

Phrase: "in attached permeabilized"

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "perifused with the 500nM free Ca2+ intracellular buffer."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0175996:intracellular [Cell Component]
   744   C0178719:Intracellular [Spatial Concept]
   744   C0332296:free [Functional Concept]
   744   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C1880497:Free [Qualitative Concept]
   744   C1996904:Free [Qualitative Concept]
Processing 00000000.tx.199: The traces are representative of at least three independent experiments. 

Phrase: "The traces"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0442822:Trace [Quantitative Concept]
   966   C1524031:Trace [Qualitative Concept]
   966   C1883002:Trace [Functional Concept]

Phrase: "are"

Phrase: "representative of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1882932:Representative [Activity]

Phrase: "at least three independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.200: FCCP, carbonyl cyanide p-trifluoromethoxyphenylhydrazone; 

Phrase: "FCCP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007044:FCCP [Organic Chemical,Pharmacologic Substance]

Phrase: "carbonyl cyanide p-trifluoromethoxyphenylhydrazone"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007044:Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone [Organic Chemical,Pharmacologic Substance]
  1000   C0667454:carbonylcyanide p-trifluoromethoxyphenylhydrazone [Organic Chemical]

Phrase: ";"
Processing 00000000.tx.201: a. u., arbitrary units. 

Phrase: "a. u.,"

Phrase: "arbitrary units."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   966   C0439183:Arbitrary unit [Quantitative Concept]
   861   C0439148:Units [Quantitative Concept]
   861   C1264693:*Arbitrary [Quantitative Concept]
   861   C1519795:Units [Quantitative Concept]
   827 E C1704753:Unit [Manufactured Object]
   827 E C1880519:Unit [Quantitative Concept]
Processing 00000000.tx.202: Effect of Extramitochondrial Ca2+ on Succinate Oxidation to CO2 in Permeabilized INS-1 Cells-- The hyperpolarizing action of succinate on m is catalyzed by succinate dehydrogenase, a Ca2+-independent enzyme (45). 

Phrase: "Effect of Extramitochondrial Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on Succinate Oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "to CO2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347816:Co2+ [Element, Ion, or Isotope]

Phrase: "in Permeabilized"

Phrase: "INS-1 Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "-"

Phrase: "-"

Phrase: "The hyperpolarizing action of succinate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441472:Action [Functional Concept]
   760   C3266814:Action [Activity]

Phrase: "on m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "is"

Phrase: "catalyzed by succinate dehydrogenase,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0038615:Succinate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0038617:succinate [Organic Chemical]
   770   C0220918:succinate [Organic Chemical,Pharmacologic Substance]

Phrase: "a Ca2+-independent enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "(45"

Phrase: ")."
Processing 00000000.tx.203: By contrast, CO2 formation from succinate requires a complete turn of the tricarboxylic acid cycle, which involves the two Ca2+-sensitive enzymes NAD-isocitrate dehydrogenase and -ketoglutarate dehydrogenase (15). 

Phrase: "By contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "CO2 formation from succinate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "requires"

Phrase: "a complete turn of the tricarboxylic acid cycle,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0541749:turn [Finding]
   744   C1709743:Turn [Spatial Concept]

Phrase: "which"

Phrase: "involves"

Phrase: "the two Ca2+-sensitive enzymes NAD-isocitrate dehydrogenase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   845   C0022157:NAD Isocitrate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
           Isocitrate Dehydrogenase
   795   C0022160:isocitrate [Organic Chemical]
   795   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0220861:isocitrate [Biologically Active Substance,Organic Chemical]

Phrase: "and -"

Phrase: "ketoglutarate dehydrogenase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0599061:ketoglutarate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.204: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.205: 9, [2,3-14C]succinate oxidation to 14CO2 was stimulated 4-fold (p<0.01) by an increase in the extramitochondrial [Ca2+] from 100to 500nM in the permeabilized INS-1 cells. 

Phrase: "9,"

Phrase: "[2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3-14C"

Phrase: "]succinate oxidation to 14CO2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030011:Oxidation [Molecular Function]

Phrase: "was"

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "4-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "(p<0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "by an increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "in the extramitochondrial"

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]"

Phrase: "from 100to 500nM"

Phrase: "in the permeabilized"

Phrase: "INS-1 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.206: View larger version (10K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(10K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.207: 9.  

Phrase: "9."
Processing 00000000.tx.208: Effect of extramitochondrial Ca2+ (100or 500nM) on [2,3-14C]succinate oxidation to 14CO2 in -toxin-permeabilized INS-1 cells. 

Phrase: "Effect of extramitochondrial Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "(100or 500nM"

Phrase: ")"

Phrase: "on [2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720176:On [Functional Concept]
   861   C1720294:On [Intellectual Product]

Phrase: "3-14C"

Phrase: "]succinate oxidation to 14CO2 in -toxin-permeabilized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0030011:Oxidation [Molecular Function]

Phrase: "INS-1 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.209: Cells were first permeabilized for 10min and then equilibrated for another 10-min period in the corresponding intracellular buffers prior to a 1-h stimulation with 1mM [2,3-14C]succinate (0.1Ci/chamber). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "permeabilized for 10min"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "equilibrated for another 10-min period"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0456692:/10 min [Temporal Concept]
   753   C0439531:/period [Temporal Concept]
   753   C0702093:/min [Temporal Concept]
   753   C1948053:Period [Temporal Concept]

Phrase: "in the corresponding intracellular buffers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffers [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "prior to a 1-h stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   812   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "with 1mM"

Phrase: "[2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3-14C"

Phrase: "]succinate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038617:succinate [Organic Chemical]
  1000   C0220918:succinate [Organic Chemical,Pharmacologic Substance]

Phrase: "(0.1Ci/chamber"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: ")."
Processing 00000000.tx.210: Values are the meanS.E. 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "the meanS.E."
Processing 00000000.tx.211: (n=3) of one experiment representative of four independent experiments.  

Phrase: "(n=3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "of one experiment representative"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1882932:Representative [Activity]

Phrase: "of four independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.212: DISCUSSION Top Abstract Introduction Procedures Results Discussion References Mitochondria play a key role in the metabolism-secretion coupling of the pancreatic beta cell (9-11, 13, 20). 

Phrase: "DISCUSSION Top Abstract Introduction Procedures Results Discussion"

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a key role in the metabolism-secretion coupling of the pancreatic beta cell"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   735   C0035820:Role [Social Behavior]
   735   C1705810:Role [Conceptual Entity]

Phrase: "(9-11,"

Phrase: "13,"

Phrase: "20"

Phrase: ")."
Processing 00000000.tx.213: Evidence for a desensitization of this organelle is presented here, and the phenomenon may account for the documented desensitization of stimulated insulin secretion observed in pancreatic beta cells (1, 4, 5) and derived cell lines (23, 46). 

Phrase: "Evidence for a desensitization of this organelle"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "is"

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "here,"

Phrase: "and"

Phrase: "the phenomenon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882365:Phenomenon [Phenomenon or Process]

Phrase: "may"

Phrase: "account for the documented desensitization of stimulated insulin secretion"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   764   C1256369:insulin secretion [Cell Function]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0036536:secretion [Biologic Function]
   742   C0036537:Secretion [Body Substance]
   742   C0178702:Desensitization [Therapeutic or Preventive Procedure]
   742   C1301725:Documented [Health Care Activity]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1551359:account [Idea or Concept]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C1609436:documented [Idea or Concept]
   742   C1709852:Desensitization [Molecular Function]
   742   C1948023:Stimulated [Natural Phenomenon or Process]
   742   C2741673:Account # [Clinical Attribute]
   742   C2981730:Account [Classification]
   708 E C1301746:document [Intellectual Product]
   708 E C1547673:Document [Intellectual Product]

Phrase: "observed in pancreatic beta cells"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   862   C0030281:Pancreatic beta Cells [Cell]
           Beta cell
   760   C0007634:Cells [Cell]
   760   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   760   C0330390:Beta [Plant]
   760   C0439096:Beta [Intellectual Product]
   760   C1441672:Observed [Functional Concept]
   760   C2004068:Beta [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "derived cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0007600:Cell lines [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "(23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "46"

Phrase: ")."
Processing 00000000.tx.214: In the present study, repeated exposures of rat islets to stimulatory glucose concentrations led to attenuated insulin exocytosis. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "repeated exposures of rat islets"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0274281:exposures [Injury or Poisoning]
   760   C0728853:exposures [Phenomenon or Process]
   726 E C0332157:Exposure [Clinical Attribute]

Phrase: "to stimulatory glucose concentrations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   884   C0427743:Glucose concentration [Laboratory Procedure]
   884   C1287281:Glucose concentration [Laboratory or Test Result]
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "led to attenuated insulin exocytosis."
Meta Candidates (Total=13; Excluded=6; Pruned=0; Remaining=7)
   760   C0015283:Exocytosis [Cell Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0332161:Attenuated [Qualitative Concept]
   760   C0599946:Attenuated [Activity]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C1708698:LED [Manufactured Object]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C1522538:Lead [Functional Concept]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.215: This desensitized secretory response was also observed with the mitochondrial substrate methyl succinate or with KCl-induced depolarization of the plasma membrane. 

Phrase: "This desensitized secretory response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "was"

Phrase: "also"

Phrase: "observed with the mitochondrial substrate methyl succinate"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0066765:methyl succinate [Organic Chemical]
   748   C0026237:Mitochondrial [Cell Component]
   748   C0038617:succinate [Organic Chemical]
   748   C0220918:succinate [Organic Chemical,Pharmacologic Substance]
   748   C0521451:Mitochondrial [Functional Concept]
   748   C1441672:Observed [Functional Concept]
   748   C1710236:Substrate [Manufactured Object]

Phrase: "or with KCl-induced depolarization of the plasma membrane."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   764   C0007603:Plasma membrane [Cell Component]
   762   C1816453:membrane depolarization [Cell Function]
   742   C0025255:Membrane [Tissue]
   742   C0032105:Plasma [Body Substance]
   742   C0205263:Induced [Functional Concept]
   742   C0596901:Membrane [Cell Component]
   742   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   742   C1706182:Membrane [Manufactured Object]
Processing 00000000.tx.216: In primary islet cells, desensitization of the mitochondria was indicated by the impaired rise of [Ca2+]m during the second exposure to methyl succinate or high potassium. 

Phrase: "In primary islet cells,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   901   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   867 E C1522529:Islet Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "desensitization of the mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0178702:Desensitization [Therapeutic or Preventive Procedure]
   770   C1709852:Desensitization [Molecular Function]

Phrase: "was"

Phrase: "indicated by the impaired rise of [Ca2+"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0221099:Impaired [Functional Concept]
   748   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0684336:Impaired [Pathologic Function]
   748   C1444656:Indicated [Finding]

Phrase: "]m during the second exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]

Phrase: "to methyl succinate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0066765:methyl succinate [Organic Chemical]
   861   C0038617:succinate [Organic Chemical]
   861   C0220918:succinate [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "high potassium."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0856882:high potassium [Finding]
   861   C0032821:Potassium [Element, Ion, or Isotope]
   861   C0597277:Potassium+ [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.217: This suggests that desensitization of Ca2+ entry into the mitochondria can be evoked by either tricarboxylic acid cycle intermediates or simply by increasing the [Ca2+]c. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that desensitization of Ca2+ entry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0178702:Desensitization [Therapeutic or Preventive Procedure]
   760   C1709852:Desensitization [Molecular Function]

Phrase: "into the mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "can"

Phrase: "be"

Phrase: "evoked by either tricarboxylic acid cycle intermediates"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C0008858:Tricarboxylic Acid Cycle [Molecular Function]
   778   C0040887:tricarboxylic acid [Organic Chemical]
   748   C0001128:Acid [Chemical]
   748   C0202406:Acid [Laboratory Procedure]
   748   C1444748:Evoked [Qualitative Concept]
   748   C1511572:Cycle [Temporal Concept]
   714   C0205103:Intermediate [Spatial Concept]
   714   C1550465:intermediate [Idea or Concept]
   714   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "or"

Phrase: "simply by increasing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0442808:Increasing [Functional Concept]
   756 E C0442805:Increase [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "the [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.218: Nevertheless, to be considered a pure mitochondrial effect, the latter condition implies that the [Ca2+]c increase would reach the same value during the second exposure to KCl or at least a level well above the threshold of the uniporter (400M) (21, 16). 

Phrase: "Nevertheless,"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "a pure mitochondrial effect,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1280500:Effect [Qualitative Concept]
   827   C2348382:Effect [Qualitative Concept]

Phrase: "the latter condition"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0012634:condition [Disease or Syndrome]
   861   C0348080:Condition [Qualitative Concept]
   861   C1705253:Condition [Conceptual Entity]
   789 E C0009647:Conditioned [Mental Process]
   789 E C1701901:Conditional [Qualitative Concept]
   789 E C1963686:Conditional [Functional Concept]
   761 E C1519605:Conditionality [Conceptual Entity]

Phrase: "implies"

Phrase: "that"

Phrase: "the [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]

Phrase: "would"

Phrase: "reach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reach [Organism Function]

Phrase: "the same value during the second exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0449993:Second value [Intellectual Product]
   748   C1522609:Value [Quantitative Concept]

Phrase: "to KCl"

Phrase: "or at least"

Phrase: "a level well above the threshold of the uniporter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0441889:Level [Qualitative Concept]
   742   C0456079:Level [Classification]
   742   C1547707:Level [Geographic Area]
   742   C2946261:Level [Pharmacologic Substance]

Phrase: "(400M"

Phrase: ")"

Phrase: "(21,"

Phrase: "16"

Phrase: ")."
Processing 00000000.tx.219: Although desensitization of the [Ca2+]c response to KCl occurs in INS-1 cells, it still attains micromolar concentrations during the second pulse (23). 

Phrase: "Although"

Phrase: "desensitization of the [Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0178702:Desensitization [Therapeutic or Preventive Procedure]
   770   C1709852:Desensitization [Molecular Function]

Phrase: "]c response to KCl"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0871261:Response [Organism Attribute]
   770   C1704632:Response [Finding]
   770   C1706817:Response [Intellectual Product]
   770   C2911692:Response [Mental Process]

Phrase: "occurs in"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1709305:Occur [Activity]
   833   C2745955:OCCUR [Temporal Concept]

Phrase: "INS-1 cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "it still"

Phrase: "attains"

Phrase: "micromolar concentrations during the second pulse"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0086045:Concentrations [Mental Process]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.220: The [Ca2+]c reduction is less marked than that of [Ca2+]m and therefore probably plays only a minor role in the mitochondrial desensitization. 

Phrase: "The [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0301630:Reduction [Natural Phenomenon or Process]
   861   C0392756:Reduction [Qualitative Concept]
   861   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "marked than that of [Ca2+"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0522501:Marked [Qualitative Concept]
   760   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C1706089:Marked [Qualitative Concept]

Phrase: "]m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "therefore probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0750492:Probably [Idea or Concept]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a minor role in the mitochondrial desensitization."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.221: In intact INS-1 cells stimulated with methyl succinate, the blunted insulin secretion correlated with an inhibited increase in [Ca2+]m upon a second exposure. 

Phrase: "In intact"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205266:Intact [Qualitative Concept]
  1000   C1554187:Intact [Idea or Concept]

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "stimulated with methyl succinate,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0066765:methyl succinate [Organic Chemical]
   770   C0038617:succinate [Organic Chemical]
   770   C0220918:succinate [Organic Chemical,Pharmacologic Substance]
   770   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "the blunted insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C1256369:insulin secretion [Cell Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "correlated with an inhibited increase in [Ca2+"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0311403:Inhibited [Qualitative Concept]
   748   C0442805:Increase [Functional Concept]
   748   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C1707520:Correlated [Qualitative Concept]

Phrase: "]m upon a second exposure."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.222: In contrast, methyl succinate-induced generation of ATP, reflecting the activation of oxidative phosphorylation, did not display any desensitization, as demonstrated in luciferase-expressing INS-1 cells. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "methyl succinate-induced generation of ATP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0079411:Generation [Temporal Concept]
   753   C3146294:Generation [Activity]

Phrase: "reflecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:Reflecting [Mental Process]

Phrase: "the activation of oxidative phosphorylation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   844   C2248185:activation of phosphorylation [Cell Function]
   760   C1879547:Activation [Activity]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "any desensitization,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0178702:Desensitization [Therapeutic or Preventive Procedure]
  1000   C1709852:Desensitization [Molecular Function]

Phrase: "as"

Phrase: "demonstrated in luciferase-expressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]

Phrase: "INS-1 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.223: The cellular responses to glucose are also desensitized with respect to [Ca2+]m and insulin secretion (23), but not in terms of ATP generation (see "Results"). 

Phrase: "The cellular responses to glucose"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0871261:responses [Organism Attribute]
   726 E C1704632:Response [Finding]
   726 E C1706817:Response [Intellectual Product]
   726 E C2911692:Response [Mental Process]

Phrase: "are"

Phrase: "also"

Phrase: "desensitized with respect to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0679133:respect [Social Behavior]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "not in terms of ATP generation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0079411:Generation [Temporal Concept]
   753   C1518422:Not [Functional Concept]
   753   C3146294:Generation [Activity]
   719   C1515273:Term [Temporal Concept]
   719   C1705313:Term [Idea or Concept]
   719   C2826302:TERM [Intellectual Product]

Phrase: "(see ""Results"""
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: ")."
Processing 00000000.tx.224: This dichotomy between two mitochondrial parameters, [Ca2+]m and ATP generation, can be explained by reduced Ca2+ uptake into the mitochondrial matrix, despite a fully activated respiratory chain. 

Phrase: "This dichotomy between two mitochondrial parameters,"

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "ATP generation,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0079411:Generation [Temporal Concept]
   861   C3146294:Generation [Activity]
   768 E C1414672:Genesis [Gene or Genome]
   768 E C2984892:Genesis [Gene or Genome]

Phrase: "can"

Phrase: "be"

Phrase: "explained by reduced Ca2+ uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0243144:Uptake [Physiologic Function]
   760   C0347980:% uptake [Quantitative Concept]
   760   C0392756:Reduced [Qualitative Concept]
   760   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "into the mitochondrial matrix,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1510421:Mitochondrial matrix [Cell Component]
   861   C0026237:Mitochondrial [Cell Component]
   861   C0521451:Mitochondrial [Functional Concept]
   861   C1704640:Matrix [Spatial Concept]
   861   C1706515:Matrix [Body Substance]

Phrase: "despite a fully"

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "respiratory chain."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162362:Respiratory Chain [Molecular Function]
  1000   C1325653:respiratory chain [Cell Component]
   861   C0337112:Chain [Manufactured Object]
   861   C1524075:Chain [Idea or Concept]
Processing 00000000.tx.225: To investigate the underlying mechanism, we have used permeabilized cells to clamp extramitochondrial [Ca2+] at a fixed permissive level of 500nM. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the underlying mechanism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "we"

Phrase: "have"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "permeabilized cells to"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "clamp"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0175721:Clamp [Medical Device]
  1000   C1705942:Clamp [Manufactured Object]
  1000   C1883710:Clamp [Functional Concept]

Phrase: "extramitochondrial"

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]"

Phrase: "at a fixed permissive level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]

Phrase: "of 500nM."
Processing 00000000.tx.226: This was chosen to ascertain Ca2+ uptake by the uniporter (16). 

Phrase: "This"

Phrase: "was"

Phrase: "chosen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707391:Chosen [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ascertain"

Phrase: "Ca2+ uptake by the uniporter"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243144:Uptake [Physiologic Function]
   760   C0347980:% uptake [Quantitative Concept]
   760   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.227: Under these conditions, the succinate-induced increase in [Ca2+]m was completely desensitized during the second stimulation. 

Phrase: "Under these conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "the succinate-induced increase in [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "was"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "desensitized during the second stimulation."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0205436:Second [Quantitative Concept]
   760   C0457385:Second [Temporal Concept]
   760   C0565930:/second [Quantitative Concept]
   760   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   760   C1561503:second [Idea or Concept]
   760   C1705190:Second [Qualitative Concept]
   760   C1948023:Stimulation [Natural Phenomenon or Process]
Processing 00000000.tx.228: This inhibitory effect takes place downstream of complex II and is apparently not due to altered transport of succinate into the mitochondria. 

Phrase: "This inhibitory effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "takes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515187:Take [Health Care Activity]

Phrase: "place downstream of complex II"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C2263441:complex II [Molecular Function]
   760   C0439855:Complex [Qualitative Concept]
   760   C0442504:Place [Spatial Concept]
   760   C0522506:Downstream [Spatial Concept]
   760   C1704241:Complex [Chemical Viewed Structurally]
   760   C1704765:Place [Functional Concept]
   760   C1882509:Place [Activity]
   760   C3496241:place [Disease or Syndrome]

Phrase: "and"

Phrase: "is"

Phrase: "apparently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750541:apparently [Idea or Concept]

Phrase: "not due to altered transport of succinate"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0678226:Due to [Functional Concept]
           due
   774   C1159613:succinate transport [Cell Function]
   774   C1550030:Transport To [Idea or Concept]
   748   C0005528:Transport, NOS [Cell Function]
   748   C0038617:succinate [Organic Chemical]
   748   C0220918:succinate [Organic Chemical,Pharmacologic Substance]
   748   C0392747:Altered [Functional Concept]
   748   C1317949:Transport [Manufactured Object]
   748   C1518422:Not [Functional Concept]
   748   C3146286:Due [Idea or Concept]
   748   C3495449:transport [Medical Device]

Phrase: "into the mitochondria."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]
Processing 00000000.tx.229: Indeed, the desensitizing effect of succinate could be reproduced with -glycerophosphate. 

Phrase: "Indeed,"

Phrase: "the desensitizing effect of succinate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "could"

Phrase: "be"

Phrase: "reproduced with -glycerophosphate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0017881:glycerophosphate [Carbohydrate,Lipid]
Processing 00000000.tx.230: This latter compound transfers reducing equivalents from the glycolytic intermediate dihydroxyacetone phosphate to the same complex II of the electron transport chain without being transported into the mitochondrial matrix (47). 

Phrase: "This latter compound"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205198:Compound [Qualitative Concept]
   861   C1706082:Compound [Chemical]

Phrase: "transfers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040671:Transfer [Mental Process]
  1000   C0728827:Transfers [Finding]
  1000   C1705822:Transfer [Activity]

Phrase: "reducing equivalents from the glycolytic intermediate dihydroxyacetone phosphate"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0439185:Equivalents [Quantitative Concept]
   711 E C0205163:Equivalent [Qualitative Concept]

Phrase: "to the same complex II"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C2263441:complex II [Molecular Function]

Phrase: "of the electron transport chain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2244392:electron transport chain [Molecular Function]
   827   C0337112:Chain [Manufactured Object]
   827   C1524075:Chain [Idea or Concept]
   734   C0013846:Electron Transport [Molecular Function]

Phrase: "without"

Phrase: "being"

Phrase: "transported into the mitochondrial matrix"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C1510421:Mitochondrial matrix [Cell Component]
   781   C0678851:mitochondrial transport [Cell Function]
   760   C0026237:Mitochondrial [Cell Component]
   760   C0521451:Mitochondrial [Functional Concept]
   760   C1704640:Matrix [Spatial Concept]
   760   C1706515:Matrix [Body Substance]
   726   C0005528:Transport, NOS [Cell Function]
   726   C1317949:Transport [Manufactured Object]
   726   C3495449:transport [Medical Device]

Phrase: "(47"

Phrase: ")."
Processing 00000000.tx.231: Thus, the desensitization evoked by both of the FADH2-producing substances (succinate and -glycerophosphate) is very similar, and a common mode of action is underscored by a clear cross-desensitization. 

Phrase: "Thus,"

Phrase: "the desensitization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0178702:Desensitization [Therapeutic or Preventive Procedure]
  1000   C1709852:Desensitization [Molecular Function]

Phrase: "evoked by both of the FADH2-producing substances"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0044036:FADH2 [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0439861:Substances [Substance]
   744   C1444748:Evoked [Qualitative Concept]

Phrase: "(succinate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038617:succinate [Organic Chemical]
  1000   C0220918:succinate [Organic Chemical,Pharmacologic Substance]

Phrase: "and -"

Phrase: "glycerophosphate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017881:glycerophosphate [Carbohydrate,Lipid]

Phrase: ")"

Phrase: "is"

Phrase: "very similar,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "a common mode of action"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C1524059:mode of action [Functional Concept]
   760   C1513371:Mode [Functional Concept]
   760   C1705738:Mode [Quantitative Concept]
   760   C2347637:Mode [Quantitative Concept]
   760   C2348146:Mode [Quantitative Concept]

Phrase: "is"

Phrase: "underscored by a clear cross-desensitization."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0178702:Desensitization [Therapeutic or Preventive Procedure]
   753   C1709852:Desensitization [Molecular Function]
   753   C2828360:Cross [Conceptual Entity]
   753   C2963144:Clear [Qualitative Concept]
Processing 00000000.tx.232: In addition, succinate-induced increases in [Ca2+]m were blocked by inhibiting complex III with antimycin A, but not by rotenone, which blocks complex I.We therefore conclude that the site of desensitization is located downstream of complex II either in the electron transport chain or at the uniporter through which Ca2+ flows into the mitochondria. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "succinate-induced increases in [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "were"

Phrase: "blocked by inhibiting complex III"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   806   C1167295:complex III [Cell Component]
   806   C1176474:Complex III [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0028778:Blocked [Pathologic Function]
   760   C0332206:Blocked [Functional Concept]
   760   C0439070:III [Intellectual Product]
   760   C0439855:Complex [Qualitative Concept]
   760   C1704241:Complex [Chemical Viewed Structurally]
   760   C1705160:III [Qualitative Concept]
   760   C2983591:BLOCKED [Research Activity]
   760   C3463820:Inhibiting [Activity]
   726 E C1533157:Block [Substance]
   726 E C1706084:Block [Geographic Area]
   726 E C2828370:Block [Quantitative Concept]

Phrase: "with antimycin A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003387:Antimycin A [Antibiotic,Organic Chemical]
   861   C0052078:antimycin [Antibiotic,Organic Chemical]

Phrase: "but"

Phrase: "not by rotenone,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035871:Rotenone [Hazardous or Poisonous Substance,Organic Chemical]
   790   C1518422:Not [Functional Concept]

Phrase: "which"

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "complex I."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2245017:Complex I [Cell Component]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "We therefore"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that"

Phrase: "the site of desensitization"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C2945843:Site of [Qualitative Concept]
   770   C0205145:Site [Spatial Concept]
   770   C1515974:Site [Body Location or Region]
   770   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "located downstream of complex II either"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C2263441:complex II [Molecular Function]
   753   C0439855:Complex [Qualitative Concept]
   753   C0522506:Downstream [Spatial Concept]
   753   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "in the electron transport chain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2244392:electron transport chain [Molecular Function]
   827   C0337112:Chain [Manufactured Object]
   827   C1524075:Chain [Idea or Concept]
   734   C0013846:Electron Transport [Molecular Function]

Phrase: "or at the uniporter"

Phrase: "through which Ca2+ flows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0806140:flows [Natural Phenomenon or Process]

Phrase: "into the mitochondria."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]
Processing 00000000.tx.233: The desensitization does not appear to be due to inhibition of the respiratory chain, the activation of which was not impaired. 

Phrase: "The desensitization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0178702:Desensitization [Therapeutic or Preventive Procedure]
  1000   C1709852:Desensitization [Molecular Function]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be due to inhibition of the respiratory chain,"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   770   C0162362:Respiratory Chain [Molecular Function]
   770   C0678226:Due to [Functional Concept]
           due
   770   C1325653:respiratory chain [Cell Component]
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C0337112:Chain [Manufactured Object]
   744   C0521346:respiratory [Functional Concept]
   744   C1524075:Chain [Idea or Concept]
   744   C1546767:Respiratory [Intellectual Product]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C2987476:Be [Conceptual Entity]
   744   C3146286:Due [Idea or Concept]
   744   C3463820:Inhibition [Activity]

Phrase: "the activation of which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "impaired."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]
Processing 00000000.tx.234: This is demonstrated by the hyperpolarization of m irrespective of extramitochondrial Ca2+. 

Phrase: "This"

Phrase: "is"

Phrase: "demonstrated by the hyperpolarization of m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]

Phrase: "irrespective of extramitochondrial Ca2+."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.235: Moreover, the sole hyperpolarization of m by succinate did not attenuate the [Ca2+]m increase during a second exposure to the stimulus, further suggesting that the change in m can be dissociated from the increase in [Ca2+]m. 

Phrase: "Moreover,"

Phrase: "the sole hyperpolarization of m"

Phrase: "by succinate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038617:succinate [Organic Chemical]
  1000   C0220918:succinate [Organic Chemical,Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "attenuate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599946:Attenuate [Activity]

Phrase: "the [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m increase during a second exposure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "to the stimulus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234402:Stimulus [Phenomenon or Process]

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the change in m"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0025320:The change [Physiologic Function]
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1705241:Change [Quantitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "dissociated from the increase in [Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0442805:Increase [Functional Concept]
   753   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.236: Indeed, m did not desensitize following two applications of succinate. 

Phrase: "Indeed,"

Phrase: "m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "desensitize"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "two applications of succinate."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0185125:applications [Health Care Activity]
   737 E C1947919:Application [Intellectual Product]
   737 E C2347934:Application [Intellectual Product]
   737 E C3539080:APPLICATION [Quantitative Concept]
Processing 00000000.tx.237: The desensitization of the [Ca2+]m response induced by KCl in intact cells is indirect evidence for the inhibitory effect of Ca2+ alone. 

Phrase: "The desensitization of the [Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0178702:Desensitization [Therapeutic or Preventive Procedure]
   760   C1709852:Desensitization [Molecular Function]

Phrase: "]m response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "induced by KCl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205263:Induced [Functional Concept]

Phrase: "in intact cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0682538:intact cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "indirect evidence for the inhibitory effect of Ca2+ alone."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0332120:Evidence of [Functional Concept]
           Evidence
Processing 00000000.tx.238: KCl (20mM) evokes increases in [Ca2+]c up to 2M (23). 

Phrase: "KCl"

Phrase: "(20mM"

Phrase: ")"

Phrase: "evokes"

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "in [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c up to 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1553033:[c] [Quantitative Concept]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.239: In permeabilized cells, direct applications of Ca2+ in this concentration range clearly caused desensitization of the [Ca2+]m response to the second pulse. 

Phrase: "In permeabilized cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "direct applications of Ca2+"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0185125:applications [Health Care Activity]
   737 E C1947919:Application [Intellectual Product]
   737 E C2347934:Application [Intellectual Product]
   737 E C3539080:APPLICATION [Quantitative Concept]

Phrase: "in this concentration range clearly caused desensitization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0178702:Desensitization [Therapeutic or Preventive Procedure]
   804   C1709852:Desensitization [Molecular Function]

Phrase: "of the [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m response to the second pulse."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]
Processing 00000000.tx.240: This applies to the transient [Ca2+]m increase, but not to the equilibration of the ion between the extra- and intramitochondrial compartments, which suggests two independent pathways for mitochondrial Ca2+ uptake. 

Phrase: "This"

Phrase: "applies to the transient"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0040704:Transient [Population Group]
   770   C0185125:Apply [Health Care Activity]
   770   C0205374:Transient [Temporal Concept]
   770   C1632850:Apply [Functional Concept]
   770   C1879355:Apply [Functional Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m increase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]

Phrase: "but"

Phrase: "not to the equilibration of the ion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0022023:Ion [Element, Ion, or Isotope]
   748   C1518422:Not [Functional Concept]
   748   C1700702:ION [Functional Concept]

Phrase: "between the extra-"

Phrase: "and"

Phrase: "intramitochondrial compartments,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1185625:Compartments [Body Space or Junction]
   861   C1382196:Compartments [Natural Phenomenon or Process]
   827 E C2986730:Compartment [Spatial Concept]

Phrase: "which"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "two independent pathways for mitochondrial Ca2+ uptake."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1704259:Pathways [Molecular Function]
   748   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.241: Moreover, the desensitization requires a complete activation involving a new steady state. 

Phrase: "Moreover,"

Phrase: "the desensitization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0178702:Desensitization [Therapeutic or Preventive Procedure]
  1000   C1709852:Desensitization [Molecular Function]

Phrase: "requires"

Phrase: "a complete activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "a new steady state."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0678587:steady state [Natural Phenomenon or Process]
   827   C0205361:Steady [Qualitative Concept]
   827   C1301808:State [Geographic Area]
   827   C1442792:State [Functional Concept]
   827   C3148680:State [Geographic Area]
Processing 00000000.tx.242: Indeed, very short applications (<1 min) of Ca2+ in the micromolar range do not lead to desensitization of [Ca2+]m responses during a second stimulation in permeabilized cells (44).2 Although the molecular nature of the mitochondrial Ca2+ uniporter has not been identified, it appears to have properties similar to those of Ca2+ channels of the plasma membrane (48). 

Phrase: "Indeed,"

Phrase: "very short applications"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0185125:applications [Health Care Activity]
   793 E C1947919:Application [Intellectual Product]
   793 E C2347934:Application [Intellectual Product]
   793 E C3539080:APPLICATION [Quantitative Concept]

Phrase: "("

Phrase: "<1 min) of Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1301862:Min 1 [Temporal Concept]
   770   C0702093:/min [Temporal Concept]

Phrase: "in the micromolar range"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1514721:Range [Quantitative Concept]
   861   C2348147:Range [Quantitative Concept]
   861   C3542016:Range [Intellectual Product]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "lead to desensitization of [Ca2+"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0178702:Desensitization [Therapeutic or Preventive Procedure]
   760   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C1709852:Desensitization [Molecular Function]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "]m responses during a second stimulation"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0871261:responses [Organism Attribute]
   719 E C1704632:Response [Finding]
   719 E C1706817:Response [Intellectual Product]
   719 E C2911692:Response [Mental Process]

Phrase: "in permeabilized cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(44"

Phrase: ").2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "Although"

Phrase: "the molecular nature of the mitochondrial Ca2+ uniporter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0349590:Nature [Idea or Concept]
   744   C1262865:Nature [Functional Concept]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ","

Phrase: "it"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "properties"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0871161:properties [Qualitative Concept]
  1000   C1292721:properties [Functional Concept]
   966 E C1882134:Property [Conceptual Entity]
   966 E C2347695:Property [Entity]

Phrase: "similar to those of Ca2+ channels of the plasma membrane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C2348205:Similar [Qualitative Concept]

Phrase: "(48"

Phrase: ")."
Processing 00000000.tx.243: It may therefore be speculated that the desensitization evoked by an increase in [Ca2+]m could involve a mechanism similar to that described for L-type Ca2+ channels (49, 50). 

Phrase: "It"

Phrase: "may"

Phrase: "therefore"

Phrase: "be"

Phrase: "speculated"

Phrase: "that"

Phrase: "the desensitization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0178702:Desensitization [Therapeutic or Preventive Procedure]
  1000   C1709852:Desensitization [Molecular Function]

Phrase: "evoked by an increase in [Ca2+"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0442805:Increase [Functional Concept]
   753   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1444748:Evoked [Qualitative Concept]

Phrase: "]m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "could"

Phrase: "involve"

Phrase: "a mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "described for L-type Ca2+ channels"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0332307:Type [Qualitative Concept]
   753   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1547052:*Type [Quantitative Concept]
   753   C1552738:described [Idea or Concept]
   719   C0439799:Channel [Spatial Concept]
   719   C1706095:Channel [Conceptual Entity]

Phrase: "(49,"

Phrase: "50"

Phrase: ")."
Processing 00000000.tx.244: Such Ca2+ channel desensitization has also been reported in insulin-secreting cells (51). 

Phrase: "Such Ca2+ channel desensitization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0178702:Desensitization [Therapeutic or Preventive Procedure]
   827   C1709852:Desensitization [Molecular Function]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "reported in insulin-secreting cells"
Meta Candidates (Total=16; Excluded=5; Pruned=0; Remaining=11)
   862   C0030281:Insulin-Secreting Cells [Cell]
           Insulin Cell
   760   C0007634:Cells [Cell]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C1327616:Secreting [Cell Function]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C3282337:Cells [Cell]
   760   C3496591:Reported [Clinical Attribute]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
   726 E C3273238:Report [Intellectual Product]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(51"

Phrase: ")."
Processing 00000000.tx.245: It is conceivable that the high frequency of the [Ca2+]c oscillations (two to five/min) observed in glucose-stimulated beta cells (12, 17, 52) serves to prevent desensitization of mitochondrial metabolism. 

Phrase: "It"

Phrase: "is"

Phrase: "conceivable"

Phrase: "that"

Phrase: "the high frequency of the [Ca2+"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0205212:High frequency [Temporal Concept]
   753   C0205250:High [Qualitative Concept]
   753   C0376249:frequency [Quantitative Concept]
   753   C0439603:Frequency [Temporal Concept]
   753   C0871396:Frequency [Quantitative Concept]
   753   C1299351:High [Qualitative Concept]
   753   C1561548:Frequency [Qualitative Concept]
   753   C1705502:Frequency [Quantitative Concept]
   753   C2700149:HIGH [Intellectual Product]

Phrase: "]c oscillations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0695434:oscillations [Therapeutic or Preventive Procedure]

Phrase: "(two to five/min)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0702093:/min [Temporal Concept]

Phrase: "observed in glucose-stimulated beta cells"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   756   C0030281:Beta cell [Cell]
   753   C0007634:Cells [Cell]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0330390:Beta [Plant]
   753   C0439096:Beta [Intellectual Product]
   753   C1441672:Observed [Functional Concept]
   753   C1948023:Stimulated [Natural Phenomenon or Process]
   753   C2004068:Beta [Qualitative Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "(12,"

Phrase: "17,"

Phrase: "52"

Phrase: ")"

Phrase: "serves"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "desensitization of mitochondrial metabolism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0178702:Desensitization [Therapeutic or Preventive Procedure]
   770   C1709852:Desensitization [Molecular Function]
Processing 00000000.tx.246: It may be important to optimize the activity of the Ca2+-sensitive dehydrogenases of the mitochondria to ensure the continuous production of metabolic coupling factors. 

Phrase: "It"

Phrase: "may"

Phrase: "be"

Phrase: "important to"

Phrase: "optimize"

Phrase: "the activity of the Ca2+-sensitive dehydrogenases of the mitochondria to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   738   C0205177:Activity [Functional Concept]
   738   C0439167:% activity [Quantitative Concept]
   738   C0441655:Activity [Activity]
   738   C1561536:*Activity [Idea or Concept]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "the continuous production of metabolic coupling factors."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   800   C0680974:factors of production [Qualitative Concept]
   748   C0033268:production [Occupational Activity]
Processing 00000000.tx.247: We show here that succinate oxidation, reflecting tricarboxylic acid cycle activity, is stimulated by extramitochondrial [Ca2+] in the physiological concentration range (500nM). 

Phrase: "We"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "here"

Phrase: "that succinate oxidation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "reflecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:Reflecting [Mental Process]

Phrase: "tricarboxylic acid cycle activity,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   756   C0008858:Tricarboxylic Acid Cycle [Molecular Function]

Phrase: "is"

Phrase: "stimulated by extramitochondrial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]"

Phrase: "in the physiological concentration range"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   827   C1514721:Range [Quantitative Concept]
   827   C2348147:Range [Quantitative Concept]
   827   C3542016:Range [Intellectual Product]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "(500nM"

Phrase: ")."
Processing 00000000.tx.248: Such an effect was previously reported for the oxidation of pyruvate and its conversion to citrate (20). 

Phrase: "Such"

Phrase: "an effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "previously"

Phrase: "reported for the oxidation of pyruvate"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   783   C1158862:pyruvate oxidation [Molecular Function]
   753   C0030011:Oxidation [Molecular Function]
   753   C0034354:pyruvate [Organic Chemical]
   753   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]
   753   C0684224:Reported [Intellectual Product]
   753   C0700287:Reported [Health Care Activity]
   753   C3496591:Reported [Clinical Attribute]
   719 E C3273238:Report [Intellectual Product]

Phrase: "and"

Phrase: "its conversion to citrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439836:Conversion [Functional Concept]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.249: The consensus model of metabolism-secretion coupling in the beta cell attributes a key role to ATP produced by the mitochondria (9, 10, 31). 

Phrase: "The consensus model of metabolism-secretion coupling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C3161035:Model [Intellectual Product]

Phrase: "in the beta cell"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0030281:Beta cell [Cell]
   861   C0007634:Cell [Cell]
   861   C0330390:Beta [Plant]
   861   C0439096:Beta [Intellectual Product]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C2004068:Beta [Qualitative Concept]

Phrase: "attributes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449234:Attribute [Idea or Concept]
  1000   C1704772:Attribute [Conceptual Entity]
  1000   C1882133:Attribute [Qualitative Concept]

Phrase: "a key role to ATP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "produced by the mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0026237:Mitochondria [Cell Component]

Phrase: "(9,"

Phrase: "10,"

Phrase: "31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.250: However, as clearly demonstrated by repeated stimulation with methyl succinate, ATP generation is not sufficient for the triggering of insulin secretion. 

Phrase: "However,"

Phrase: "as"

Phrase: "clearly"

Phrase: "demonstrated by repeated stimulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205341:Repeated [Functional Concept]
   770   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   770   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "with methyl succinate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0066765:methyl succinate [Organic Chemical]
   861   C0038617:succinate [Organic Chemical]
   861   C0220918:succinate [Organic Chemical,Pharmacologic Substance]

Phrase: "ATP generation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0079411:Generation [Temporal Concept]
   861   C3146294:Generation [Activity]
   768 E C1414672:Genesis [Gene or Genome]
   768 E C2984892:Genesis [Gene or Genome]

Phrase: "is"

Phrase: "not sufficient for the triggering of insulin secretion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205410:Sufficient [Qualitative Concept]
Processing 00000000.tx.251: Hence, in intact INS-1 cells, ATP production was preserved in the face of blunted [Ca2+]m and secretory responses during the second application of methyl succinate. 

Phrase: "Hence,"

Phrase: "in intact"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205266:Intact [Qualitative Concept]
  1000   C1554187:Intact [Idea or Concept]

Phrase: "INS-1 cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "ATP production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "was"

Phrase: "preserved in the face of blunted"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0015450:Face [Body Location or Region]
   753   C0033085:Preserved [Laboratory Procedure]
   753   C1281591:Face [Body Part, Organ, or Organ Component]
   753   C1997138:Blunted [Qualitative Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "secretory responses during the second application of methyl succinate."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   742   C0871261:responses [Organism Attribute]
   708 E C1704632:Response [Finding]
   708 E C1706817:Response [Intellectual Product]
   708 E C2911692:Response [Mental Process]
Processing 00000000.tx.252: This will result in diminished activation of the mitochondrial Ca2+-sensitive dehydrogenases (15), the stimulation of which is required for full activation of the mitochondrial metabolism. 

Phrase: "This"

Phrase: "will"

Phrase: "result in diminished activation of the mitochondrial Ca2+-sensitive dehydrogenases"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   739   C0026237:Mitochondrial [Cell Component]
   739   C0030016:Dehydrogenases [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0205216:Diminished [Quantitative Concept]
   739   C0332324:Sensitive [Functional Concept]
   739   C0521451:Mitochondrial [Functional Concept]
   739   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   739   C1274040:Result [Functional Concept]
   739   C1546471:Result [Idea or Concept]
   739   C1550474:sensitive [Idea or Concept]
   739   C1879547:Activation [Activity]
   739   C2825142:Result [Finding]

Phrase: "(15"

Phrase: ")"

Phrase: ","

Phrase: "the stimulation of which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   770   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "is"

Phrase: "required for full activation of the mitochondrial metabolism."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0025519:Metabolism [Organism Function]
   744   C0025520:metabolism [Functional Concept]
   744   C0026237:Mitochondrial [Cell Component]
   744   C0443225:Full [Qualitative Concept]
   744   C0521451:Mitochondrial [Functional Concept]
   744   C1514873:Required [Functional Concept]
   744   C1879547:Activation [Activity]
Processing 00000000.tx.253: An unidentified mitochondrial factor, distinct from ATP, has been proposed to participate in the triggering of insulin exocytosis (13). 

Phrase: "An unidentified mitochondrial factor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "distinct from ATP,"

Phrase: "has"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "participate in the triggering of insulin exocytosis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0015283:Exocytosis [Cell Function]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   714   C0032930:Trigger [Clinical Attribute]
   714   C1444748:Trigger [Qualitative Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.254: Its generation requires both a rise in [Ca2+]m and the provision of carbons to the tricarboxylic acid cycle (13). 

Phrase: "Its generation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0079411:Generation [Temporal Concept]
  1000   C3146294:Generation [Activity]
   907 E C1414672:Genesis [Gene or Genome]
   907 E C2984892:Genesis [Gene or Genome]

Phrase: "requires"

Phrase: "both a rise in [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "the provision of carbons"

Phrase: "to the tricarboxylic acid cycle"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0008858:Tricarboxylic Acid Cycle [Molecular Function]
   901   C0040887:tricarboxylic acid [Organic Chemical]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]
   827   C1511572:Cycle [Temporal Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.255: Thus, we speculate that during the desensitization of the beta cell, despite normal ATP generation, this mitochondrial factor is missing due to insufficient elevation of [Ca2+]m. 

Phrase: "Thus,"

Phrase: "we"

Phrase: "speculate"

Phrase: "that during the desensitization of the beta cell,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0030281:Beta cell [Cell]
   744   C0007634:Cell [Cell]
   744   C0178702:Desensitization [Therapeutic or Preventive Procedure]
   744   C0330390:Beta [Plant]
   744   C0439096:Beta [Intellectual Product]
   744   C1269647:Cell [Cell]
   744   C1704653:Cell [Medical Device]
   744   C1709852:Desensitization [Molecular Function]
   744   C1948049:Cell [Spatial Concept]
   744   C2004068:Beta [Qualitative Concept]

Phrase: "despite normal ATP generation,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0079411:Generation [Temporal Concept]
   827   C3146294:Generation [Activity]
   734 E C1414672:Genesis [Gene or Genome]
   734 E C2984892:Genesis [Gene or Genome]

Phrase: "this mitochondrial factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1521761:Factor [Functional Concept]
   861   C2827422:Factor [Conceptual Entity]

Phrase: "is"

Phrase: "missing due to insufficient elevation of [Ca2+"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   778   C0678226:Due to [Functional Concept]
           due
   748   C0205412:Insufficient [Qualitative Concept]
   748   C0231180:Insufficient [Qualitative Concept]
   748   C0439775:Elevation [Therapeutic or Preventive Procedure]
   748   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0702240:Elevation [Spatial Concept]
   748   C1551393:Missing [Idea or Concept]
   748   C1705492:Missing [Qualitative Concept]
   748   C3146286:Due [Idea or Concept]
   748   C3272743:MISSING [Qualitative Concept]
   714 E C2349206:Miss [Conceptual Entity]

Phrase: "]m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.256: As a consequence of deficient generation of coupling factors, insulin secretion is impaired. 

Phrase: "As a consequence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0686907:Consequence [Functional Concept]

Phrase: "of deficient generation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0079411:Generation [Temporal Concept]
   861   C3146294:Generation [Activity]
   768 E C1414672:Genesis [Gene or Genome]
   768 E C2984892:Genesis [Gene or Genome]

Phrase: "of coupling factors,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "impaired."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]
Processing 00000000.tx.257: The nature of the coupling factors of mitochondrial origin remains to be established.  

Phrase: "The nature of the coupling factors of mitochondrial origin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0349590:Nature [Idea or Concept]
   742   C1262865:Nature [Functional Concept]

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "established."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]
Processing 00000000.tx.258: ACKNOWLEDGEMENTS We thank C.

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "C."
Processing 00000000.tx.259: Bartley, G.

Phrase: "Bartley,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.260: Chaffard, and O.Dupont for expert technical assistance. 

Phrase: "Chaffard,"

Phrase: "and"

Phrase: "O.Dupont for expert technical assistance."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0331805:DuPont [Health Care Related Organization]
Processing 00000000.tx.261: We are also grateful to Dr. 

Phrase: "We"

Phrase: "are"

Phrase: "also grateful to Dr."
Processing 00000000.tx.262: M.Palmer (University of Mainz, Mainz, Germany) for providing Staphylococcus -toxin, Drs. 

Phrase: "M."

Phrase: "Palmer"

Phrase: "(University of Mainz,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Mainz,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")"

Phrase: "for providing Staphylococcus -toxin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0040548:Staphylococcus toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   827   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]

Phrase: "Drs."
Processing 00000000.tx.263: L.

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.264: Serrander and O.Nsse (University of Geneva, Geneva, Switzerland) for kind help with m measurements in attached cells, Dr. 

Phrase: "Serrander"

Phrase: "and"

Phrase: "O.Nsse"

Phrase: "(University of Geneva,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Geneva,"

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")"

Phrase: "for kind"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332307:Kind [Qualitative Concept]

Phrase: "help with m measurements"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0018896:Help [Social Behavior]
   770   C0242485:measurements [Functional Concept]
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]
   770   C1552861:help [Idea or Concept]

Phrase: "in attached cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.265: P.

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.266: Iynedjian (University of Geneva) for INS-r3-LUC7 cells, and Dr. 

Phrase: "Iynedjian"

Phrase: "(University of Geneva"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: ")"

Phrase: "for"

Phrase: "INS-r3-LUC7 cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.267: T.Pozzan (University of Padua, Padua, Italy) for helpful discussions.  

Phrase: "T.Pozzan"

Phrase: "(University of Padua,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Padua,"

Phrase: "Italy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022277:Italy [Geographic Area]

Phrase: ")"

Phrase: "for helpful discussions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0557061:discussions [Therapeutic or Preventive Procedure]
   827 E C2584313:Discussion [Social Behavior]
Processing 00000000.tx.268: FOOTNOTES * This work was supported by Swiss National Science Foundation Grants 32-32376.91and 32-49755.96and by a European Union Network grant (to C.B.W.) through the Swiss Federal Office for Education and Science.

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521721:Supported [Conceptual Entity]
   966 E C0183683:Support [Medical Device]

Phrase: "by Swiss National Science Foundation Grants 32-32376.91and 32-49755.96and"

Phrase: "by a European Union Network grant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0018173:Grant [Quantitative Concept]
   812   C1548284:Grant [Idea or Concept]

Phrase: "("

Phrase: "to C.B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "W.) through the Swiss Federal Office"

Phrase: "for Education"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0013621:Education [Educational Activity]
  1000   C0013622:education [Classification]
  1000   C0013658:Education, NOS [Finding]
  1000   C0039401:Education [Educational Activity]
   928 E C1555905:Educational [Intellectual Product]

Phrase: "and"

Phrase: "Science."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]
Processing 00000000.tx.269: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.270: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.271: Section 1734solely to indicate this fact. 

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.272: To whom correspondence should be addressed. 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.273: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.274: 41-22-702-55-48; 

Phrase: "41-22-702-55-48"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0450382:55 [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.275: Fax: 41-22-702-55-43; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "41-22-702-55-43"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0450382:55 [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.276: E-mail: claes.wollheim{at}medecine.unige.ch . The abbreviations used are: [Ca2+]m, mitochondrial Ca2+ concentration[Ca2+]c, cytosolic Ca2+ concentrationm, mitochondrial membrane potential. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "claes.wollheim{at}medecine.unige.ch ."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0558269:Ch. [Professional or Occupational Group]
   799   C1552984:[Ch] [Quantitative Concept]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]m,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "mitochondrial Ca2+ concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "cytosolic Ca2+ concentrationm,"

Phrase: "mitochondrial membrane potential."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C1720920:Membrane Potential, Mitochondrial [Cell Function]
   901   C0025251:Membrane Potential [Cell Function]
   901   C0596952:Mitochondrial membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   827   C3245505:Potential [Qualitative Concept]
   755 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.277: 2 P. 

Phrase: "2 P."
Processing 00000000.tx.278: Maechler, E.D.

Phrase: "Maechler,"

Phrase: "E.D."
Processing 00000000.tx.279: Kennedy, and C.B.

Phrase: "Kennedy,"

Phrase: "and"

Phrase: "C.B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.280: Wollheim, unpublished observations.  

Phrase: "Wollheim,"

Phrase: "unpublished observations."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]
Processing 00000000.tx.281: REFERENCES Top Abstract Introduction Procedures Results Discussion References Nesher, R., and Cerasi, E. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Procedures Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0557061:Discussion [Therapeutic or Preventive Procedure]
   799   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Nesher,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Cerasi,"

Phrase: "E."
Processing 00000000.tx.282: (1987) Endocrinology 121, 1017-1024[Abstract] Sako, Y., and Grill, V. 

Phrase: "(1987"

Phrase: ")"

Phrase: "Endocrinology 121,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: "1017-1024"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Sako,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Grill,"

Phrase: "V."
Processing 00000000.tx.283: E. 

Phrase: "E."
Processing 00000000.tx.284: (1990) Diabetes 39, 1580-1583[Abstract] Leahy, J. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Diabetes 39,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "1580-1583"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Leahy,"

Phrase: "J."
Processing 00000000.tx.285: L., Cooper, H. 

Phrase: "L., Cooper,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0335912:Cooper [Professional or Occupational Group]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.286: E., Deal, D. 

Phrase: "E.,"

Phrase: "Deal,"

Phrase: "D."
Processing 00000000.tx.287: A., and Weir, G. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Weir,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.288: C. 

Phrase: "C."
Processing 00000000.tx.289: (1986) J. 

Phrase: "(1986"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.290: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.291: Invest. 

Phrase: "Invest."
Processing 00000000.tx.292: 77, 908-915[Medline] [OrderarticleviaInfotrieve] Anello, M., Rabuazzo, A. 

Phrase: "77,"

Phrase: "908-915"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Anello,"

Phrase: "M."

Phrase: ","

Phrase: "Rabuazzo,"

Phrase: "A."
Processing 00000000.tx.293: M., Degano, C., Caltabiano, V., Patan, G., Vigneri, R., and Purrello, F. 

Phrase: "M."

Phrase: ","

Phrase: "Degano,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Caltabiano,"

Phrase: "V.,"

Phrase: "Patan,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Vigneri,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Purrello,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.294: (1996) Diabetes 45, 502-506[Abstract] Ling, Z., and Pipeleers, D. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Diabetes 45,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "502-506"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Ling,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0452995:Ling [Food]
  1000   C3486754:LING [Pharmacologic Substance]

Phrase: "Z.,"

Phrase: "and"

Phrase: "Pipeleers,"

Phrase: "D."
Processing 00000000.tx.295: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.296: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.297: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.298: Invest. 

Phrase: "Invest."
Processing 00000000.tx.299: 98, 2805-2812[Abstract/Free FullText] Boden, G., Ruiz, J., Kim, C. 

Phrase: "98,"

Phrase: "2805-2812"

Phrase: "[Abstract/Free FullText"

Phrase: "] Boden,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ruiz,"

Phrase: "J.,"

Phrase: "Kim,"

Phrase: "C."
Processing 00000000.tx.300: J., and Chen, X. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "X."
Processing 00000000.tx.301: (1996) Am. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.302: J.

Phrase: "J."
Processing 00000000.tx.303: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.304: 270, E251-E258[Abstract/Free FullText] Robertson, R. 

Phrase: "270,"

Phrase: "E251-E258"

Phrase: "[Abstract/Free FullText"

Phrase: "] Robertson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.305: P., Olson, L. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Olson,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.306: K., and Zhang, H.-J. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Zhang,"

Phrase: "H.-J."
Processing 00000000.tx.307: (1994) Diabetes 43, 1085-1089[Abstract] Jonas, J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Diabetes 43,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "1085-1089"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Jonas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1652689:Jonas [Eukaryote]

Phrase: "J."
Processing 00000000.tx.308: C., Li, G., Palmer, M., Weller, U., and Wollheim, C. 

Phrase: "C., Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Palmer,"

Phrase: "M."

Phrase: ","

Phrase: "Weller,"

Phrase: "U.,"

Phrase: "and"

Phrase: "Wollheim,"

Phrase: "C."
Processing 00000000.tx.309: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.310: (1994) Biochem. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.311: J. 

Phrase: "J."
Processing 00000000.tx.312: 301, 523-529[Medline] [OrderarticleviaInfotrieve] Newgard, C. 

Phrase: "301,"

Phrase: "523-529"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Newgard,"

Phrase: "C."
Processing 00000000.tx.313: B., and McGarry, J. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "McGarry,"

Phrase: "J."
Processing 00000000.tx.314: D. 

Phrase: "D."
Processing 00000000.tx.315: (1995) Annu. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.316: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.317: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.318: 64, 689-719[CrossRef][Medline] [OrderarticleviaInfotrieve] Matschinsky, F. 

Phrase: "64,"

Phrase: "689-719"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Matschinsky,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.319: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.320: (1996) Diabetes 45, 223-241[Abstract] Prentki, M. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Diabetes 45,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "223-241"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Prentki,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.321: (1996) Eur. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.322: J.

Phrase: "J."
Processing 00000000.tx.323: Endocrinol. 

Phrase: "Endocrinol."
Processing 00000000.tx.324: 134, 272-286[Medline] [OrderarticleviaInfotrieve] Wollheim, C. 

Phrase: "134,"

Phrase: "272-286"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Wollheim,"

Phrase: "C."
Processing 00000000.tx.325: B., Lang, J., and Regazzi, R. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Lang,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Regazzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.326: (1996) Diabetes Rev. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Diabetes Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.327: 4, 276-297 Maechler, P., Kennedy, E. 

Phrase: "4,"

Phrase: "276-297 Maechler,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Kennedy,"

Phrase: "E."
Processing 00000000.tx.328: D., Pozzan, T., and Wollheim, C. 

Phrase: "D."

Phrase: ","

Phrase: "Pozzan,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Wollheim,"

Phrase: "C."
Processing 00000000.tx.329: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.330: (1997) EMBO J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.331: 16, 3833-3841[Abstract/Free FullText] Hansford, R. 

Phrase: "16,"

Phrase: "3833-3841"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hansford,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.332: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.333: (1985) Rev. 

Phrase: "(1985"

Phrase: ")"

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.334: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.335: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.336: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.337: 102, 1-72[Medline] [OrderarticleviaInfotrieve] McCormack, J. 

Phrase: "102,"

Phrase: "1-72"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] McCormack,"

Phrase: "J."
Processing 00000000.tx.338: G., Halestrap, A. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Halestrap,"

Phrase: "A."
Processing 00000000.tx.339: P., and Denton, R. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Denton,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.340: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.341: (1990) Physiol. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Physiol."
Processing 00000000.tx.342: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.343: 70, 391-425[Free FullText] Hansford, R. 

Phrase: "70,"

Phrase: "391-425"

Phrase: "[Free FullText"

Phrase: "] Hansford,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.344: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.345: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.346: Bioenerg. 

Phrase: "Bioenerg."
Processing 00000000.tx.347: Biomembr. 

Phrase: "Biomembr."
Processing 00000000.tx.348: 26, 495-508[Medline] [OrderarticleviaInfotrieve] Pralong, W. 

Phrase: "26,"

Phrase: "495-508"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Pralong,"

Phrase: "W."
Processing 00000000.tx.349: F., Spt, A., and Wollheim, C. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Spt,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Wollheim,"

Phrase: "C."
Processing 00000000.tx.350: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.351: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.352: Biol. 

Phrase: "Biol."
Processing 00000000.tx.353: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.354: 269, 27310-27314[Abstract/Free FullText] Hajnczky, G., Robb-Gaspers, L. 

Phrase: "269,"

Phrase: "27310-27314"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hajnczky,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Robb-Gaspers,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.355: D., Seitz, M. 

Phrase: "D."

Phrase: ","

Phrase: "Seitz,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.356: B., and Thomas, A. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Thomas,"

Phrase: "A."
Processing 00000000.tx.357: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.358: (1995) Cell 82, 415-424[Medline] [OrderarticleviaInfotrieve] Rutter, G. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Cell 82,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "415-424"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Rutter,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.359: A., Burnett, P., Rizzuto, R., Brini, M., Murgia, M., Pozzan, T., Tavar, J. 

Phrase: "A.,"

Phrase: "Burnett,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Rizzuto,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Brini,"

Phrase: "M."

Phrase: ","

Phrase: "Murgia,"

Phrase: "M."

Phrase: ","

Phrase: "Pozzan,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Tavar,"

Phrase: "J."
Processing 00000000.tx.360: M., and Denton, R. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Denton,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.361: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.362: (1996) Proc. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.363: Natl. 

Phrase: "Natl."
Processing 00000000.tx.364: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.365: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.366: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.367: 93, 5489-5494[Abstract/Free FullText] Civelek, V. 

Phrase: "93,"

Phrase: "5489-5494"

Phrase: "[Abstract/Free FullText"

Phrase: "] Civelek,"

Phrase: "V."
Processing 00000000.tx.368: N., Deeney, J. 

Phrase: "N., Deeney,"

Phrase: "J."
Processing 00000000.tx.369: T., Shalosky, N. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Shalosky,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.370: J., Tornheim, K., Hansford, R. 

Phrase: "J.,"

Phrase: "Tornheim,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hansford,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.371: G., Prentki, M., and Corkey, B. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Prentki,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Corkey,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.372: E. 

Phrase: "E."
Processing 00000000.tx.373: (1996) Biochem. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.374: J. 

Phrase: "J."
Processing 00000000.tx.375: 318, 615-621[Medline] [OrderarticleviaInfotrieve] Gunter, T. 

Phrase: "318,"

Phrase: "615-621"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Gunter,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.376: E., Gunter, K. 

Phrase: "E.,"

Phrase: "Gunter,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.377: K., Sheu, S. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sheu,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.378: S., and Gavin, C. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Gavin,"

Phrase: "C."
Processing 00000000.tx.379: E. 

Phrase: "E."
Processing 00000000.tx.380: (1994) Am. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.381: J.

Phrase: "J."
Processing 00000000.tx.382: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.383: 267, C313-C339[Abstract/Free FullText] Rizzuto, R., Simpson, A. 

Phrase: "267,"

Phrase: "C313-C339"

Phrase: "[Abstract/Free FullText"

Phrase: "] Rizzuto,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Simpson,"

Phrase: "A."
Processing 00000000.tx.384: W.M., Brini, M., and Pozzan, T. 

Phrase: "W."

Phrase: "M."

Phrase: ","

Phrase: "Brini,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Pozzan,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.385: (1992) Nature 358, 325-327[CrossRef][Medline] [OrderarticleviaInfotrieve] Kennedy, E. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Nature 358,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "325-327"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kennedy,"

Phrase: "E."
Processing 00000000.tx.386: D., Rizzuto, R., Theler, J. 

Phrase: "D."

Phrase: ","

Phrase: "Rizzuto,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Theler,"

Phrase: "J."
Processing 00000000.tx.387: M., Pralong, W. 

Phrase: "M."

Phrase: ","

Phrase: "Pralong,"

Phrase: "W."
Processing 00000000.tx.388: F., Bastianutto, C., Pozzan, T., and Wollheim, C. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Bastianutto,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Pozzan,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Wollheim,"

Phrase: "C."
Processing 00000000.tx.389: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.390: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.391: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.392: Invest. 

Phrase: "Invest."
Processing 00000000.tx.393: 98, 2524-2538[Abstract/Free FullText] Tzagoloff, A. 

Phrase: "98,"

Phrase: "2524-2538"

Phrase: "[Abstract/Free FullText"

Phrase: "] Tzagoloff,"

Phrase: "A."
Processing 00000000.tx.394: (1982) Mitochondria, pp. 

Phrase: "(1982"

Phrase: ")"

Phrase: "Mitochondria,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "pp."
Processing 00000000.tx.395: 62-180, Plenum Publishing Corp., New York Magnus, G., and Keizer, J. 

Phrase: "62-180,"

Phrase: "Plenum Publishing Corp.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0683758:Corp. [Organization]

Phrase: "New York Magnus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0027976:New York [Geographic Area]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Keizer,"

Phrase: "J."
Processing 00000000.tx.396: (1997) Am. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.397: J.

Phrase: "J."
Processing 00000000.tx.398: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.399: 273, C717-C733[Abstract/Free FullText] Pralong, W. 

Phrase: "273,"

Phrase: "C717-C733"

Phrase: "[Abstract/Free FullText"

Phrase: "] Pralong,"

Phrase: "W."
Processing 00000000.tx.400: F., Bartley, C., and Wollheim, C. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Bartley,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Wollheim,"

Phrase: "C."
Processing 00000000.tx.401: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.402: (1990) EMBO J. 

Phrase: "(1990"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.403: 9, 53-60[Abstract] Nilsson, T., Schultz, V., Berggren, P.-O., Corkey, B. 

Phrase: "9,"

Phrase: "53-60"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Nilsson,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Schultz,"

Phrase: "V.,"

Phrase: "Berggren,"

Phrase: "P.-O.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Corkey,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.404: E., and Tornheim, K. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Tornheim,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.405: (1996) Biochem. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.406: J. 

Phrase: "J."
Processing 00000000.tx.407: 314, 91-94[Medline] [OrderarticleviaInfotrieve] Sener, A., Rasschaert, J., and Malaisse, W. 

Phrase: "314,"

Phrase: "91-94"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Sener,"

Phrase: "A.,"

Phrase: "Rasschaert,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Malaisse,"

Phrase: "W."
Processing 00000000.tx.408: J. 

Phrase: "J."
Processing 00000000.tx.409: (1990) Biochim. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Biochim."
Processing 00000000.tx.410: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.411: Acta 1019, 42-50[Medline] [OrderarticleviaInfotrieve] Gembal, M., Detimary, P., Gilon, P., Gao, Z. 

Phrase: "Acta 1019,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450318:1019 [Intellectual Product]

Phrase: "42-50"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Gembal,"

Phrase: "M."

Phrase: ","

Phrase: "Detimary,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Gilon,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Gao,"

Phrase: "Z."
Processing 00000000.tx.412: Y., and Henquin, J. 

Phrase: "Y.,"

Phrase: "and"

Phrase: "Henquin,"

Phrase: "J."
Processing 00000000.tx.413: C. 

Phrase: "C."
Processing 00000000.tx.414: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.415: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.416: Invest. 

Phrase: "Invest."
Processing 00000000.tx.417: 91, 871-880[Medline] [OrderarticleviaInfotrieve] Ohta, M., Nelson, D., Nelson, J., Meglasson, M. 

Phrase: "91,"

Phrase: "871-880"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ohta,"

Phrase: "M."

Phrase: ","

Phrase: "Nelson,"

Phrase: "D."

Phrase: ","

Phrase: "Nelson,"

Phrase: "J.,"

Phrase: "Meglasson,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.418: D., and Erecinska, M. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Erecinska,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.419: (1990) J. 

Phrase: "(1990"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.420: Biol. 

Phrase: "Biol."
Processing 00000000.tx.421: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.422: 265, 17525-17532[Abstract/Free FullText] Liang, Y., Bai, G., Doliba, N., Buettger, C., Wang, L., Berner, D. 

Phrase: "265,"

Phrase: "17525-17532"

Phrase: "[Abstract/Free FullText"

Phrase: "] Liang,"

Phrase: "Y.,"

Phrase: "Bai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234880:bai [Individual Behavior]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Doliba,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Buettger,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Wang,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Berner,"

Phrase: "D."
Processing 00000000.tx.423: K., and Matschinsky, F. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Matschinsky,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.424: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.425: (1996) Am. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.426: J.

Phrase: "J."
Processing 00000000.tx.427: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.428: 270, E846-E857[Abstract/Free FullText] Schuit, F., De Vos, A., Farfari, S., Moens, K., Pipeleers, D., Brun, T., and Prentki, M. 

Phrase: "270,"

Phrase: "E846-E857"

Phrase: "[Abstract/Free FullText"

Phrase: "] Schuit,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "De Vos,"

Phrase: "A.,"

Phrase: "Farfari,"

Phrase: "S."

Phrase: ","

Phrase: "Moens,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Pipeleers,"

Phrase: "D."

Phrase: ","

Phrase: "Brun,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Prentki,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.429: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.430: Biol. 

Phrase: "Biol."
Processing 00000000.tx.431: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.432: 272, 18572-18579[Abstract/Free FullText] Soejima, A., Inoue, K., Takai, D., Kaneko, M., Ishihara, H., Oka, Y., and Hayashi, J.-I. 

Phrase: "272,"

Phrase: "18572-18579"

Phrase: "[Abstract/Free FullText"

Phrase: "] Soejima,"

Phrase: "A.,"

Phrase: "Inoue,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Takai,"

Phrase: "D."

Phrase: ","

Phrase: "Kaneko,"

Phrase: "M."

Phrase: ","

Phrase: "Ishihara,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Oka,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0069389:OKA [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "Y.,"

Phrase: "and"

Phrase: "Hayashi,"

Phrase: "J.-I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.433: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.434: Biol. 

Phrase: "Biol."
Processing 00000000.tx.435: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.436: 271, 26194-26199[Abstract/Free FullText] Kennedy, E. 

Phrase: "271,"

Phrase: "26194-26199"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kennedy,"

Phrase: "E."
Processing 00000000.tx.437: D., Maechler, P., and Wollheim, C. 

Phrase: "D."

Phrase: ","

Phrase: "Maechler,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Wollheim,"

Phrase: "C."
Processing 00000000.tx.438: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.439: (1998) Diabetes 47, 374-380[Abstract] Asfari, M., Janjic, D., Meda, P., Li, G., Halban, P. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Diabetes 47,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "374-380"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Asfari,"

Phrase: "M."

Phrase: ","

Phrase: "Janjic,"

Phrase: "D."

Phrase: ","

Phrase: "Meda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1084907:Meda [Fish]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Halban,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.440: A., and Wollheim, C. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Wollheim,"

Phrase: "C."
Processing 00000000.tx.441: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.442: (1992) Endocrinology 130, 167-178[Abstract] Maechler, P., Wang, H., and Wollheim, C. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Endocrinology 130,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: "167-178"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Maechler,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Wang,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Wollheim,"

Phrase: "C."
Processing 00000000.tx.443: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.444: (1998) FEBS Lett. 

Phrase: "(1998"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.445: 422, 328-332[CrossRef][Medline] [OrderarticleviaInfotrieve] Wayner, E. 

Phrase: "422,"

Phrase: "328-332"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Wayner,"

Phrase: "E."
Processing 00000000.tx.446: A., Gil, S. 

Phrase: "A.,"

Phrase: "Gil,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412493:GIL [Gene or Genome]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.447: G., Murphy, G. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Murphy,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.448: F., Wilke, M. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Wilke,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.449: S., and Carter, W. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Carter,"

Phrase: "W."
Processing 00000000.tx.450: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.451: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.452: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.453: 121, 1141-1152[Abstract] Palmer, M., Jursch, R., Weller, U., Valeva, A., Hilgert, K., Kehoe, M., and Bhakdi, S. 

Phrase: "121,"

Phrase: "1141-1152"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Palmer,"

Phrase: "M."

Phrase: ","

Phrase: "Jursch,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Weller,"

Phrase: "U.,"

Phrase: "Valeva,"

Phrase: "A.,"

Phrase: "Hilgert,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kehoe,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Bhakdi,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.454: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.455: Biol. 

Phrase: "Biol."
Processing 00000000.tx.456: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.457: 268, 11959-11962[Abstract/Free FullText] Duchen, M. 

Phrase: "268,"

Phrase: "11959-11962"

Phrase: "[Abstract/Free FullText"

Phrase: "] Duchen,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.458: R., Smith, P. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.459: A., and Ashcroft, F. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Ashcroft,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.460: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.461: (1993) Biochem. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.462: J. 

Phrase: "J."
Processing 00000000.tx.463: 294, 35-42[Medline] [OrderarticleviaInfotrieve] Nsse, O., Serrander, L., Lew, D. 

Phrase: "294,"

Phrase: "35-42"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Nsse,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Serrander,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Lew,"

Phrase: "D."
Processing 00000000.tx.464: P., and Krause, K. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Krause,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.465: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.466: (1998) EMBO J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.467: 17, 1279-1288[Abstract/Free FullText] Sekine, N., Fasolato, C., Pralong, W. 

Phrase: "17,"

Phrase: "1279-1288"

Phrase: "[Abstract/Free FullText"

Phrase: "] Sekine,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Fasolato,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Pralong,"

Phrase: "W."
Processing 00000000.tx.468: F., Theler, J. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Theler,"

Phrase: "J."
Processing 00000000.tx.469: M., and Wollheim, C. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Wollheim,"

Phrase: "C."
Processing 00000000.tx.470: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.471: (1997) Diabetes 46, 1424-1433[Abstract] MacDonald, M. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Diabetes 46,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "1424-1433"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] MacDonald,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.472: J., and Fahien, L. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Fahien,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.473: A. 

Phrase: "A."
Processing 00000000.tx.474: (1988) Diabetes 37, 997-999[Abstract] Idahl, L. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Diabetes 37,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "997-999"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Idahl,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.475: A., and Lembert, N. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Lembert,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.476: (1995) Biochem. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.477: J. 

Phrase: "J."
Processing 00000000.tx.478: 312, 287-292[Medline] [OrderarticleviaInfotrieve] Rizzuto, R., Bastianutto, C., Brini, M., Murgia, M., and Pozzan, T. 

Phrase: "312,"

Phrase: "287-292"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Rizzuto,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Bastianutto,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Brini,"

Phrase: "M."

Phrase: ","

Phrase: "Murgia,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Pozzan,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.479: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.480: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.481: 126, 1183-1194[Abstract] Voet, D., and Voet, J.G.(1995) Biochemistry, 2nd Ed., pp. 

Phrase: "126,"

Phrase: "1183-1194"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Voet,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Voet,"

Phrase: "J.G.(1995"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "Biochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "2nd Ed.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538926:ED [Idea or Concept]

Phrase: "pp."
Processing 00000000.tx.482: 538-562, John Wiley &Sons, Inc., New York, NY Kilpatrick, E. 

Phrase: "538-562,"

Phrase: "John Wiley &Sons,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037683:Son [Family Group]

Phrase: "Inc.,"

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "NY Kilpatrick,"

Phrase: "E."
Processing 00000000.tx.483: D., and Robertson, R. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Robertson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.484: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.485: (1998) Diabetes 47, 606-611[Abstract] MacDonald, M. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Diabetes 47,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "606-611"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] MacDonald,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.486: J., and Brown, L. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.487: J. 

Phrase: "J."
Processing 00000000.tx.488: (1996) Arch. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.489: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.490: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.491: 326, 79-84[CrossRef][Medline] [OrderarticleviaInfotrieve] Litsky, M. 

Phrase: "326,"

Phrase: "79-84"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Litsky,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.492: L., and Pfeiffer, D. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Pfeiffer,"

Phrase: "D."
Processing 00000000.tx.493: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.494: (1997) Biochemistry 36, 7071-7080[CrossRef][Medline] [OrderarticleviaInfotrieve] De Leon, M., Wang, Y., Jones, L., Perez-Reyes, E., Wei, X., Soong, T. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Biochemistry 36,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "7071-7080"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] De Leon,"

Phrase: "M."

Phrase: ","

Phrase: "Wang,"

Phrase: "Y.,"

Phrase: "Jones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443013:Jones [Intellectual Product]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Perez-Reyes,"

Phrase: "E.,"

Phrase: "Wei,"

Phrase: "X.,"

Phrase: "Soong,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.495: W., Snutch, T. 

Phrase: "W., Snutch,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.496: P., and Yue, D. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Yue,"

Phrase: "D."
Processing 00000000.tx.497: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.498: (1995) Science 270, 1502-1506[Abstract] Zhou, J., Olcese, R., Qin, N., Noceti, F., Birnbaumer, L., and Stefani, E. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Science 270,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1502-1506"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Zhou,"

Phrase: "J.,"

Phrase: "Olcese,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Qin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812297:QIN [Gene or Genome]
  1000   C1705148:QIN [Gene or Genome]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Noceti,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Birnbaumer,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Stefani,"

Phrase: "E."
Processing 00000000.tx.499: (1997) Proc. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.500: Natl. 

Phrase: "Natl."
Processing 00000000.tx.501: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.502: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.503: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.504: 94, 2301-2305[Abstract/Free FullText] Satin, L. 

Phrase: "94,"

Phrase: "2301-2305"

Phrase: "[Abstract/Free FullText"

Phrase: "] Satin,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.505: S., Tavalin, S. 

Phrase: "S."

Phrase: ","

Phrase: "Tavalin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.506: J., and Smolen, P. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Smolen,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.507: D. 

Phrase: "D."
Processing 00000000.tx.508: (1994) Biophys. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Biophys."
Processing 00000000.tx.509: J. 

Phrase: "J."
Processing 00000000.tx.510: 66, 141-148[Abstract] Gilon, P., Shepherd, R. 

Phrase: "66,"

Phrase: "141-148"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Gilon,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Shepherd,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554210:Shepherd [Professional or Occupational Group]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.511: M., and Henquin, J. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Henquin,"

Phrase: "J."
Processing 00000000.tx.512: C. 

Phrase: "C."
Processing 00000000.tx.513: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.514: Biol. 

Phrase: "Biol."
Processing 00000000.tx.515: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.516: 268, 22265-22268[Abstract/Free FullText] Copyright  1998 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "268,"

Phrase: "22265-22268"

Phrase: "[Abstract/Free FullText"

Phrase: "] Copyright  1998 by The American Society"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0009993:Copyright [Intellectual Product]
   753   C0037455:society [Organization]
   753   C0596070:American [Population Group]
   753   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

